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Abstract 
Objectives: As suppression of mutans streptococci in young children may prevent or 
delay colonisation of the oral cavity, tooth brushing with dentifrices containing anti- 
Streptococcus mutans activity may aid in preventing caries. The aims of this study 
were to compare the effects of children's toothpastes, mouth rinses, oral antiseptics 
and fluoride solutions on the growth of Streptococcus mutans and non-mutans 
bacteria (Streptococcus sanguinis and Lactobacillus acidophilus).  
Methods: The agar diffusion assay at neutral pH was used to determine bacterial 
growth inhibition. Zones of bacterial inhibition were measured using a micrometer 
gauge. 
Results: Dentifrices containing 1,450 ppm fluoride produced greater growth 
inhibition of both S. mutans and S. sanguinis than those with < 500 ppm. No 
inhibition was seen for pure solutions of sodium fluoride or sodium 
monofluorophosphate at fluoride concentrations up to 10%. Stannous fluoride 
exerted anti-bacterial effects at concentrations above 1%. Significant growth 
inhibition of both S. mutans and S. sanguinis was seen with sodium lauryl sulphate 
at 0.25% and with triclosan at 0.01%. 
The mouth rinses containing 2% chlorhexidine gluconate, 0.05% cetylpyridinium 
chloride and 0.05% sodium fluoride produced anti-bacterial effects against S. 
mutans, S. sanguinis and L. acidophilus. Of the pure compounds, 0.01% 
chlorhexidine produced the greatest zone of growth inhibition against S. mutans. 
Of the combinations tested, 0.1% sodium fluoride with 5% povidone iodine produced 
synergistic anti-bacterial effects against S. mutans and S. sanguinis. The 
combination of 10% povidone iodine with 0.5% sodium hypochlorite produced 
additive anti-bacterial effects against L. acidophilus. Interference was seen in some 
combinations such as chlorhexidine with sodium lauryl sulphate, most likely through 
anion-cation reactions. However, 0.1% sodium fluoride when combined with 0.01% 
chlorhexidine did not interfere with the anti-bacterial effects of chlorhexidine alone 
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against S. mutans or S. sanguinis, but it reduced the anti-bacterial effects of cetyl 
pyridinium chloride alone against these bacteria.  
Conclusion: Sodium lauryl sulphate and triclosan are major bacterial inhibitory 
compounds in children’s dentifrices. Mouth rinses containing chlorhexidine, sodium 
fluoride and cetyl pyridinium chloride have growth inhibitory effects against 
Streptococcus mutans, Streptococcus sanguinis and Lactobacillus acidophilus. The 
combinations of povidone iodine with sodium hypochlorite and povidone iodine with 
sodium fluoride produced additive and synergistic effects respectively.  
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1. Background to thesis 
Worldwide, Early Childhood Caries (ECC) remains a difficult condition to control, with 
few practical methods for prevention. As Streptococcus mutans is one of the main 
bacteria implicated in ECC, reduction of this bacteria using anti-bacterial agents is a 
possible method of caries control. Tooth brushing is considered a common mode of 
caries prevention and is recommended to all children and adults alike in many 
countries, including Australia. A recent study by Pukallus1 has shown that brushing 
alone can reduce the risk of caries. This is likely due to the physical disturbance of 
plaque which relies on good motor control of the tooth brush to engage all areas of 
plaque accumulation. Children are still developing these motor skills so it is important 
for parents to be taught how to brush their children's teeth. As children can be 
incompliant with tooth brushing, the use of a dentifrice containing antiseptic or 
remineralising agents is recommended for added benefit over brushing alone. These 
agents are able to produce anti-bacterial effects throughout the oral cavity due to, in 
the case of a dentifrice, the foaming action and do not rely solely on the physical 
disturbance of the plaque. This study aims to compare the anti-bacterial effects of 
fluoride and antiseptic compounds which have potential for clinical use against early 
childhood caries. 
 
ECC is a chronic childhood disease resulting from a complex interaction between 
bacteria, the hosts tooth surface and carbohydrates that results in acid formation and 
enamel demineralisation.2-5 ECC is defined by the American Academy of Paediatric 
Dentistry as the presence of one or more decayed, missing or filled tooth surfaces in 
any primary tooth in a child aged 71 months or younger.2 It is of great concern due to 
the heavy burden it places on the child, family and the oral health system in place. If 
left untreated, ECC can lead to severe dental pain which is a leading symptom of 
paediatric hospital admissions attributable to a lack of primary dental care and 
financial limitations.6 In some children, ECC can result in systemic infections and 
facial cellulitis, a common presentation in paediatric hospital admissions that 
requires extended hospital stays and extensive dental treatment under a general 
anaesthetic, also accruing large costs.6  
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Numerous papers report on a reduced quality of life for the child.6-8 If left untreated, 
ECC can result in severe toothaches and breakdown of tooth structure. This directly 
affects the child’s ability to eat, speak and sleep and can result in failure to thrive and 
poor development of language skills. Teasing can occur in a social situation causing 
the child embarrassment.7 Following comprehensive dental rehabilitation, an 
increase in social interaction, smiling and attentiveness in school is generally seen 
along with improved eating, sleeping and overall growth.9-11 Also of note, it has been 
shown that childhood caries experience negatively impacts caries prevalence at age 
20.12 Hence, prevention and treatment of ECC is vital to ensure long term oral health 
for the child.  
 
Dentifrices are tooth cleaning agents which are commercially available in paste, 
powder, gel or liquid form. Essential components of common toothpastes are 
abrasives, binders, surfactants and humectants. In addition, fluoride compounds 
such as sodium fluoride (NaF), sodium monofluorophosphate (MFP) and stannous 
fluoride (SnF2) have been added to toothpaste for several decades for anti-caries 
activity.13 The main anti-caries action of fluoride in toothpaste is thought to be 
prevention of demineralisation and enhancement of remineralisation of early carious 
lesions.14 However, although fluoride is well known to be bactericidal,14 it is unclear 
whether any anti-Streptococcus mutans activity is associated with the fluoride found 
in toothpastes.  
 
In Australia, fluoridated toothpaste of concentration 500 ppm is used by children.15 At 
this low concentration, the risk of fluorosis is reduced while still exerting anti-caries 
effects.16 However, it has been shown that standard toothpaste formulations (1000 
ppm F) have greater caries preventive effects as measured by the change in 
decayed, missing, filled tooth surfaces from baseline.16 For this reason, in America 
and Europe, this higher concentration fluoride toothpaste is used by children and 
adults alike, with children requiring close supervision.17 Numerous studies have been 
performed examining the effects of various concentrations of fluoride on mutans 
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streptococci.13, 16, 18-20 However, most of these studies are clinical and compare 
commercially available toothpastes.  
 
In addition to topical fluoride, high risk children are likely to benefit from the 
additional use of anti-bacterial compounds.21 Mouth rinses are another valuable 
topical caries preventive agent, most commonly prescribed to a high caries risk 
individual or to medically or physically compromised patients whose tooth brushing 
and flossing regime is not adequate to prevent caries. Many studies have shown a 
positive reduction in caries following use of an antiseptic mouth rinse in adults.22-25 
Timely removal of S. mutans from the mouths of young children can reduce caries 
risk by preventing their colonisation in the mouth, as demonstrated in studies using 
chlorhexidine (CHX) varnish,26 CHX gel,27 and povidone iodine (PI) solution.28 
Common oral antiseptics are CHX, cetyl pyridinium chloride (CPC), PI and essential 
oils (EO). Although many of these compounds are commercially available in mouth 
rinse formulations that are unsuitable for children younger than 6 years old, the 
antiseptics can be delivered in other modes such as gels and varnishes which 
facilitate better dosage control. These antiseptics were all selected for testing in 
commercially available mouth rinse formulations without alcohol. The only exception 
was CPC which could only be purchased in an alcohol containing rinse. The pure 
antiseptic compounds were then compared in a dose response experiment to 
determine the minimum concentration at which bacterial growth inhibition occurs.  
 
CHX is a potent bisguanide that inhibits plaque formation, induces cell death and, 
similar to fluoride, comes in numerous formulations, all of which provide superior 
substantivity for long-term action at the tooth’s surface. Side effects such as staining 
and taste alteration are common so prescription is limited. Commercially available 
mouth rinse formulations come in concentrations of 0.12% and 0.2% with and 
without alcohol. Research has clinically examined toothpastes, gels and mouth 
rinses containing CHX at concentrations ranging from 0.12% to 2%.1, 29-31 No studies 
have performed an in vitro dose response examination on CHX and its growth 
inhibitory effect on cariogenic bacteria. 
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PI is not commonly used as an oral antiseptic in Australia but provides a valuable 
alternative to CHX. It is frequently used as an antiseptic in medicine and dental 
surgery and is bactericidal against mutans streptococci at low concentrations and 
short application times.32-34 In vitro dose response experimentation is needed for PI. 
 
CPC is a common oral antiseptic with bactericidal tendencies. It has an inherently 
strong ability to adhere to oral surfaces and bacterial cell walls, though with limited 
substantivity.35-37 Similar to CHX, CPC can cause extrinsic tooth staining.38 Many 
clinical studies contest to its ability to reduce plaque bacterial levels, however, 
laboratory based studies are lacking.25, 35, 37  
 
EO are found in the formulation known as Listerine. Many studies have been 
performed on Listerine producing mixed results regarding its ability to reduce plaque 
bacterial counts.22, 39-42 However, examination in vitro of its specific growth inhibitory 
effects is lacking. 
 
For safety, low concentrations of antiseptics that can be effectively combined with 
fluoride compounds would be ideal for paediatric use. The advantages of 
combinations with synergistic or additive effects are the enhancement of anti-caries 
and anti-plaque activities of low concentrations of the individual compounds, and the 
reduction of risks and side effects. Thus far, it is more common to prescribe children 
at high caries risk two separate products, such as a separate fluoride toothpaste and 
mouth rinse or additional in-office topical application of another agent such as CHX. 
This enables control of the concentration and quantity of product applied. However, 
minimal evidence exists for other combinations of CPC, PI, CHX or sodium 
hypochlorite (NaOCl). These compounds, along with NaF, were hence tested in all 
combinations. Additionally, we found SLS to have growth inhibitory effects against S. 
mutans so this was also included as a test compound. 
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The first stage of this research was to conduct a thorough review of the literature. 
This established what knowledge was already available on the role of topical 
chemotherapeutic agents on caries incidence and risk, as outlined above. Gaps in 
the research surrounding these chemotherapeutic agents were identified, some of 
which are hoped to be examined further through this research. One such area 
requiring further research is the growth inhibitory effects of various concentrations of 
antiseptic agents on cariogenic and non-cariogenic bacteria. Many studies have 
been performed on the in vivo effects of various concentrations of toothpastes or 
mouth rinses already on the market as detailed below in the literature review. 
However, the dose response relationship of the active components on bacterial 
growth inhibition has not been tested. This research plans to analyse these agents 
using validated agar diffusion techniques in order to determine the bacterial growth 
inhibitory effects of individual antiseptic and fluoride compounds. 
 
The method chosen to examine these antiseptic agents was the agar diffusion 
assay. This method is well established and there is much data supporting its use in 
testing bacterial growth inhibition by antibiotics.43-45 Following experimentation to 
establish the techniques and conditions to achieve optimal results, protocol was 
established to enable the testing of both pastes and solutions.  
 
The bacteria chosen to test were S. mutans, Streptococcus sanguinis and 
Lactobacillus acidophilus. S. mutans is commonly isolated from the mouths of 
children with caries and it has been shown that children who develop caries at a 
younger age are colonised with S. mutans at a younger age with higher bacterial 
counts.46-48 Lactobacillus (LB) is involved in the progression of carious lesions.46 
Both S. mutans and LB are acidogenic and aciduric and are commonly isolated from 
carious lesions and plaque in high caries risk individuals.46 L. acidophilus was 
selected as a representative of the LB group due to ease of purchase. S. sanguinis, 
by comparison, is not associated with caries.49 In fact, much evidence exists for its 
antagonistic effect with S. mutans whereby if one bacteria is present, the other is 
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usually absent or low in numbers.50-52 Thus, S. sanguinis was selected for a non-
cariogenic bacterial comparison. 
 
This thesis begins with a critical review of the literature on the anti-caries and anti-
bacterial effects of toothpastes and antiseptics. This is followed by Chapter Three 
which is a scientific paper exploring the effects of commercially available toothpastes 
and their constituents on the growth of oral bacteria using the agar diffusion assay. 
Chapter Four is a scientific paper reporting on the growth inhibitory effects of mouth 
rinses and their constituents on oral bacteria. Chapter Five presents the final 
scientific paper that discusses the effects of combinations of antiseptic compounds 
and sodium fluoride on oral bacteria. This thesis ends with Chapter Six which 
contains a general discussion of the research findings, conclusions of the thesis and 
recommendations for future research. 
 
2. Aims and hypotheses  
The aims of the present thesis are: 
(1) To compare the anti-bacterial activity of therapeutic agents which have 
potential for clinical use against S. mutans and non-mutans bacteria (S. 
sanguinis and L. acidophilus). The agents to be tested include: 
(i) Oral antiseptics: chlorhexidine, povidone iodine, cetyl pyridinium 
chloride, sodium hypochlorite and essential oils; 
(ii) Remineralising agents: fluoride compounds, eg sodium fluoride, 
sodium monofluorophosphate and stannous fluoride; 
(2) To investigate combinations of therapeutic agents to determine 
possible interactions of the agents, e.g. synergistic activity against S. mutans 
and non-mutans bacteria (S. sanguinis and L. acidophilus) 
The aims are based on the following hypotheses: 
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(1) Some oral therapeutic agents have greater anti-bacterial activity 
against S. mutans compared to non-mutans bacteria such as lactobacilli and 
S. sanguinis 
(2) Bactericidal agents such as chlorhexidine and povidone iodine have 
greater activity against S. mutans compared to remineralising agents 
including fluoride compounds 
(3) Bactericidal mouthwashes containing chlorhexidine and povidone 
iodine have greater activity against S. mutans compared to remineralising 
mouthwashes containing sodium fluoride 
(4) Certain combinations of bactericidal and remineralising agents have 
synergistic activity against S. mutans 
 
3. Significance of aims 
It is hoped that the results from this study will provide a deeper understanding into 
the relationship between these oral therapeutic agents and oral bacterial growth 
inhibition. It is desirable to use a product with high efficacy so that maximal anti-
caries effects are achieved at low concentrations. The minimum bacterial growth 
inhibitory concentrations of the agents identified in this study will aid in the 
formulation of effective agents at concentrations safe for children that can be 
delivered in toothpastes, mouth rinses and gels. Furthermore, the results will give 
insight into which product has the greatest growth inhibitory effects and may be 
suitable for use in children. Determination of the effects of these agents on both 
cariogenic and non-cariogenic bacteria will aid in the understanding and design of 
products that act specifically on cariogenic bacteria without altering the relative 
proportions of the normal flora.  
 
4. Early Childhood Caries  
ECC is a chronic childhood disease that affects the child’s well being and quality of 
life.3-5, 53 ECC is defined by the American Academy of Paediatric Dentistry as the 
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presence of one or more decayed (noncavitated or cavitated lesions), missing (due 
to caries) or filled tooth surfaces in any primary tooth in a child aged 71 months or 
younger.2 It has a high prevalence despite being both preventable and reversible.4 
ECC is of great concern due to its rapidly progressing nature and the fact that the 
child becomes infected with cariogenic bacteria early in the teeth eruption schedule.4, 
54-56 
 
Caries is a disease process that occurs when cariogenic bacteria such as mutans 
streptococci (MS), namely S. mutans and Streptococcus sobrinus, and lactobacilli 
metabolise fermentable carbohydrates.5 This fermentation process produces acid 
end products that demineralise the carbonated hydroxyapatite crystals within 
enamel.4, 5 Remineralisation naturally occurs when the acids are buffered by salivary 
enzymes and calcium and phosphate ions re-enter the enamel. Caries arises when 
the demineralisation-remineralisation equilibrium is unbalanced.4 Clinically, ECC 
initially presents with white spots on the maxillary incisors which can swiftly break 
down into yellow-brown cavities.57  
 
The deciduous dentition has inherent morphological differences to the permanent 
dentition such as being less mineralised and having a greater diffusion coefficient.58, 
59 Deciduous enamel is also half as thick as permanent enamel with narrower 
enamel prisms.60 Studies have shown a higher susceptibility of the deciduous 
dentition to tooth wear which has been attributed to the reduced thickness of the 
enamel rather than to its greater solubility in acid.61 As a result of these factors, 
caries progresses quicker through deciduous enamel.62, 63  
 
It has been shown by Isaksson12 that childhood caries experience has an impact on 
caries prevalence at age 20 with greater number of carious teeth from ages 3 to 15, 
resulting in greater number of carious and restored teeth in 20 year olds. Similarly, 
those with carious lesions in early childhood but are caries-free at age 15, had low 
caries prevalence at age 20. This is further corroborated by a study by Kohler64 that 
showed that children colonised with MS at a young age, had higher salivary MS 
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levels at 19 years of age and a higher caries experience in terms of decayed and 
filled surfaces. Those who were non-colonised with MS at a young age were able to 
remain negative for MS into adulthood. These studies show that controlling caries 
during childhood can result in reduced caries experience in adulthood.  
 
As such, early preventive dental visits are recommended to ensure early diagnosis 
and control of risk factors. A systematic review by Bhaskar65 found early preventive 
dental visits before the age of 3 to be beneficial for high risk children or those already 
with ECC. However, there was no evidence for the first visit occurring prior to 1 year 
of age, despite the assumption that the earlier risk factors are identified, the reduced 
the caries experience and related restorative expenditures. Following identification of 
risk factors, primary prevention of caries is necessary through measures such as use 
of a fluoridated toothpaste, topical application of fluoride or an antiseptic such as PI, 
fissure sealants on six year old molars and regular dental visits.66  
4.1 Caries outcomes 
Dental caries adversely affects the quality of life of a child and their family. The 
greatest impact is due to dental pain. This can worsen sleep patterns, the child’s 
ability to eat, ability to learn and overall emotional happiness.9, 67 A broken down 
dentition can also lead to teasing in a social situation and embarrassment for the 
child.68, 69  
 
Dental pain is a leading paediatric hospital admission symptom attributable to lack of 
primary dental care and financial limitations.6, 70 Facial cellulitis is a common 
presentation in many of these cases requiring extended hospital stays and extensive 
dental treatment under a general anaesthetic, accruing large costs.6 This places 
huge economic burden on the tax payers and hospitals in the public health system. 
By comparison, families through the private health system are left with this hefty bill. 
Also of concern are the waiting lists for treatment within the public health system. 
The opportunity to have treatment under a general anaesthetic is not common and 
the family may be left to manage the child's pain for many months until it is their turn 
for treatment.  
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Parents generally report negative impacts on physical, mental and social functioning 
with improvement following dental treatment.8, 68, 71 Physically, children with ECC are 
more likely to suffer malnourishment problems such as low body weight, poor height 
and iron deficiency.9, 72, 73 Acs and colleagues identified a link between dental caries 
and failure to thrive in children from low-income families.10, 11 A review of the 
literature by Schroth et al9 also identified speech difficulties either related to speaking 
or learning to speak as a poor outcome of ECC resulting from premature loss of 
primary maxillary incisors. However, there is conflicting evidence for these findings 
as some children adapt very easily. In terms of education, dental pain causes a 
distraction from learning, poor school performance and commonly results in lack of 
school attendance whether due to staying home or missing class to see the school 
nurse.6, 74, 75 This reduces their socialising time, also delaying their social progress.  
 
Treatment for ECC has been shown to improve many of these adverse quality of life 
factors. Post-treatment, an increase in social interaction, smiling and attentiveness in 
school is generally seen.9 Acs et al10 showed comprehensive dental rehabilitation 
resulted in improved ability to eat and sleep and overall improved health leading to 
catch-up growth to a healthy weight comparable to their age group. However, it must 
be remembered that severe cases requiring tooth extractions can result in further 
hindrances to socialisation such as poor appearance, low self-esteem and shyness.  
4.2 Caries risk factors  
Caries is a multi-factorial disease involving four major factors: bacteria, fermentable 
carbohydrates, susceptible host and time.76-79 It is exacerbated by dietary factors 
such as bottle use and high frequency and long duration of sugar intake. Prolonged 
bottle feeding especially around bedtime, poor oral hygiene, drinking non-fluoridated 
water, large family size and low family income all contribute to the high prevalence of 
ECC.2, 76, 77, 80, 81 Children with environmental exposure to tobacco smoke during 
pregnancy and the first year of life also have an increased caries severity.82  
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Undernourished children have increased risk of caries83 while low birth weight is not 
considered a risk factor despite the fact that these children tend to be exposed to 
more risk factors such as poor oral hygiene and increased sugar intake.84 The 
relationship between malnourishment and caries risk has been related to low vitamin 
D, calcium and albumin levels.85 A further study by Schroth and coworkers86 found 
low maternal prenatal levels of Vitamin D impacted the calcium level of the primary 
dentition and lead to increased rates of ECC.   
 
MS colonies have been isolated from the oral mucosa of pre-dentate infants most 
likely through maternal transmission.4, 5 Wan and coworkers54 examined risk factors 
that lead to MS colonisation in six-month old predentate infants. They found the 
leading factors in caries development to be frequency of sugar intake, breast-
feeding, saliva transfer habits and the overall degree of human interaction the child 
experiences.54 These findings have been substantiated by other studies.4, 47, 87 
Maternal factors included high S. mutans levels, poor oral hygiene, high snacking 
frequency and low socio-economic status.54 High salivary MS levels in mothers are 
associated with higher MS levels and caries incidence in their children.88 This is 
further substantiated in a study by Gripp and Schlagenhauf89 that showed that 
suppressing MS counts in mothers through professional tooth cleaning and CHX 
varnish application resulted in significantly lower numbers of MS-colonised infants at 
2 years of age. Similarly, Robertson and coworkers90 showed that CHX varnish 
application in mothers, resulted in reduced severity of caries although not the 
prevalence of caries. Another known risk factor is malnutrition of the child which can 
delay tooth eruption and alter the composition of primary teeth and bone, resulting in 
weakened tooth structure.78  
 
Enamel developmental defects are another predisposing factor for ECC. Enamel 
defects occur when there is a disturbance to the apposition and mineralisation of 
enamel during formation. Numerous studies have shown that the presence of 
enamel defects, such as enamel hypoplasia and opacities, to place a child at 
increased risk of ECC.91-93 It must be noted that there is complexity surrounding the 
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study of young children due to the variable number of teeth present, the growing 
presence of MS and changes in diet.94 
 
Saliva plays a vital role in the clearance and inactivation of cariogenic bacteria in the 
oral cavity as well as providing protection for tooth structure. Saliva contains 
antimicrobial components such as agglutinins which promote agglutination of S. 
mutans and clearance from the oral cavity.95 Adhesion of S. mutans to tooth 
structure is reduced by the action of salivary proteases which break down surface 
protein antigens.95 MS are regulated by immunological factors such as salivary IgA 
and IgG which inhibit adhesion and pathogenesis of S. mutans.95 These 
immunological factors are regulated by HLA genes. Saliva also contains numerous 
ions including protein, sodium, chloride and bicarbonate, all of which increase with 
increased stimulation, for example, from chewing gum.96 Bicarbonate diffuses into 
plaque where it neutralises acids to increase pH, thus promoting remineralisation.4, 96 
For remineralisation to occur, there are 5 key chemical components required.97 
These include a sufficiently high salivary pH value, sufficiently high salivary calcium 
and phosphate levels, the presence of salivary peptides that govern nucleation of 
hydroxyapatite crystals and the presence of the required organic and inorganic 
matrix (the mineral-deficient enamel or dentin). 
 
Compromised salivary production, either in quantity or quality, increases the risk of 
caries. This occurs on a nightly basis when, during sleep, saliva production is greatly 
reduced and swallowing does not occur preventing clearance from the oral cavity.98 
As such, it is vital to clean the teeth prior to bed to reduce caries risk. It may be of 
benefit to use an anti-cariogenic product overnight for prolonged effect.  
Tooth brushing is effective at reducing caries and periodontal disease.99 It should 
first be introduced upon the eruption of the first deciduous tooth and should be 
continued by the parent and then under close supervision throughout childhood. The 
early establishment of this practice leads to good oral hygiene behaviour throughout 
life. School tooth brushing programs are common and studies have shown that 
supervised tooth brushing at school with a fluoridated toothpaste results in a lower 
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caries incidence in high-caries risk children.99-101 However, these programs are often 
only implemented for short periods when funding and timing allows so a thorough 
tooth brushing regime needs implementation at home by the parents. 
4.3 Ecological plaque hypothesis 
The ecological plaque hypothesis is one of numerous theories suggested for the 
aetiology of dental caries.80 This theory proposes that there are many different 
bacterial species present in plaque and that changes in the oral environment lead to 
a shift in the balance of resident oral microflora.80 By comparison, the specific plaque 
hypothesis suggests that only a few bacterial species are responsible for the caries 
disease process, including MS.80 3-5, 57, 80, 102, 103 There is increasing recognition that 
S. mutans is one of the most important cariogenic bacteria, and acceptance of the 
concept that reducing its levels will likely lead to a reduction in caries risk.104 In 
addition, timely removal of S. mutans from the mouths of young children can also 
lower caries risk by preventing their colonisation of the mouth.27 MS colonies have 
been isolated from the oral cavity immediately after birth but increase in numbers 
with age55, 81, 103 with a high prevalence in children with a high caries risk.95 However, 
it is the intricate relationship between the microbial composition and diffusion 
properties of plaque rather than the extent of plaque that leads to caries.80 These 
factors vary greatly among individuals, sites, and between the primary and 
secondary dentition and are influenced by disease.80, 105   
 
It is well documented that the early presence of MS is a risk factor for ECC however 
it is simply a marker of a cariogenic environment and not a causal factor.3, 30, 103 MS 
grow within the plaque biofilm which provides resistance against antibiotic treatment 
and the host immune system by creating impenetrable microenvironments.106, 107 
Within these microenvironments, some species are able to thrive while others 
diminish. For example, MS and lactobacilli act in a positive feedback mechanism 
supporting the growth of both species.80 Biofilms containing MS are also part of a 
positive feedback loop where MS produce competence-stimulating peptides (CSP) 
that favour cellular accumulation and biofilm formation and these cells, in turn, 
upregulate CSP production.108 A resultant increase in the overall numbers and 
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activity of these and other gram-positive bacteria gives rise to carious lesions.106  
 
5. Cariogenic bacteria 
5.1 Mutans streptococci (MS) 
Caries development has long been documented as the end result of complex 
interactions between indigenous bacteria.109 Teeth become colonized by many 
commensal bacterial species that alter the environment to one optimal for their 
survival and at equilibrium with host defences.78 The first oral microbes to colonize 
the oral cavities of newborn infants are Streptococcus salivarius, Streptococcus mitis 
and Streptococcus oralis.95 Two studies have isolated MS and Lactobacillus from the 
mouths of predentate children with increasing numbers of bacteria with age.54, 56, 110 
Following eruption of the primary dentition, the bacterial profile becomes more 
complex,95 however, work by Gizani and coworkers111 has shown that the 
streptococcal species colonise soft-tissues at a greater rate than teeth.  
 
MS show a high prevalence in children with a high caries risk.95, 109, 112 van Ruyven 
and coworkers79 determined that as caries status worsened, levels of MS in plaque 
increased as did numerous other non-mutans streptococci species. S. mutans is 
thought to be associated with the initiation of the disease while S. sobrinus is 
associated with progression95 since the establishment of S. mutans supports the 
adherence of S. sobrinus.46 However caries experience is higher in children and 
sites where both bacterial species have been identified.95, 109, 113 S. mutans is more 
prevalent than S. sobrinus, however, S. sobrinus has a stronger association with 
caries incidence.114-116 For both streptococcal species, caries-free status can be 
associated with presence of these bacteria.114, 116, 117 Similarly, caries can occur in 
the absence of these bacteria.114, 116, 117 This can be explained by the complex 
interaction between the heterogeneous microflora, pH, fermentable carbohydrate 
and tooth factors that result in caries.114 It has been shown that children who develop 
caries are colonised by MS at younger ages and have higher MS counts.48  
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Corby and coworkers106 compared the bacteria present in the oral cavity in health 
and disease and found MS, Lactobacillus and Actinomyces to be abundant in 
disease.47 Thus far, no causal relationship has been proven, however, MS has been 
found to be present in both plaque and saliva in patients with a high caries risk and 
has a strong, well-documented association to both the onset and development of the 
caries disease process.46, 47, 106, 118, 119  
 
Through the use of denaturing gradient gel electrophoresis, Li and coworkers120 
identified the composition of the microbial plaque community in children with ECC 
and those that were caries-free. They discovered that plaque in children with ECC 
has increased numbers of acidogenic and aciduric bacteria but that there is 
decreased diversity in species. Throughout the caries disease process, different 
species dominate from initiation through to deep lesion development. Early 
colonisation with MS is likely to result in their persistence as they have less 
competition for nutrients and colonisation sites.95 
5.2 Streptococcus mutans 
S. mutans is one of the key bacterial species implicated in ECC.104 Clinical studies 
have provided evidence that children who develop caries are colonised by S. mutans 
at younger ages and have higher S. mutans counts compared to caries-free 
children.48 Furthermore, timely removal of S. mutans from the mouths of young 
children can reduce caries risk by preventing their colonisation in the mouth, as 
demonstrated in studies using CHX varnish,26 CHX gel,27 and PI solution.28  
 
S. mutans are gram-positive, facultative anaerobes and are non-motile and catalase-
negative.78, 95 Adherence is one of S. mutans many virulence factors. S. mutans 
synthesise extracellular polysaccharides in the presence of fermentable 
carbohydrates which enable adherence to the tooth surface.46, 47, 95, 121 It involves two 
stages; initial binding to the acquired salivary pellicle and subsequent sucrose-
dependent cellular accumulation.95 Initially, colonisation is mediated by adhesins 
produced by S. mutans.95 Later, glucosyltransferases produce extracellular 
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polysaccharides known as glucans.95, 114, 121 Glucan binding proteins (GBP) enable 
strong binding of the bacteria to glucan deposits on the tooth surface resulting in 
increased plaque thickness, sugar diffusion rates, acid production and thus, 
cariogenicity.95, 121 Mattos-Graner and coworkers121 found a strong relationship 
between water insoluble glucan synthesis and caries activity in their analysis of 20 
MS isolates from 12 to 30 month old children.  
 
S. mutans also synthesise intracellular polysaccharides which are stored and 
metabolised when dietary carbohydrate resources are low.47, 95 The outcome is 
continual acid production especially evident overnight when salivary secretions and 
sugar consumption are low.  
 
Acidogenicity and acidurance allow S. mutans to survive at low pH levels.46, 47, 95, 119, 
121 It is this property that allows them to become the dominant species while less 
aciduric species are eliminated. They produce acids that reduce the pH to below 
enamel’s critical pH of 5.5 leading to demineralisation, making them a highly 
cariogenic bacteria.46, 47, 118, 119 S. mutans acidogenicity and acidurance is superior to 
other plaque microbiota with a terminal pH of approximately 4.79 S. mutans also has 
the ability to produce antibiotics, namely mutacins, which inhibit the growth of less 
caries-inductive strains by inhibiting enzyme functions and the generation of 
adenosine triphosphate, a key energy source.78  
5.3 Lactobacillus 
Lactobacillus (LB) is another aciduric and acidogenic, gram-positive microbe that is 
selected for in low pH environments and, hence, associated with caries 
progression.114, 122-124 They coaggregate with S. mutans and act as the secondary 
invader rather than initiator.123 They consistently produce a terminal pH of 4.2, 
similar to S. mutans.114 LB are colonisers of mucosal surfaces, especially the dorsum 
of the tongue, so are present in the oral cavity from an early age, prior to tooth 
eruption.46, 123 Colonisation with LB and MS begins at age 6-12months so this is a 
key time period when prevention should be started.125 Colonisation with LB has been 
associated with poor tooth brushing cooperation, unrestored maternal cavitation and 
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problematic pregnancy.125 Their presence in saliva occurs due to sloughing of 
epithelium from the tongue and carious lesions.46 They are usually found in lower 
numbers than S. mutans and are most prevalent in large caries lesions which extend 
into dentine.123, 124 Acid tolerance and acid production are two significant pathogenic 
properties of LB.123 However, there is still some uncertainty surrounding the specific 
mechanisms of these properties.123  
5.4 Other cariogenic species 
Other bacterial species that are currently under scrutiny regarding their cariogenic 
potential include Scardovia wiggsiae, S. salivarius and S. mitis.117, 126 Tanner and 
coworkers117 has recently identified S. mutans and S. Wiggsiae as the most 
frequently caries-associated species in children. Their work found 80% of the 
children with both these species had ECC while 80% of the children with neither 
were caries-free. They also isolated S. wiggsiae from caries sites independent of S. 
mutans indicating that S. mutans may not be necessary for caries initiation and 
progression.  
5.5 Streptococcus sanguinis 
S. sanguinis is generally considered non-cariogenic49, 51, 127, 128 despite sharing 
structural properties and virulence factors with S. mutans.128-130 These virulence 
factors include attachment to tooth structure through glucan synthesis and 
production of acids.128, 129 Adherence to smooth surfaces, however, is far weaker by 
S. sanguinis than S. mutans due to inferior glucan synthesis and the requirement for 
specific conditions for sucrose-dependent adherence.131 
 
Westergren and Emilson49 infected hamsters with S. sanguinis and S. mutans and 
found, with similar levels of infection, S. sanguinis did not produce caries while S. 
mutans resulted in deep carious lesions. It has been shown that various strains of S. 
sanguinis produce less fissure plaque than S. mutans with a reduced extracellular 
matrix surrounding cells.127  
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A longitudinal study by Caufield and coworkers50 examined the transmission and 
acquisition of S. sanguinis in mother-child pairs. They found a discrete window of 
infectivity at 9 months old with increasing proportions of salivary S. sanguinis with 
further tooth eruption. Antagonism between S. sanguinis and S. mutans was noted 
as early colonization of S. sanguinis delayed colonization of S. mutans. Similarly, 
following colonization with S. mutans, S. sanguinis levels decreased. This finding is 
supported by previous studies that concluded that an increase in the S. mutans to S. 
sanguinis ratio increases the risk of caries.51, 52 
 
6. Fluoride 
There is increasing evidence that good oral hygiene and plaque control is associated 
with reduced risk for ECC.87, 132 As most children brush their teeth with toothpaste, it 
is well accepted that caries prevention from tooth brushing results from the fluoride 
present in the toothpaste. The role of a good antimicrobial agent is to prevent 
attachment of bacteria to biofilms and to reduce bacterial proliferation and 
pathogenicity.133 Fluoride compounds have been widely studied but it is only since 
the 1950’s that dentifrices containing fluoride have been formulated with therapeutic 
benefit.13 For an efficacious dentifrice to be formulated, it is vital that the abrasive 
system is compatible with the free fluoride ion to produce a bioavailable source of 
fluoride.13 Stephen13 performed a meta-analysis on numerous fluoride compounds 
and determined that NaF in mouth rinse formulations brings about the greatest 
reduction in number of decayed, missing or filled tooth surfaces (DMFS) when 
compared to SnF2, MFP, amine fluoride (AmF) and acid phosphate fluoride (APF). 
He also stated that there is a strong dose dependent relationship between fluoride 
use and caries reduction.13 Similarly, fluoride has shown a consistent benefit in 
reducing the progression and incidence of non-cavitated carious lesions.134, 135 
 
Primary teeth have a thinner enamel layer, a lower mineral content (including 
calcium) and higher organic content like that of dentine which makes them more 
susceptible to cariogenic bacteria compared to permanent teeth.136, 137 Newly 
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erupted permanent teeth are also highly susceptible to caries due to their immature 
enamel.27, 138 Remineralisation is best promoted by extended availability of fluoride at 
the tooth surface rather than with higher fluoride dosage.136 It is also dependent on 
the bioavailability of the fluoride, the adherence of the compound to the tooth surface 
and the solubility of the compound.136  
 
Commonly in high risk individuals, a combination of preventive products is 
prescribed and show benefits for combating caries. For example, use of a fluoride 
mouth rinse as an adjunct to regular twice daily use of fluoride toothpaste is a 
common suggestion to older children of high caries risk. A meta-analysis of 34 
studies relating to fluoride mouth rinses has shown a clear reduction in caries in 
terms of decayed, missing and filled tooth surfaces in response to use of a fluoride 
mouth rinse and toothpaste.139 This is supported by a study by Kaneko and 
coworkers140 that found a reduction in MS levels and overall caries experience in 
schoolchildren following the long-term use of a fluoride mouth rinse. The long-term 
use of a fluoride mouth rinse has also been shown to have greater action at reducing 
levels of MS than lactobacilli.141  
6.1 Fluoride mode of action 
Fluoride has numerous modes of action both at a mineral and bacterial level. 
Fluoride penetrates the tooth structure through the formation of fluorapatite and 
fluorhydroxyapatite crystals during the remineralisation process.14, 138, 142 These 
crystals provide both anti-caries properties by being more acid resistant and anti-
bacterial properties by inhibiting bacterial metabolism within the biofilm.14, 138 The 
critical pH for dissolution of tooth structure is 5.5.14 In the presence of fluoride, this 
value is decreased to approximately 4.4 which allows for prolonged ion exchange at 
the tooth’s surface before demineralisation takes place.14 Fluoride also enhances 
calcium and phosphate ion precipitation within the lesion which obstructs further 
damage by acid penetration and diffusion into the enamel.14, 138 Simultaneously, 
calcium fluoride is deposited on the tooth surface and serves as a fluoride 
reservoir.143 During remineralisation, part of the calcium fluoride can be redeposited 
as fluorapatite.143 These mechanisms aid in maintaining a balance between 
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demineralisation and remineralisation, favouring remineralisation and preventing 
caries.  
 
The greatest anti-caries effects are seen when fluoride is maintained within plaque 
rather than within the tooth itself, where it can exert direct anti-bacterial effects.142 
Fluoride within plaque fluid also has greater remineralisation capacity than that in 
saliva resulting in reduced enamel solubility.16, 144 Lynch and coworkers144 
determined that at low pH which usually supports demineralisation, fluoride within 
plaque can promote remineralisation of the superficial enamel. Secondary 
demineralisation occurred in the deep areas of lesions while insoluble fluoridated 
mineral formed within the body and superficial layer. These two steps occur 
concurrently in the process known as lamination. The deep demineralisation that 
occurred may be the result of this structure being more soluble than the previously 
remineralised body of the lesion and also due to the inability for fluoride to reach this 
depth.  
 
Fluoride is a strong anti-bacterial agent that can both directly kill bacteria and inhibit 
metabolic pathways.14 Fluoride is deposited near the surface of plaque where 
cariogenic bacteria are most metabolically active.142 Through the binding of 
electronegative fluoride to positively charged enzymes, fluoride can inhibit their 
functions and modulate bacterial metabolism.14 For example, fluoride inactivates the 
glycolytic enzyme enolase which in turn directly blocks peroxidises.142, 145-147 This 
process is enhanced by the presence of magnesium and phosphate and results in 
inhibition of glycolysis. The divalent cations magnesium and calcium have been 
shown to increase fluoride binding to bacterial cells both in vitro148, 149 and in vivo.150 
Clinically, this was evident through an increased fluoride concentrations in plaque 
and inhibition of bacterial acid production. This is further corroborated by Takahashi 
and Washio,151 who showed inhibition of lactate production and a decrease in 
phosphoenolpyruvate following fluoride use in vivo and by Hannig and coworkers,152 
who showed inhibition of initial biofilm formation on dental hard tissues, especially to 
dentin. Fluoride can also bind to heme-based catalase such as peroxidase thus 
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inhibiting its actions directly.142, 145 This can compromise the bacteria's ability to cope 
with oxidative damage from hydrogen peroxide in acid environments.142 Another 
mode of action is the formation of metal-fluoride complexes impeding the action of 
proton-translocating F-ATPases, thus preventing ATP synthesis, a key energy 
source.142, 145 The most efficacious metabolic regulators are metal complexes 
between fluoride and aluminium or beryllium.142 As a weak acid, fluoride enhances 
membrane permeability to protons thus provoking cytoplasmic acidification and 
reduced glycolytic enzyme action.142, 145 It is most effective at arresting glycolysis 
and thus reducing acidification with lactic acid in intact cells exposed to acidic 
environments.14, 145  
6.2 Fluoride formulations and compounds  
Fluoride is readily available in numerous formulations and as one of several 
compounds. So far, NaF has dominated the market in Australia as the anti-bacterial 
agent of choice in toothpastes, available in both children's low strength fluoride 
toothpastes as well as adult strength and high dose fluoride pastes. MFP also 
appears in children's toothpastes while SnF2 is a desensitizing agent found in some 
adult strength toothpastes. There are other fluoride compounds utilised in dental 
products such as AmF and APF, however these are less common. In high risk 
individuals, a combination of preventive products is prescribed and show benefits for 
combating caries. For example, fluoride is also available in mouth rinse, varnish and 
gel formulations recommended for use additional to brushing twice daily with a 
fluoride toothpaste.  
 
Water fluoridation is a public health caries preventive measure in action in Australia. 
Reduction in caries in communities with fluoridated water has been reported as 
between 15 to 60 percent depending on dentition, population and use of preventive 
agents.153 However, there is considerable discussion regarding the benefits of 
community water fluoridation as most populations in the developed world have 
regular fluoride exposure. Communities with water fluoridation have experienced 
caries reducing benefits both topically and systemically, pre- and post-eruptively in 
permanent and primary teeth.19, 153, 154 Fluoride's pre-eruptive effect on caries in 
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permanent teeth has been shown to be greater than the post-eruptive effect,154-156 
and this was especially evident for pit and fissure surfaces.154, 156 Municipal drinking 
water supplies in temperate climates contain fluoride at 1 part per million (ppm).57 In 
addition to water fluoridation, topical fluoride treatment in children aims to prevent 
new lesions from developing, slow the progression of existing lesions and to prevent 
the development of fluorosis.136 For this purpose, fluoride toothpastes are 
recommended for use twice daily.19, 133 
 
There is strong evidence supporting the use of fluoride toothpastes to reduce the 
incidence of caries and periodontal disease.16, 18, 157 Various fluoride compounds 
have been used in toothpastes including NaF, MFP, AmF and SnF2. The efficacy of 
a fluoride dentifrice depends on the concentration of fluoride, the frequency and 
duration of application and the fluoride compound used.19, 133 It is the frequency and 
duration of application that has the greatest anti-caries effect with optimal caries 
reduction obtained when the fluoride levels are maintained at a low concentration by 
frequent application.136, 138 As an example, APF reaches maximum fluoride release 
and uptake by the oral tissues during the first four minutes of application and hence 
should be applied for this length of time.19 Fluoride varnishes adhere to tooth 
surfaces for prolonged periods of time so have increased exposure and uptake rates 
for enhanced anti-bacterial and remineralising effects19 and are highly recommended 
for individuals at high caries risk with professional applications of fluoride varnish 
recommended for children under 6 years of age.20 A review by Beltran-Aguilar and 
coworkers143 concluded that fluoride varnishes are an efficacious caries-preventive 
agent and are easy to apply and safe for children and adults alike. 
 
When looking at the optimal concentration of fluoride in toothpaste, conflicting data 
exists for use in children. Due to the high risk of fluorosis in children, a lower 
concentration of fluoride is generally desired. However, data shows that the higher 
the concentration of fluoride, the greater the caries preventive effect.16, 18 Fluoridated 
dentifrices of concentrations under 1000 ppm have shown both positive and negative 
results in relation to their ability to demonstrate anti-caries effect when compared to 
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placebo.16-18, 158 Reduction in the amount of toothpaste used is another common 
option to reduce the risk of fluorosis and allows the use of a higher concentration 
fluoridated toothpaste (1000 ppm), which is of particular advantage in high caries risk 
children. The international standard level recommended is now 1000 ppm for use in 
both children and adolescents.17 Although the anti-caries effects of toothpastes 
containing less than 500 ppm fluoride has not been proven, in Australia, low dose 
fluoride toothpaste is recommended for children younger than 6 years old to reduce 
the risk of fluorosis.15  
 
There are numerous fluoride compounds available on the market. NaF and MFP are 
both available in children’s toothpastes at low concentrations in Australia.159 NaF 
forms a calcium fluoride layer on the tooth’s surface which provides a slow releasing 
ionic exchange.159, 160 It is a strong remineralising agent as it produces a 
homogeneous lesion and is able to maintain high salivary fluoride levels post-
brushing and post-rinsing.160 MFP is a covalently bound fluoride compound.159 It is 
hydrolysed to free fluoride ions in the oral cavity by phosphatases which interact with 
bacteria and tooth structure ionically in a similar manner to NaF. 
 
A clinical study by Issa161 (2004) tested toothpastes containing NaF, MFP and AmF 
at varying concentrations from 500 ppm F to 1450 ppm F. They concluded that the 
higher concentration of fluoride produced the greatest salivary fluoride levels post-
brushing. AmF 1450 ppm F produced the greatest salivary fluoride levels with NaF 
1450 ppm F also efficacious 2 hours after brushing. 
 
SnF2 is a desensitising agent that acts by occluding dentinal tubules
133 with known 
anti-bacterial effects against S. mutans.162, 163 The anti-caries and anti-plaque effects 
of SnF2 were first reported by Muhler.
164 These anti-caries effects have been further 
corroborated.165-167 For example, Woodhouse168 showed a self-applied topical paste 
containing 10% SnF2 to reduce caries in terms of decayed, missing and filled teeth 
by 19% by comparison to a placebo control in school children aged 12-13 years. 
Similarly, McConchie and coworkers169 has shown daily use of a SnF2 mouth rinse in 
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school children (mean age of 10 years) to result in significant reductions in the 
numbers of new caries at both 100ppm and 200ppm concentrations. This is a 
possible method of caries control for high risk children. However, individual advice 
must be given by oral health professionals accounting for the needs of that particular 
child. 
 
A few studies by Schmid and coworkers have demonstrated caries-inhibiting effects 
of AmF.170-172 The combination of SnF2 with AmF in a toothpaste and mouth rinse 
formulation has shown improvements in plaque and bleeding scores, increased 
plaque and enamel fluoride content post brushing and a decrease in acid 
solubility.173  
 
APF application produces a high concentration of calcium fluoride-like material on 
enamel and dentin that can last for up to 7 days post-application.137 These long-
lasting fluoride reservoirs maintain the mineralisation equilibrium. Silver diamine 
fluoride (SDF) has slow dissolution and great anti-caries effect through the formation 
of silver phosphate ions.136 It is a low cost product with easy application and works to 
prevent both caries and dentinal hypersensitivity.136 Santos and coworkers136 
determined that Duraphat NaF varnish and SDF had the greatest anti-caries effects 
when compared to other fluoride varnishes and toothpastes. The group of dentifrices 
included numerous NaF, APF and SDF compounds. However, the application times 
varied between the groups with some receiving two applications. Similarly, a study 
by Weintraub and coworkers174 has shown a decrease in caries incidence following 
application of Duraphat 5% NaF varnish once or twice per year on school children. 
On the other hand, a study by Zickert and Emilson175 has shown topical application 
of a NaF varnish to not alter the plaque and salivary levels of S. mutans applied to 
school children, suggesting that the caries-reducing effect of NaF varnishes is not 
due to anti-mutans activity of the fluoride.  
 
Guggenheim and coworkers105 compared the caries and plaque inhibiting effects of 
fluoride containing dentifrices and CHX in a rat model. The inorganic fluoride 
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compounds (NaF and MFP) as well as the organic fluoride compound (AmF) were 
both effective in caries inhibition when applied topically. Plaque inhibition was found 
to be highly dependent on the sucrose content of the diet as more agents are able to 
inhibit plaque formation or reduce plaque extent in a lower sucrose environment. It 
must be noted that some fluoride compounds commonly known to cause potent 
caries or plaque inhibition have reduced efficacy in the presence of certain co-agents 
within the dentifrice. For example, Meridol (GABA International AG, Therwil, 
Switzerland), an anti-plaque agent containing AmF and SnF2, shows poor plaque 
inhibition despite the two compounds being individually strong plaque inhibitors.  
 
Arnold and coworkers160 compared the anti-caries effects of AmF, NaF and sodium 
MFP toothpaste formulations. Following demineralisation of 90 caries-free premolars 
and application of the toothpaste formulations, it was found that complete 
remineralisation resulted from AmF and MFP compounds while NaF resulted in 
partial remineralisation with a non-homogenous lesion under polarised light 
microscopy. AmF left the greatest fluoride content in the superficial layer of the 
lesion thus making the lesion more acid resistant and stable. Another study by 
Arnold and coworkers176 proved that AmF has a strong remineralisation effect when 
acidified at the optimal pH of 4.5-5.1. AmF application results in fluorapatite and 
calcium fluoride formation which provide a fluoride reservoir that is pH dependent 
with greatest remineralisation capacity and reduced solubility at low pH.  
 
Ekambaram and coworkers158 evaluated the remineralising potential of four fluoride 
compounds on primary teeth. Following demineralisation, primary teeth were treated 
with either 500 ppm AmF, 500ppm MFP, 500 ppm MFP and xylitol, 500 ppm NaF or 
a non-fluoridated dentifrice. NaF was the only compound to decrease the lesion 
depth while MFP and AmF decelerated the progression of demineralisation.  
 
There is much data supporting the anti-caries effect of MFP.177-180 However, 
conflicting studies exist comparing the anti-caries efficacy of dentifrices containing 
NaF and MFP. One study by Edlund and Koch181 showed NaF to be more effective 
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at reducing caries incidence in children when compared to MFP. A meta-analysis by 
Stookey and coworkers182 supported this finding that NaF is significantly more 
effective at preventing caries by comparison to MFP but the authors noted that the 
formulation and abrasive system used in the dentifrice must provide stability, 
availability and bioavailability of the ionic fluoride. However, DePaola and 
coworkers183 showed MFP and NaF containing toothpastes to have comparable anti-
caries effects. A review of 10 clinical studies comparing the anti-caries efficacy of 
these two common fluoride compounds reported mixed results, depending on the 
study and the diverse experimental conditions.184  
 
A randomized controlled trial by Hausen and coworkers185 explored the effects of 
non-invasive caries prevention in children with active initial lesions. The authors 
employed home fluoride toothpaste use, fluoride and xylitol lozenges, fluoride/CHX 
varnish, oral hygiene and dietary counselling in the experimental group of 250 
children of mean age 11 years old. By comparison to the control group who 
underwent a basic preventive regime offered by the public dental system, the mean 
DMFS increments for the experimental group was reduced by 44%. They concluded 
that caries can be controlled with multiple preventive measures emphasising regular 
fluoride application.  
 
It is clear that there are mixed results supporting the use of these fluoride 
compounds. So far, NaF has taken over the market in Australia as the anti-bacterial 
agent in toothpastes. It is the complex interaction of the ingredients within 
toothpastes including the fluoride compound, abrasives, binders, surfactants and 
humectants that result in a viable dentifrice.  
6.3 Fluorosis  
Dental fluorosis is the hypomineralisation of tooth enamel caused by the ingestion of 
fluoride above the optimal level during enamel formation.18 Clinical presentation of 
fluorosis varies from faint white lines or mottling in its milder form to brown staining 
or pitting with breakdown of the enamel in its more severe form.18 The exact 
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mechanism behind the development of fluorosis is not well understood but it is 
commonly accepted that the ingested fluoride interferes with enamel formation.18 
There is strong evidence that the use of fluoridated toothpaste can prevent dental 
caries.16, 18 In saying that, evidence also supports the statement that the use of 
fluoridated toothpaste on children under 12 months of age increases the risk of 
fluorosis.18 Data is limited due to fewer studies addressing caries in infants and the 
inability to perform a randomised controlled trial to assess fluorosis itself for ethical 
reasons. Stronger evidence exists for the relationship between fluoride concentration 
and fluorosis incidence with higher levels of fluoride (>1000 ppm) putting a child at 
increased risk.18 Do and coworkers186 have shown that fluoride exposure in the first 3 
years of life was associated with a higher prevalence of mild fluorosis but 
significantly lower prevalence and severity of caries. However, the benefits and risks 
must be carefully examined on a case to case basis as some high-caries-risk 
children may receive greater health benefits from the use of a topical fluoride agent 
of higher fluoride concentration. 
 
With a reported increase in dental fluorosis,187 parents are becoming increasingly 
wary of this risk following use and ingestion of fluoridated water and toothpastes and, 
as such, are turning to non-fluoridated options.187, 188 However, very few non-
fluoridated toothpastes have been found to be successful anti-cariogenic agents.  
Carvalho and coworkers188 performed agar diffusion assays of 5 non-fluoridated 
toothpastes against cariogenic bacteria including MS and Lactobacillus. They only 
found one toothpaste to have growth inhibitory effects and this was not greater than 
a fluoridated toothpaste. Fluoride is still the leading agent in caries prevention, so it 
must be stressed that the safe and supervised use of fluoride in children has far 
superior anti-caries effect with regular use than other products currently available.139  
 
7. Oral Antiseptics 
Topical fluoride applied in toothpastes is now well accepted as one of the mainstays 
of caries prevention and in-office applications of fluoride containing varnishes are 
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currently recommended for high risk children.16, 17 In addition to topical fluoride, high 
risk children are likely to benefit from the additional use of anti-bacterial 
compounds.21 
7.1 Chlorhexidine 
CHX is an antiseptic agent that inhibits plaque formation by selectively inhibiting 
growth of gram-positive cariogenic micro-organisms including S. mutans189, 190 and 
some species of LB.109 It is important to note that each species of oral bacteria 
responds differently to the agent. It is a potent, hydrophilic bisguanide that can inhibit 
development of initial carious lesions by reducing levels of MS in both high and low 
sucrose environments.105, 189 CHX contains a cation which binds to negatively 
charged objects including bacterial cell walls, salivary pellicle, plaque and mucosa 
accounting for its high substantivity.27 Despite its substantivity, it cannot eliminate 
MS completely and requires regular use to maintain low levels of these bacteria.189 
At low concentrations, CHX is bacteriostatic when it interferes with cell wall 
transportation leading to leakage of intracellular components.29, 30 At high 
concentrations, CHX is bactericidal causing precipitation of intracellular cytoplasm 
and impeding the action of glucosyltransferase thus preventing adhesion of bacteria 
to the tooth’s surface.29 A meta-analysis by van Rijkom and coworkers190 revealed a 
caries reduction of up to 46% following CHX use on permanent teeth in 11-15 year 
old children.  
 
Numerous studies have shown CHX to have superior bactericidal effects against 
plaque bacteria than other antiseptic mouthwashes such as those containing 
essential oils (EO), NaF and cetylpyridinium chloride (CPC).23, 38, 40, 191 However, one 
study by van Strijp and coworkers192 did not show a decrease in acid production of 
plaque samples or prevention of demineralisation of dentine or enamel following 
twice daily use of a 0.2% CHX mouth rinse. 
7.2 Chlorhexidine formulations 
Ranked in order of effectiveness, CHX is available as a varnish, gel, mouth rinse, 
toothpaste and impregnated dental floss.189, 193 The effectiveness of CHX is highly 
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variable and dependent on application method, application frequency, composition, 
fluoride regime and patient caries risk.190 Close monitoring is necessary and 
alterations to prescription may be required according to the individuals needs.29 
Composition of varnish or rinse should be ascertained prior to prescription as CHX is 
commonly inactivated by other agents in the formulation.133  
 
CHX gel is most commonly used in a 1% concentration and can be applied at home 
with a toothbrush or chair side within a tray.29 When applied as an intensive 
treatment with numerous applications per day for 2 to 14 days, the reduction in MS 
levels can last for up to a month.29 CHX varnish comes in numerous concentrations 
with 40% being the most effective long-term therapy against MS.29 Varnish provides 
increased substantivity with CHX remaining on soft and hard oral tissues for up to 26 
weeks post-treatment.29 Similar to a gel, MS levels remain lowered after the 
termination of treatment with a CHX varnish but will eventually return to baseline.29, 30 
The most corroborated CHX therapy involves intensive professional application of a 
gel within a custom-designed tray for 3 lots of 5 minutes repeated on 2 consecutive 
days or professional application every 3-4months. Longer application intervals have 
reduced inhibitory effect.30, 193  
 
For use in paediatric dentistry, CHX has been shown to be highly effective in 
reducing ECC when applied in the form of a high concentration (40%) varnish 
delivered 6 monthly by professionals.194 However, clinical trials have showed that 
daily application of 0.12% CHX gel did not result in lower caries rates compared to 
controls, probably due to poor compliance of gel use associated with the 
unacceptable taste of the gel for young children.195 
 
According to Twetman,30 at home, self-application of CHX gel for 5 minutes each day 
for 14 days can be effective. However, the home use of CHX is commonly ineffective 
due to the bitter after-taste of CHX resulting in poor compliance.1, 190 Decreasing the 
concentration or application time can combat this problem.29 Further clinical trials 
were performed by Pukallus and coworkers,1 where a CHX gel was used daily along 
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with twice daily tooth brushing with 304% fluoride toothpaste on infants aged 0-
24months. They found that the tooth brushing reduced the incidence of caries 
regardless of the use of CHX but this was attributed to low compliance. Similarly, 
Emilson and coworkers196 showed that after 14 days of applying a 1% CHX gel, all 5 
participants in the study eliminated S. mutans from their mouths. 
 
Common side effects following long-term CHX usage include altered taste sensation, 
tooth discolouration, gingival bleeding, increased calculus formation and epithelial 
desquamation.30 As a cationic antiseptic, it precipitates dietary chromogens to 
produce extrinsic stains, so is only prescribed for short term use to avoid this 
reaction.38 As such, CHX is contraindicated as a primary caries preventive therapy 
and is only indicated in support of other oral hygiene techniques in patients with 
active caries or those who are medically compromised or disabled.30 However, these 
common complications are not always reported as each individual responds 
differently to CHX treatment.27  
 
The first longitudinal, double-blind, placebo-controlled CHX study on MS colonisation 
was performed by Wan and coworkers.31 Their results showed a significant decrease 
in MS levels following use of a 0.2% CHX gel in children with low initial MS levels 
(<300 CFU/ml). However, children with high initial MS levels and those taking the 
placebo, showed similar results over the course of treatment. MS colonisation was 
also found to be highly dependent on tooth brushing and diet.  
 
Law and Seow27 later studied MS positive children over a 12 month time period. 
Along with dietary and oral hygiene advice, a 0.2% CHX gel was brushed once daily 
for 6-12 months. A decrease in MS levels with longer use of CHX was noted. After 3 
months, 28% of the children were negative for MS while after 12 months 70% of the 
children were negative for MS. When examining post-treatment recolonisation, they 
found that after 9 months, 20% of the children were still MS negative indicating the 
good substantivity of CHX. Discontinuation of CHX therapy often results in 
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maintained caries reduction due to development of good dietary and oral hygiene 
habits as well as CHX’s superior substantivity.29, 189 
7.3 Povidone iodine 
PI is an antiseptic agent used in many areas of medicine and dentistry such as 
prophylactically prior to, during and after dental surgery.32-34 It is a complex of iodine 
with polyvinyl pyrrolidone.33 This compound decreases side effects of pure iodine 
such as staining and irritation and increases water solubility for enhanced action.33 
Contraindications include pregnancy, thyroid disease and iodine hypersensitivity.32 
This compound has a high specificity for highly cariogenic bacterial species such as 
MS and produces bactericidal effects.33, 34 PI is water soluble with slow release of 
iodine resulting in long-term anti-bacterial effects.33 As an oral antiseptic, PI is most 
commonly available as a mouth rinse. 
 
Work by Lopez and colleagues24, 28 supports the concept that PI reduces MS levels 
in children at high risk of ECC. They showed that an in-chair topical application of 
10% PI is effective at preventing white spot lesions in toddlers when applied every 2 
months, even if the child is bottle feeding on cariogenic substrates at naptime.24, 28 
Similarly, Berkowitz and coworkers197 have shown that a once-only topical 
application of 10% PI followed by APF in children produces a prolonged decrease in 
MS and LB levels over 3 months. This approach did not, however, prevent new 
carious lesions from developing over the subsequent year post application, probably 
due to persistent cariogenic dietary factors and poor oral hygiene.197 PI can have an 
MS-inhibitory effect of over 95% CFU/ml of saliva.197 This MS suppression can be 
maintained in the oral cavity for up to 90 days post-application possibly due to the 
increased susceptibility of demineralised enamel to PI.197 Simratvir and coworkers198 
showed that a 3-monthly topical application of 10% PI following dental restorative 
treatment can reduce S. mutans levels and prevent further occurrence of caries.  
 
Tanzer and coworkers34 found the conditions for optimal bactericidal effects to be 
similar to those for CHX. They showed highly cariogenic species such as MS to be 
killed by inorganic iodine at concentrations as low as 0.04% applied for a single 5 
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minute treatment while less cariogenic species only displayed reduced acid 
production.34 This specificity is supported by PI’s selective inhibition against 
glucosyltransferase, a highly active enzyme in cariogenic bacteria.33, 34  
7.4 Essential oils 
EO containing mouthwashes are currently on the market, one of the leading brands 
being Listerine. Their bactericidal properties can be attributed to their ability to 
effectively permeate through established plaque.199 There the EO disrupt the cell 
wall and inhibit enzyme activity resulting in cell death. They also prevent bacterial 
aggregation and proliferation.199 However, there is conflicting data in respect to 
Listerine's anti-plaque efficacy. Several studies have shown beneficial effects of EO 
mouth rinses such as significantly reducing total plaque bacterial counts,22, 41, 200-202 
reducing MS levels in teenagers,203 and improving plaque and bleeding scores in 
orthodontic patients;204 while other studies have shown negligible anti-bacterial 
effects.39, 40 Specific action against MS was tested and confirmed by Fine and 
coworkers.22 They took plaque swabs and saliva samples from subjects using 
Listerine mouthwash twice daily in addition to regular oral hygiene practices and 
found a significant reduction in MS levels both from plaque and saliva following a 12-
day period, with plaque showing a greater reduction in bacterial counts. When 
combined with regular tooth brushing, a greater reduction in plaque accumulation 
was noted, thus indicating that Listerine was more active against newly formed 
plaque.191, 205, 206  
 
By comparison to 0.2% CHX, Netuschil and coworkers191 found an essential oil 
mouth rinse (Listerine) to have significantly less reduction in plaque index, total 
bacterial counts, colony-forming units and plating efficiency. The essential oil did 
hinder plaque regrowth but results were comparable to the control rinse of 0.02% 
quinine-hydrochloride. Another study by Wiken Albertsson and coworkers42 has 
shown EO to be less effective at reducing the amount of S. mutans and LB.  
 
Numerous studies have explored individual EO and their effects on oral bacteria, 
specifically S. mutans. Promising results have been shown for essentials oils 
50 
 
isolated from Lippia sidoides207, 208, Myristica fragrans (nutmeg)209, Curcuma longa210 
and cloves211.  
7.5 Cetyl pyridinium chloride 
CPC is a strong antiseptic mouth rinse commonly prescribed in the dental field. CPC 
is a quaternary ammonium compound with strong anti-bacterial properties including 
its inherently strong ability to adhere to oral surfaces, though with limited 
substantivity.35-37, 212 It has high binding affinity for negatively charged bacterial cell 
walls allowing for membrane disruption, leakage of cytoplasmic components and 
inhibition of metabolism and proliferation.23, 25, 37, 213 These behaviours are similar to 
those seen with CHX, however, clinically CPC produces a relatively quick return to 
pre-rinse salivary bacterial levels with short residual salivary anti-bacterial activity.36 
It also prevents cellular aggregation and thus plaque maturation.37 Similar to CHX, 
CPC can cause extrinsic tooth staining, though to a lesser extent than CHX.38 A high 
affinity for gram-positive species such as MS has been shown.23, 25, 213  
 
Numerous studies give evidence of CPC's ability to reduce plaque bacterial levels 
and, hence, plaque formation in both alcohol-containing and alcohol-free 
formulations.23, 25, 35, 37, 212, 214, 215 CPC has also been shown to reduce gingival 
inflammation, gingival bleeding and plaque levels by comparison to a placebo mouth 
rinse.216, 217 The use of CPC in gel or varnish form has thus far only been studied by 
combining CPC with zinc gluconate in a gel 218 or with acrylic resin in a varnish219 
producing anti-calculus and anti-bacterial effects. 
 
In trials employing CPC mouth rinses as adjuncts to regular tooth brushing, the 
reduction in plaque and gingivitis was limited.220 The cause has been proposed as 
an interaction between the CPC and toothpaste ingredients resulting in inactivation 
of an active ingredient.220 It has also been suggested that poor compliance in at-
home trials and the Hawthorne effect may be involved.220 A study by Sheen and 
colleagues38 has shown a reduction in tooth staining when CPC and CHX were used 
both immediately before and after a toothpaste slurry, indicating inactivation of the 
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antiseptic agent. They concluded that these oral antiseptics should be used some 
time after the use of toothpaste.  
 
By comparison, there is minimal evidence for the use of CPC in children as an anti-
caries agent. Work by Pawha and coworkers221 demonstrated the clinical 
effectiveness of a commercially available 0.07% CPC mouth rinse at reducing the 
plaque index and bleeding scores in children and young adults (10-25 years old) 
undergoing fixed orthodontic appliance treatment. Further, use of a pre-surgical 
0.05% CPC mouth rinse by children aged 10-15 years has shown efficacy at 
reducing both aerobic and anaerobic oral microorganisms.222 
 
Numerous comparisons between CPC and various other mouth rinses have been 
performed. By comparison with a fluoride mouth rinse, CPC has been found to 
significantly reduce anaerobic bacteria in supragingival plaque over a 14 day 
period.223 CPC additionally reduces periodontal and halitosis associated pathogens, 
however to a lesser extent than a CHX mouth rinse.215 Nelson-Filho and 
colleagues224 showed that a 0.05% CPC mouth rinse is effective at disinfecting 
toothbrushes used by preschool-aged children at day-care, although not to the 
extent of CHX. Similar plaque levels and gingival bleeding scores have been 
observed in trials comparing a CPC mouth rinse to an essential oil mouth rinse.225, 
226  
 
Patients undergoing fixed appliance therapy have a greater caries risk related to 
increased levels of S. mutans.227 Al-Musallam228 has shown the incorporation of 
CPC into a commercially available orthodontic adhesive (Transbond XT) to have 
antimicrobial activity with increased bacterial inhibition with increased concentration. 
With 2.5% CPC in the adhesive material, the tensile strength remained constant. 
7.6 Sodium hypochlorite 
Sodium hypochlorite (NaOCl) is commonly used as a disinfectant for cleaning baby 
products such as bottles and pacifiers. Disinfecting objects shared between mother 
and child, such as bottles, cutlery and toothbrushes using a strong antiseptic can 
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help to reduce the vertical transmission of oral cariogenic bacteria from mother to 
child. NaOCl has also been suggested as a disinfectant for toothbrushes, with 
promising results for MS reduction.229 NaOCl is not commonly used as a mouth rinse 
due to its poor palatability. However, recent studies are reviewing its use for treating 
adult periodontal disease in formulations with improved taste as evidence shows it 
can improve plaque and bleeding scores at concentrations as low as 0.05%.230, 231 
 
7.7 Sugar alcohols  
As mentioned previously, caries is initiated by the breakdown of carbohydrates by 
certain bacteria. As such, it is safe to assume that dietary sugar restriction will likely 
lead to caries reduction. This assumption has lead to examination of sugar 
alternatives. The sugar alcohols are a dietary sugar substitute that can be used to 
reduce the incidence of caries.78, 232 They are metabolically derived from their 
corresponding aldose sugars.232 As such, they are also known as alditols. Sugar 
alcohols are crystalline substances with varying sweetness.232 The two most 
common sugar alcohols used in the dental field are xylitol and sorbitol. One of the 
anti-cariogenic properties is the reduced ability or inability for oral microorganisms to 
metabolise sugar alcohols.97, 232, 233 However, the different molecular masses provide 
variation in biological properties of alditols. This must be remembered as each alditol 
has unique properties and differing anti-caries capacity. Many alditols have been 
tested for fermentation by oral bacteria and have been subdivided as either hypo- or 
non-acidogenic.234 Sorbitol is hypo-acidogenic while xylitol is non-acidogenic and 
anti-cariogenic.  
 
7.7a Xylitol 
Xylitol is available in numerous formulations including chewing gum, pastilles, 
dentifrice, mouth rinse and pacifiers.232 Use of a xylitol dentifrice provides 
simultaneous mechanical cleaning and can provide additive effects with other 
ingredients such as fluoride and detergents. These additive effects can also be 
achieved with the use of a mouth rinse which is normally a short-term treatment 
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option. A review by van Loveren25 concluded that xylitol is generally considered more 
effective than sorbitol at caries prevention clinically but its anti-mutans effects are not 
confirmed. Reviews by Mickenautsch and colleagues235 and Lingstrom and 
colleagues233 have produced evidence supporting a reduction in caries following 
sugar-free gum chewing. However, both reviews show disparate findings for direct 
therapeutic effects by xylitol or sorbitol on dental plaque. Both concluded that further 
well-designed randomised trials are needed to confirm the caries-reducing effect of 
sugar alcohols and their underlying mechanisms. 
 
As mentioned earlier, bacterial colonisation in infants is highly associated with 
maternal bacterial counts and oral hygiene practices. As such, treatment targeting 
both mother and child are of use in combating the disease early. A series of studies 
by Söderling and colleagues236-238 have shown that reducing maternal MS counts 
with xylitol chewing gum can significantly reduced MS colonisation in their children's 
teeth at the age of 2 years and significantly reduced dentinal caries at the age of 5 
years. In a follow up study, they showed early prevention of MS transmission from 
mother to child can have long-term effects on the child's MS colonisation but 
preventive measures must be maintained over a lifetime as their effects diminish with 
time. It has been shown that a minimum of 5-6 grams and 3 exposures per day from 
chewing gum is needed for the clinical reduction of plaque and saliva MS counts.239-
241  
 
The use of xylitol chewing gum by children has also shown efficacy for reducing 
plaque mass as well as MS and lactobacilli counts.242-244 Furthermore, xylitol gum 
can have a long-term growth retarding effect on MS and lactobacilli as reduced 
bacterial growth has been observed 15 months following the termination of xylitol 
use.244 By comparison, these studies found only a reduction in plaque mass 
following use of a sorbitol chewing gum possibly due to passive effects by the 
stimulation of saliva.242-244  
7.7b Sorbitol 
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D-Glucitol (Sorbitol) is the most common sugar substitute in the United States for 
use in chewing gums and over-the-counter medicines. This is owing to its cost-
effectiveness by comparison to other sugar alcohols such as xylitol. It is a hexitol-
type molecule that is more effective at reducing the incidence of caries when 
compared to sucrose but is considered inferior to xylitol.232, 245 Mixtures of xylitol and 
sorbitol can exhibit additive effects; however the concentration of xylitol in the 
mixture tends to determine the anti-caries effect.232, 246 
 
Sorbitol is a low cariogenic sweetener as it does not lower plaque pH to below the 
threshold for enamel demineralisation, unlike sucrose.245  However, sorbitol is not 
non-cariogenic as oral bacteria can adapt to metabolise sorbitol when their regular 
sugar source is restricted.245 Evidence suggests that sorbitol can in fact stimulate the 
growth of S. mutans in such conditions as it is readily converted to its glucose and 
fructose components which act as the carbohydrate substrates for these bacteria.232 
As such, consuming large amounts of sorbitol can increase growth and fermentation 
of cariogenic bacteria.77  
 
8. Dentifrice Ingredients 
Tooth brushing has long been accepted as a mechanism to maintain acceptable oral 
health with fluoridated toothpaste being the long-term gold standard in caries 
prevention. In addition to fluoride, dentifrices contain a number of other agents which 
may inhibit the growth of S. mutans, including surfactants, antiseptics such as 
triclosan, flavours and humectants. Other dentifrice components such as binders, 
fillers and abrasives are unlikely to exert antibacterial actions. Common agents 
include sodium pyrophosphate, polyethylene glycol, sodium lauryl sulphate and 
triclosan. The role of these agents are explained further in this section.  
 
8.1 Sodium pyrophosphate 
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Sodium pyrophosphate is a tartar control agent found in many toothpastes and has 
been shown to reduce calculus by at least 20% by comparison to a control, non-
pyrophosphate containing dentifrice.247, 248 Despite this, sodium pyrophosphate is not 
known to have any anti-bacterial effects. However, through the blocking of active 
protein sites on apatite crystals, some propose that sodium pyrophosphate can 
reduce bacterial adhesion to tooth surfaces.247, 249 By blocking active protein sites 
such as calcium sites on the hydroxyapatite crystals, sodium pyrophosphate retards 
pellicle formation and displaces proteins and organic substances from the enamel 
surface. This results in good cleansing of the oral cavity, reduced calculus formation 
and possibly reduced bacterial adhesion to the tooth surface.247, 249, 250 Evidence 
suggests that sodium pyrophosphate does not influence the remineralisation or anti-
caries effect of fluoride249 and can, in fact, have enhanced anti-calculus effect when 
combined with NaF.251  
8.2 Polyethylene Glycol 
In the field of medicine, polyethylene glycol (PEG) is widely used as for bowel 
preparation before colonic surgery and colonoscopy due to its ability to form a 
physical barrier between the intestinal epithelium and invasive microbes.252-254 
Although interference with bacterial growth is not a known property of PEG, several 
studies have shown anti-bacterial effects.255, 256 
 
In the dental field, PEG is a humectant used in toothpaste. The main anti-bacterial 
action attributed to PEG is the reduction of bacterial adhesion to enamel surfaces 
through a high binding affinity for hydroxyapatite crystals.257-259 A novel polymer of 
PEG with pyrophosphate was tested by Chen et al and was shown to effectively 
inhibit salivary protein adsorption to artificial hydroxyapatite and inhibit saliva protein-
promoted S. mutans adhesion.259  
 
Recent research is exploring the treatment of titanium implant surfaces with PEG in 
order to reduce bacterial adhesion and, hence, biofilm formation on the implant 
surface aiming to improve success rates of implant therapy.260, 261 This is achieved 
due to PEGs ability to inhibit salivary protein adsorption, involved in the initial stages 
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of biofilm formation, which was shown by Tanaka and colleagues to be more 
effective on rough implant surfaces rather than on smooth implant surfaces. They 
also identified a reduction in biofilm formation and easier detachment of S. mutans 
biofilms from the PEG-titanium implant surface. 261 Along with a reduction of bacterial 
adhesion to the implant surface, Bozzini and coworkers260 have shown an increase 
in PEG surface density on the implant to result in increased osteoblast proliferation 
and resultant stimulation of bone formation.  
8.3 Sodium lauryl sulphate 
Sodium lauryl sulphate (SLS) is an anionic detergent found in most toothpastes 
available on the market today. SLS is used for its foaming qualities but also has anti-
bacterial actions. It undergoes adsorption to bacterial cell surfaces to interfere with 
cell integrity.262-264 SLS inhibits growth of mutans streptococci and inhibits enzymic 
activities of glucosyltransferases.265, 266 Glucosyltransferases synthesise water-
insoluble glucans from sucrose which is a key step in caries induction.265 SLS has 
been shown to reduce lactate production by S. mutans and to reduce extracellular 
polysaccharide formation.264  
 
Another mode of action in vivo is the alteration of the adsorption of proteins to 
enamel, thus affecting the formation of the salivary pellicle.267 A study by Hamilton 
and coworkers268 has shown SLS to have etching abilities and to result in an 
undesirable increased susceptibility of treated enamel to acid attack. Their study, 
however, used a high concentration of SLS (10%) for a short period of time, unlike 
tooth brushing and was not clinically based.  
 
Petersen and colleagues264 showed an additive inhibitory effect when combining 
SLS with NaF. This was only seen, however, for thinner glucose-grown biofilms. 
Another study has shown that the presence of SLS in a dentifrice with fluoride or as 
a pre-treatment prior to fluoride application, can reduce the amount of fluoride 
deposited on the tooth surface and thus reduce the effects of fluoride.269 The 
combining of SLS with zinc citrate has also been researched and shown additive 
inhibitory effects with a 70% reduction in plaque scores from baseline.270 
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8.4 Triclosan 
Triclosan is a broad-spectrum anti-bacterial agent found in numerous toothpastes 
that is active against both gram positive and gram negative bacteria including S. 
mutans.271 It's main mode of action involves the disruption of bacterial cytoplasmic 
membranes to block fatty acid biosynthesis.272 It has greatest effect on plaque-free 
surfaces indicating it can prevent bacterial adhesion and inhibit growth of plaque.271 
Two downfalls of triclosan include poor water solubility and poor retention in the oral 
cavity.273 As such, it is often combined with a copolymer of 
polyvinylmethylether/maleic acid (PVM/MA) for enhanced substantivity and 
efficacy.272, 274, 275 A copolymer of 0.13% calcium glycerophosphate in a calcium 
carbonate base has been shown to significantly reduce plaque and gingival bleeding 
scores by comparison to PVM/MA with triclosan as a constant.276 Similarly, 
combining triclosan with zinc citrate has shown additive anti-plaque effects.271 Gilbert 
and coworkers277 reported Triclosan's oral retention measurements two minutes 
following tooth brushing as 38% with greater retention quantities following the use of 
a higher dose of Triclosan.  
 
Review articles report clinically significant improvements in plaque control and 
gingivitis following use of a triclosan-containing dentifrice.272, 275 However, triclosan 
has been reported to neither enhance nor interfere with remineralisation or the anti-
caries effect of fluoride.272, 278, 279 Hawley and coworkers280 concluded that a 
dentifrice containing 0.24% NaF/silica abrasive with 0.3% triclosan/2.0% copolymer 
produces equivalent anti-caries effects as a dentifrice without the 
triclosan/copolymer. A dentifrice containing 0.24% NaF/silica abrasive with 0.3% 
triclosan/2.0% copolymer has also been shown to produce enhanced 
remineralisation and enhanced fluoride uptake on interproximal enamel by 
comparison to a dentifrice without the triclosan/copolymer.281 Triclosan has been 
shown to produce enhanced protection for dentin when exposed to low 
concentrations of S. mutans, ie a mild acid attack, as measured by lactate 
production, calcium loss and mean final pH over five experimental days.279 A study 
by van Loveren and colleagues282 revealed that pre-treatment with a triclosan-
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containing dentifrice greatly reduced the cariogenic outcomes on enamel and 
concluded that enamel may act as a reservoir for triclosan. Numerous review articles 
report clinically significant improvements in plaque control and gingivitis following 
use of a triclosan-containing dentifrice.272, 274, 275, 283  
 
Another delivery system of recent interest is the use of dentotropic micelles which 
aim to increase triclosan solubility, increase hydroxyapatite binding and provide 
prolonged drug release.273, 284, 285 In vitro testing of triclosan-loaded tooth-binding 
micelles has shown great promise including the ability to inhibit biofilm formation and 
reduce the viability of pre-existing biofilms.273 This antimicrobial formulation has also 
been used with pyrophosphate.285  
 
9. Interactions 
It is possible that certain preventive agents have synergistic and additive anti-
bacterial effects when combined. Synergism can be defined as the interaction of two 
or more substances to produce a combined effect greater than the sum of their 
separate effects.286 As low concentrations of chemicals are required to improve 
safety and reduce side effects in children, it is pertinent to look for combinations of 
compounds that have synergistic or additive anti-bacterial effects. As synergistic 
agents produce a combined effect greater than the sum of their separate effects, 
efficacy can be achieved using low concentrations of individual compounds that are 
safe for children.287 Combinations with additive properties are also beneficial as 
relatively low concentrations of individual compounds can be employed to boost the 
effects.288 These strategies for boosting the efficacy and safety of medications are 
commonly applied in medicine and dentistry. For example, the staining and mucosal 
irritation of pure iodine is reduced by combining iodine with polyvinyl pyrrolidone.33  
 
In contrast to synergistic and additive effects which are usually beneficial, some 
combinations of antiseptics can result in interference and reduced efficacy.289, 290 
Drug-drug interactions are common and usually result from the interaction of two 
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agents which increase or diminish the magnitude or duration of action resulting in an 
unintended reaction.289, 290 Chemically reactive agents compete with each other to 
prevent the other agent from interacting with its intended receptor target or by 
reacting with molecules, ions or proteins.289 
9.1 Fluoride and Chlorhexidine  
Initial studies have explored the combined use of separate fluoride and CHX gels 
which have been found to have synergistic anti-bacterial effects with extended MS 
suppression.189 Simultaneous application of varnishes, gels or rinses containing CHX 
or fluoride have been shown to lower S. mutans counts and increase enamel mineral 
density.291-293 In addition, a varnish containing both NaF and CHX was associated 
with sustained reduction of interdental S. mutans.294 A blind, randomized-controlled 
trial by Olympio and coworkers295 studied 83 orthodontic patients and their use of 
either a 1100ppm NaF toothpaste, a 0.95% CHX toothpaste or these dentifrices in 
combination. They confirmed that CHX was superior to NaF in terms of reduced 
gingivitis, bleeding scores and plaque and calculus formation. Combined treatment 
showed additive anti-plaque effects. In a few volunteers, staining and bitter taste was 
observed. The use of a 1% CHX gel in office followed by at home application of a 1% 
NaF gel for a 2 week period produced a greater reduction in salivary S. mutans 
levels and slower rate of return of S. mutans than the placebo group.296  
 
 Many studies have tested the effects of combining fluoride and CHX in a single 
product. It has been found that these two agents can co-exist without interfering with 
the other's protective properties.297 As a dentifrice, fluoride and CHX combinations 
have been shown to produce a greater reduction in caries than a single fluoride or 
CHX dentifrice.298 However, the difference was not statistically significant. A two year 
study by Luoma and colleagues293 observed a group of high caries risk 11-15 year 
olds provided with either a fluoride mouth rinse, a combined fluoride-CHX mouth 
rinse, a placebo solution or no rinse. The reduction in mean DMFS increments and 
bleeding gingival scores was greatest for the combined fluoride-CHX mouth rinse 
group with fluoride and the placebo rinse having comparable results. A similar study 
by Spets-Happonen and coworkers299 showed a reduction in S. mutans levels and 
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gingival bleeding scores following daily rinsing with a CHX-fluoride rinse. An in vitro 
study by Meurman300 confirmed synergistic interactions between CHX and fluoride in 
relation to their ability to inhibit adhesion of bacteria to enamel and their anti-bacterial 
effects. The combined CHX and fluoride group showed the greatest reduction in 
adsorption of radiolabelled bacteria to hydroxyapatite and functioned at the lowest 
inhibitory concentration by comparison to fluoride and CHX alone. It was also able to 
cause disruption to streptococcal cells similar to the CHX group. 
9.2 Fluoride and Povidone iodine  
Numerous studies have explored the combined use of a fluoride varnish and topical 
PI treatment showing additive anti-caries effects. The combined use of topical PI and 
fluoride varnish has been shown to result in more caries-free first permanent molars 
in children aged 5 to 7 years within a school year compared to fluoride varnish 
alone.288 It was concluded that the combined topical application of this antiseptic 
agent at the same time as fluoride varnish provides additional caries preventive 
effects to a fluoride varnish alone. Milgrom and colleagues301 performed a further 
study showing a 31% reduction in new carious lesions over fluoride varnish alone in 
the primary dentition following the combined treatment with separate 10% PI and 5% 
fluoride varnishes. A clinical trial by Xu and coworkers302 revealed no added 
bacteriostatic or cariostatic effects following use of a single PI/fluoride foam rather 
than regular fluoride foam and concluded that further evidence is required to support 
this relationship.  
9.3 Fluoride and Essential oils  
EO in combination with fluoride have been evaluated in several studies with mixed 
results. An EO and fluoride mouth rinse has been shown to produce greater fluoride 
uptake and enamel remineralisation than a separate fluoride or EO mouth rinse as 
determined by surface microhardness evaluation.303 However, another study testing 
the microhardness of demineralised enamel in a similar modality revealed only an 
equal increase in microhardness following treatment with an EO/fluoride mouth rinse 
and a fluoride rinse alone.304 Plaque acidogenicity has also been shown to be 
affected by an EO mouth rinse, with no added benefit from the addition of fluoride.305 
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Zheng and Wang306 performed a comparison between a CHX rinse, an EO and 
EO/fluoride mouth rinse on root-caries pathogens (S. mutans, S. sobrinus, 
Lactobacillus rhamnosus and Actinomyces naeslundii) and found that CHX had the 
greatest effect on bacterial growth inhibition while the EO/fluoride rinse could not 
effectively reduce numbers of these bacteria.  
9.4 Fluoride and Sodium lauryl sulphate  
SLS has long been used as a detergent in fluoridated toothpastes. An early study by 
Barkvoll and coworkers,269 explored the effect of SLS on the deposition of calcium 
fluoride on enamel in vitro. They found that the use of a dentifrice containing MFP 
and SLS as well as a pre-treatment of SLS before fluoride application, decreased the 
amount of calcium fluoride deposited on enamel. This was believed to prevent 
fluoride's extended anti-caries effect at the tooth surface. Giertsen307 examined the 
effect of mouth rinses containing various combinations of triclosan, zinc, SLS and 
fluoride on acid formation by dental plaque in vivo. Her results revealed a slight but 
statistically insignificant decrease in acid formation as tested by pH levels following 
use of a mouth rinse containing fluoride and SLS. This is further supported by 
Petersen and coworkers,264 who examined the effects of NaF and SLS on acid- and 
polyccharide-formation of biofilm and planktonic S. mutans cells. They found an 
additive inhibitory effect on S. mutans acid formation and extracellular 
polysaccharide formation which can enhance the inhibition of dental plaque 
formation and pathogenicity.  
9.5 Fluoride and Cetyl pyridinium chloride  
CPC is an anti-plaque compound whose anti-bacterial effects are thought to 
augment the effects of fluoride toothpaste.308 An experimental rinse containing both 
CPC and NaF, used twice daily after regular tooth brushing over a period of 2 
months demonstrated an improvement in plaque scores and dental sensitivity.309 
Another study showed that tooth brushing and rinsing with CPC maximised plaque 
reduction.308 In contrast, other studies have shown that the combined use of CPC 
and fluoride toothpaste have antagonistic effects in terms of plaque scores.38, 220 
There is evidence for the inactivation of CPC by fluoride, similar to CHX, so it is 
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suggested that at least 30 minutes be allowed between brushing with a fluoridated 
dentifrice and rinsing with CPC to optimise the anti-plaque effect.38, 220, 308  
9.6 Chlorhexidine and Sodium hypochlorite 
The combined use of NaOCl and CHX has predominately been within the field of 
endodontic irrigants. Their anti-caries effects have not been well researched. The 
combined use of NaOCl and CHX as irrigants results in precipitate formation which 
occludes dentinal tubules, reduces marginal sealing and favours microleakage.310-312 
It is believed that the precipitate is parachloroaniline, a hydrolysis product of CHX 
with known toxic and carcinogenic degradation products.311, 313 This has been 
evaluated through many methods including x-ray photon spectroscopy311 and 
environmental scanning electron microscopy.313 These changes were also shown to 
be dose dependent, both in respect to the concentration of CHX and the 
concentration of NaOCl.310, 311 Basrani and coworkers311 showed that a minimum 
concentration of 0.023% NaOCl will result in precipitate formation and colour change 
when added to 2% CHX. It is, hence, suggested that NaOCl and CHX not be used 
simultaneously during endodontic procedures.310, 311 Valera and coworkers314 
prepared root canals irrigating with 2.5% NaOCl, then saline solution, then CHX gel 
which resulted in greater cleaning of root canal walls with the highest number of 
open dentinal tubules by comparison to a CHX liquid. Use of EDTA as a final irrigant 
also showed improvement in cleaning. Vianna and Gomes315 performed an agar 
diffusion assay and broth dilution test on the combined growth inhibitory effects of 
NaOCl and CHX at varying concentrations on Enterococcus faecalis. They 
concluded that the combination of NaOCl with CHX did not produce additive effects 
greater than that of CHX alone, and, in fact, the higher the concentration of NaOCl, 
the less growth inhibition of Enterococcus faecalis.  
9.7 Chlorhexidine and Povidone iodine 
The combined efficacy of CHX with PI in the dental field has not been investigated. 
Most research into the combined use of CHX and PI is in the field of surgical site 
antisepsis. Many articles have indicated that the combined use of both agents in 
surgical site preparation results in synergistic anti-bacterial effects and decreased 
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rates of infection.316-318 Guzel and colleagues316 recommended a three minute 
cleaning with CHX followed by a 30 second cleaning with PI for improved skin 
disinfection in preparation for neurosurgical procedures. This antiseptic combination 
has also been suggested for decontamination of human donor eyes prior to corneal 
preservation.319   
9.8 Chlorhexidine and Sodium lauryl sulphate 
Little research has explored the interaction of CHX with SLS in a single product. It is 
well known that toothpastes containing SLS can reduce the antimicrobial effects and 
substantivity of CHX due to formation of a salt following a cationic (CHX) and anionic 
(SLS) reaction.320-325 Work by van Strydonck and coworkers326 showed that rinsing 
with a 1.5% SLS slurry prior to use of a 0.2% CHX rinse reduced the anti-plaque 
efficacy of CHX. This has been confirmed by a systematic review by Kolahi and 
Soolari320 which revealed that CHX interacts with SLS to produce insoluble salts 
which reduce the anti-plaque effect of CHX. Using an SLS containing mouth rinse or 
a dentifrice slurry following a CHX rinse significantly increased plaque scores. 
Inactivation of CHX was further examined by Kolahi and Soolari320 by determining 
the amount of tooth staining produced. Tooth staining was reduced by 18% when a 
dentifrice was used prior to a CHX rinse. However, staining was reduced by 79% 
when CHX rinsing preceded tooth brushing. It has also been shown that tooth 
staining by CHX mouth rinses is reduced when rinsing is followed by dentifrice 
use.38, 320 Venu and coworkers showed that a dentifrice containing both CHX and 
SLS reduced S. mutans counts for 3 hours while CHX alone had superior anti-
bacterial effects and substantivity for 7 hours.327  
 
On the other hand, two other previous studies by van Strydonck and coworkers328, 329 
have demonstrated that tooth brushing with a 1.5% SLS-containing dentifrice after a 
CHX rinse made no difference to the anti-plaque effect of CHX. These studies 
suggest that while SLS can interfere with the anti-plaque action of CHX, the 
interference can be obviated by applying CHX prior to the application of SLS. Hence, 
it is now recommended that there should be an interval period of approximately 30 
minutes to 2 hours between brushing with an SLS-containing paste and rinsing with 
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CHX to ensure the greatest anti-bacterial effect.320, 323 
 
10. Conclusions 
ECC is a chronic bacterial infection that is still very much present in today’s society. 
The fight against ECC is an uphill battle but targeting children at a young age with 
preventive strategies will reduce the prevalence of this chronic and destructive 
disease. As S. mutans is one of the main bacteria implicated in ECC, reduction of 
this bacteria using anti-bacterial agents is a possible method of caries control. The 
literature supports the use of preventive chemotherapeutics such as fluoride, CHX 
and PI in order to remove cariogenic bacteria such as S. mutans and, hence, reduce 
the risk of ECC. Combinations of these agents show promise with additional anti-
bacerial, anti-plaque and adhesion inhibitory effects. While many anti-bacterial 
agents have been shown to be effective against S. mutans, large scale clinical 
studies are warranted to determine their safe and efficacious use in children. In 
addition, further laboratory testing is warranted to examine the possible synergistic or 
additive effects of combinations of these anti-bacterial agents. 
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Chapter 2: 
Inhibitory effects of children's toothpastes on 
Streptococcus mutans, Streptococcus sanguinis and 
Lactobacillus acidophilus: A laboratory study 
  
100 
 
Abstract 
Objectives: As suppression of Streptococcus mutans in young children may prevent or 
delay colonisation of the oral cavity, tooth brushing with dentifrices containing anti- S. 
mutans activity may aid in preventing caries. The aims of this study were to compare the 
effects of children’s dentifrices on the growth of S. mutans and non-mutans bacteria 
(Streptococcus sanguinis and Lactobacillus acidophilus).  
 
Methods: The agar diffusion assay at neutral pH was used to examine the antibacterial 
activity of commercial dentifrices and their major constituents.  
 
Results: Dentifrices containing 1,450 ppm fluoride produced greater growth inhibition of 
both S. mutans and S. sanguinis than those with < 500 ppm. No inhibition was seen for 
pure solutions of sodium fluoride or sodium monofluorophosphate at fluoride 
concentrations up to 100,000 ppm. Stannous fluoride exerted antibacterial effects at 
concentrations above 10,000 ppm. Significant growth inhibition of both S. mutans and S. 
sanguinis was seen with sodium lauryl sulphate at 2,500 ppm and with triclosan at 100 
ppm. No inhibitory effects were seen for xylitol, sorbitol, sodium pyrophosphate or 
polyethylene glycol at concentrations up to 80,000 ppm. 
 
 Conclusion: Sodium lauryl sulphate is the major bacterial inhibitory compound in 
children’s dentifrices.  
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Introduction 
Worldwide, early childhood caries (ECC) remains difficult to control, with few practical 
methods available for prevention. As Streptococcus mutans is one of the key bacterial 
species implicated in ECC, its suppression or elimination is a possible method of caries 
control. As well as providing a physical method for disrupting dental plaque biofilms, 
dentifrices contain a number of agents which may inhibit the growth of S. mutans, 
including fluoride compounds, surfactants, antiseptics such as triclosan, flavours and 
humectants. Other dentifrice components such as binders, fillers and abrasives are 
unlikely to exert antibacterial actions. 
 
Fluoride compounds including sodium fluoride (NaF), sodium monofluorophosphate 
(NaMFP) and stannous fluoride (SnF2) have been added to dentifrices for several 
decades,1, 2 to help prevent demineralisation of enamel and to enhance remineralisation 
of early carious lesions. Although fluoride can be bactericidal at high concentrations and 
particularly under low pH conditions, it is unclear whether any anti-S. mutans activity is 
exerted by fluoride at the levels found in commercial dentifrices used for children.3, 4 
Many “adult” dentifrices contain 1,000 – 1,500 ppm fluoride. In Australia, dentifrices with 
less than 500 ppm fluoride are recommended for young children due to concerns 
regarding accidental ingestion and the risk of fluorosis.5 Dentifrices with fluoride 
concentrations below 500 ppm have not demonstrated consistent anti-caries effects.2, 6 
 
A range of compounds are added to dentifrices to enhance their palatability and 
cleansing properties, including sugar alcohols such as xylitol as a sweetener (which may 
also have potential anti-S. mutans effects),7 and sodium lauryl sulphate (SLS) as a 
surfactant.8 Other key dentifrice ingredients may include triclosan or stannous fluoride to 
inhibit plaque formation,9 and sodium pyrophosphate to reduce calculus formation.10 We 
hypothesized that children’s dentifrices could exert anti-bacterial activity against S. 
mutans due to the presence of fluoride or other ingredients such as SLS. Although the 
main properties of toothpastes have been reported by the manufacturers, comparative 
information among the common toothpastes and details regarding the effects on 
cariogenic bacteria have not been well researched. Given the clinical importance of tooth 
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brushing in caries prevention for young children, the aims of this study, therefore, were (i) 
to investigate the effects of various commercial children’s dentifrices on the growth of S. 
mutans and non-mutans bacteria (S. sanguinis and Lactobacillus acidophilus) and (ii) to 
determine the antibacterial effects of the various compounds used in dentifrices. 
 
Materials and Methods 
Commercially available children's dentifrices with fluoride concentrations of less than 500 
ppm were compared to adult dentifrices with 1,450 ppm fluoride and a 5,000 ppm fluoride 
dentifrice. The details of the products are shown in Table 1.  
 
S. mutans ATCC 25175 and S. sanguinis ATCC 10556 were obtained from the American 
Type Culture Collection (ATCC; Manassas, VA, USA) and maintained in 15% glycerol 
stocks at -80 °C, while L. acidophilus were purchased in capsule form as L. acidophilus 
NCFM (Inner Health Plus, Northgate, Australia). S. mutans and S. sanguinis were revived 
from freeze-dried vials and cultured on trypticase soy agar (Becton Dickinson, Franklin 
Lakes, NJ, USA) supplemented with 5% defibrinated sheep blood (Equicell, Melbourne, 
VIC, Australia). After the plates had been incubated for 7 days at 37ºC, bacterial colonies 
were subcultured in brain heart infusion broth (BHI; Becton Dickinson) for 2-3 days at 37 
°C. The purity of the plate and broth cultures was monitored by Gram staining and 
colonial morphology. Bacterial identification was carried out using the API rapid ID 32 
Strep and API 50 CHL identification kits (BioMerieux SA, Marcyl'Etoile, France). 
 
Inhibition of growth was assessed for S. mutans, S. sanguinis and L. acidophilus using 
the agar diffusion assay, an approach which has been validated in previous 
investigations.11-13 In this method, pre-prepared Mueller-Hilton agar petri dishes (MH 
agar, Thermo Fisher Scientific, Rockford, IL, USA) were employed for S. mutans and S. 
sanguinis. This protein-free agar is a standard bacterial medium used for antimicrobial 
sensitivity testing14 as it supports the growth of streptococci. For L. acidophilus, Rogosa 
agar (MRS agar, Becton Dickinson, Franklin Lakes, NJ, USA) was used.15 
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In each agar plate, four wells of 5 mm in diameter were formed in the agar by removing 
plugs cut with a stainless steel punch.13 The wells were spaced approximately 30 mm 
apart and 20 mm from the outer edge. All procedures were performed under sterile 
conditions. Each well was filled with 0.1 mL of dentifrice. For each plate, a mixture of 5 
mL aliquots of bacterial suspension (6x108 bacteria/ mL) and 5 ml of melted Mueller-
Hinton agar at 45 °C was poured evenly over the surface of the agar containing wells 
loaded with the test products.13 
 
The culture plates were inverted and incubated at 37 °C for 72 hrs. At the end of this 
incubation period, bacterial growth was confluent on the agar surface except at areas of 
growth inhibition, which were indicated by clear areas around the test well containing the 
relevant product (Fig. 1).11, 12 The areas of growth inhibition were viewed by inverting the 
agar plate, and were measured directly using a micrometer gauge. All measurements 
were performed in triplicate, and the mean and standard deviations calculated. For each 
agent tested, the experiments were performed in triplicate for S. mutans, S. sanguinis 
and L. acidophilus.  
 
Dose response testing was also performed on various compounds found in the 
dentifrices. NaF, NaMFP and SnF2 (all from Sigma-Aldrich, St Louis, MO, USA) were 
used at fluoride concentrations from 100 to 100,000 ppm in distilled water. Sucrose, 
fructose, xylitol and sorbitol (all from Sigma-Aldrich), were used from 1,000 to 100,000 
ppm, and SLS (Amresco Inc, Solon, OH, USA) from 100 to 10,000 ppm. Triclosan 
(Sigma-Aldrich), sodium pyrophosphate (Alfa Aksar, Heysham, England), and 
polyethylene glycol 600 (Scharlab S.L., Sentmenat, Spain) were all used from 100 ppm 
to 8,000 ppm. The test agents were dissolved in 0.15 M phosphate buffered saline, pH 
7.2 (PBS), and added into the test wells. Chlorhexidine gluconate (2% w/v) was used as 
the positive control, and either distilled water or PBS as the  negative/vehicle control. 
 
Statistical Analysis 
One-way ANOVA with Bonferroni post-tests (for parametric data) and the Kruskal-Wallis 
test with Dunn post-test (for non-parametric data) were used to test for differences in the 
zone of inhibition amongst the commercial dentifrices, pure compounds and bacteria. 
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Statistical analysis was performed using Instat (GraphPad Software Inc., California, 
USA), and the alpha value was set at 0.05. 
 
Results  
Table 2 shows the results for commercial children’s dentifrices. Colgate My First and Oral 
B Stages both inhibited the growth of all three bacteria. Both were significantly better 
than Macleans Milk Teeth. Greater growth inhibition was seen for L. acidophilus than for 
S. mutans or S. sanguinis (p<0.01). There were no statistically significant differences in 
growth inhibition between S. mutans and S. sanguinis.  
 
Table 3 shows the results for adult dentifrices containing fluoride at 1,450 ppm from NaF, 
NaMFP or SnF2, or at 5,000 ppm from NaF. All adult dentifrices gave significantly greater 
inhibition for S. mutans than for L. acidophilus (p<0.01 for all products). The extent of 
growth inhibition did not differ between S. mutans and S. sanguinis for Colgate Total, 
Oral B Tooth and Gums and Macleans Extreme Clean.  
 
In terms of fluoride levels, dentifrices with less than 500 ppm fluoride gave less growth 
inhibition against S. mutans and S. sanguinis than those with 1,450 ppm fluoride (p<0.01) 
(Tables 2, 3 and 4). In contrast, growth inhibition of L. acidophilus was similar between < 
500 ppm and 1,450 ppm products (Tables 2, 3 and 4). As shown in Table 4, for 
lactobacilli there were no statistically significant differences between products containing 
NaMFP (Colgate Pro Relief), NaF (Colgate Total), and SnF2 (Oral B Pro Health). In 
contrast, the differences in growth inhibition for S. mutans and S. sanguinis among these 
various products were all statistically significant (all p<0.01).  
 
Across the study, Colgate Total produced the greatest mean growth inhibition on S. 
mutans and S. sanguinis, while Colgate Pro Relief produced the least. For Colgate Total 
the inhibition zone for L. acidophilus was less than half of that seen for S. mutans (16.8 ± 
1.8 versus 44.6 ± 2.3 mm respectively, p<0.01) (Tables 2 and 3). 
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In terms of the effects of pure compounds, dose response experiments using fluoride 
solutions at concentrations between 100 and 100,000 ppm failed to show growth 
inhibition of any three bacterial species for both NaF and NaMFP, while SnF2 inhibited 
bacterial growth at a minimum inhibitory concentration (MIC) of 10,000 ppm. With SnF2, 
growth inhibition was statistically different between S. mutans and L. acidophilus at 
concentrations of 10,000 ppm, 15,000 ppm and 40,000 ppm (Table 5). 
 
The dose response experiments using fructose, sucrose, xylitol, sorbitol and mannitol at 
concentrations ranging from 100 to 8,000 ppm did not reveal any growth inhibition. The 
same trend was found for polyethylene glycol and sodium pyrophosphate. In contrast, 
significant growth inhibition was seen for SLS for all three bacterial species (Table 6). 
The MIC was 500 ppm for L. acidophilus, and 2,500 ppm for both S. mutans and S. 
sanguinis. Greater inhibition zones were seen for L. acidophilus than for S. mutans 
(p<0.001), but differences between the two streptococci were not significant. Triclosan 
showed an inverse pattern to SLS, in that it inhibited the growth of both S. mutans and S. 
sanguinis (with an MIC of 100 ppm), but was ineffective against L. acidophilus (Table 7). 
 
Discussion 
The results of this study provide several insights into the effects of dentifrices and their 
components on S. mutans. There is increasing evidence that mechanical oral hygiene 
through tooth brushing is associated with reduced risk for early childhood caries.16, 17 As 
most children brush their teeth with a dentifrice, caries preventive effects could arise from 
both the fluoride and non-fluoride components of the dentifrice. While the major 
mechanism of caries reduction by fluoride is remineralisation of early lesions and 
prevention of demineralisation,18, 19 fluoride can exert antibacterial effects when present 
at high levels and particularly under acidic pH conditions.3 The importance of pH is seen 
in that under the conditions used in this study (neutral pH), both NaF and NaMFP used at 
levels nearly 10 times greater than those found in dentifrices did not inhibit the growth of 
S. mutans, S. sanguinis  or L. acidophilus.  
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Under low pH conditions, fluoride is most able to bind to tooth surfaces and to bacterial 
cells.20 Fluoride is able to bind to specific enzymes and proteins to inhibit their actions, 
and this occurs to a greater extent in acidic environments,4 due to the formation of 
hydrogen fluoride,20 which crosses the bacterial cell membrane readily to dissociate in 
the cytoplasm. The released fluoride acts as a metabolic inhibitor while the protons 
acidify the cytoplasm, leading to cell death.4, 21 Since the current study used neutral pH 
conditions, the known antibacterial actions of fluoride on S. mutans were not seen 
because the Mueller-Hinton agar has a pH of 7.2-7.4.22 At this pH, fluoride is less active, 
and less able to interfere with acid production and proliferation of bacteria.  
 
It is also worth noting that, regarding the antimicrobial effects of fluoride, it is often difficult 
to apply the in-vitro results to the in-vivo situation.23 Most investigations have 
demonstrated that the concentrations of fluoride found in plaque cannot influence the 
microbial composition.24 Furthermore, the fluoride concentrations attained in plaque after 
application of 1500 ppm fluoride toothpaste do not appear to have anti-microbial effects 
on plaque bacteria.25 
 
An interesting point of comparison is that stannous fluoride exerted antibacterial effects 
at neutral pH, which can be attributed to the action of the stannous ion, which has known 
antibacterial properties.26, 27 SnF2 is a more potent antibacterial agent than NaF, with a 
lower minimum inhibitory concentration.28 Clinical studies have shown that suppression 
of S. mutans levels when used in mouth rinse and dentifrice formulations, with a degree 
of substantivity due to up to 25% of the stannous ion remaining in the oral cavity for up to 
4 hours post rinsing.29 The stannous ion binds to bacterial cell walls and penetrates into 
bacterial cells.30 The bound stannous ions may impair bacterial attachment, while 
internalized ions block functional sites of enzymes and precipitate proteins,31 thereby 
interfering with growth and reducing cell viability.30 32 Together, these actions explain the 
greater growth inhibition of S. mutans produced by SnF2 than NaF seen in the current 
study.  
 
An important observation in the present study was the strong effects exerted on the 
growth of S. mutans by SLS. This agent is known to reduce lactate production, 
glucosyltransferase activity and extracellular polysaccharide formation by S. mutans.8, 33 
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It also interferes with the adsorption of proteins to enamel, thus impairing the formation of 
salivary pellicle.34 In the present study, SLS gave growth inhibition against all three 
bacteria tested, with an MIC of 2,500 ppm against S. mutans and S. sanguinis and 500 
ppm against L. acidophilus. This anti-mutans activity of SLS may explain past clinical 
outcomes of low or zero levels of S. mutans after the commencement of tooth brushing 
with children’s dentifrice,16 and fewer mutans streptococci positive children in those 
young children who had their teeth brushed twice daily with a children’s dentifrice 
compared to those who had less frequent tooth brushing.35  
 
Triclosan is well known to exert broad-spectrum antibacterial activity against both Gram 
negative and Gram positive bacteria including S. mutans,9 by disrupting bacterial 
cytoplasmic membranes and blockading fatty acid biosynthesis.36 It interferes with 
bacterial adhesion and growth.9 In the present study, triclosan gave an MIC of 100 ppm 
for S. mutans and S. sanguinis, but did not inhibit the growth of L. acidophilus at levels 
below 8,000 ppm. Due to its limited water solubility and low retention in the oral cavity,37 
in some commercial dentifrices such as Colgate Total, triclosan is combined with a 
copolymer of polyvinylmethylether/ maleic acid (PVM/MA), giving enhanced substantivity 
and anti-plaque efficacy.36, 38 In the present study, both dentifrices containing triclosan 
(Colgate Total and Oral B Tooth and Gums) produced statistically greater growth 
inhibition on all three bacteria compared to the pure triclosan solutions tested, which can 
be explained by the presence of SLS in the dentifrices. These two dentifrices gave the 
greatest growth inhibition for S. mutans and S. sanguinis seen amongst the commercial 
dentifrices tested. These streptococci have similar structural properties,39, 40 so this is not 
unexpected.  
 
However, the antimicrobial effects of triclosan are likely to be diluted to sub-lethal 
concentrations when mixed with saliva in the mouth. As the use of sub-lethal 
concentrations of triclosan may promote the development of cross or co-resistance to 
other clinically important antimicrobial agents, some authors have proposed that the use 
of triclosan be restricted to well documented purposes.41 
 
While many studies have reported that regular tooth brushing lowers caries risk, it is 
unclear to what extent this relates to gross disruption of the dental plaque biofilm, 
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selective suppression of cariogenic bacteria, or remineralisation from fluoride. The 
present results indicate that some dentifrice components such as SLS, triclosan and 
stannous fluoride can exert inhibitory properties on bacterial growth, whilst others such 
as xylitol and sorbitol (which are added to improve taste), polyethylene glycol (a 
humectant) and sodium pyrophosphate (an anti-calculus agent) do not, in the assay 
system used. Past studies have shown that xylitol and sorbitol are metabolised only 
minimally by the test bacteria used in this study.7, 42 The agar diffusion assay does not 
rely upon bacterial adhesion, which is why agents which can block binding to apatite 
crystals sites, such as sodium pyrophosphate10  and polyethylene glycol (PEG)43, 44 did 
not show antibacterial activity. 
 
While the present laboratory results provide insight into the antibacterial activity of 
children’s toothpaste, the clinical implications were not investigated. In the mouth, saliva 
is likely to influence the activity of the active components through modulation of the pH or 
dilution of the compounds to less effective concentrations. Furthermore, the laboratory 
exposure time of 72 hours may not be reached in the mouth due to clearance of the 
agent from salivary flow. 
 
In conclusion, inhibiting the growth of S. mutans in young children during the early stages 
of colonisation may prevent its long term establishment in the oral cavity. To this end, 
tooth brushing with dentifrices containing compounds with anti-S. mutans activity can 
contribute to the prevention of early childhood caries. The present study shows that 
children's dentifrices can inhibit the growth of S. mutans, and this is largely due to sodium 
lauryl sulphate. 
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Tables and Figures 
 
Figure 1. A culture plate with wells overlaid with S. mutans. 1 =  Oral B Stages, 2 =  0.1% 
sodium fluoride, 3 = Macleans Milk Teeth, and 4 = Colgate My First. Clear zones of 
growth inhibition are observed around wells 1, 3 and 4, but none around well 2. 
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Table 1. Fluoride compounds and other ingredients in dentifrices commercially 
available in Australia  
 Product Fluoride  
Other ingredients 
(listed by manufacturer) 
 
Standard adult 
fluoride 
concentration 
dentifrice 
Colgate Total 
(Colgate 
Palmolive Pty Ltd, 
Sydney, Australia) 
Sodium fluoride 
(1,450 ppm F) 
Water, Hydrated silica, Glycerin, 
Sorbitol, PVM/MA, Copolymer, 
Sodium lauryl sulfate, Flavour, 
Carrageenan, Titanium dioxide, 
Sodium saccharin, Triclosan 
Oral B Tooth and 
Gums (Procter & 
Gamble, 
Cincinnati, USA) 
Sodium fluoride 
(1,450 ppm F) 
Aqua, Hydrated silica, Sorbitol, PEG-
6, Sodium lauryl sulphate, 
Tetrapotassium pyrophosphate, 
Disodium pyrophosphate, 
Tetrasodium pyrophosphate, Aroma, 
Cellulose gum, Cl77891, Xanthan 
gum, Carbomer, Sodium saccharin, 
Triclosan, Limonene 
Macleans 
Extreme Clean 
(GlaxoSmithKline 
Pty Ltd, 
Melbourne, 
Australia) 
Sodium fluoride 
(1,450 ppm F) 
Water, Sorbitol, Hydrated silica, 
Glycerin, PEG-6, Sodium Lauryl 
Sulphate, flavour, Xanthan Gum, 
Titanium Dioxide, Cocamidopropyl 
Betaine, Sodium Saccharin, Sodium 
Fluoride, C177492, C173360. 
Colgate Sensitive 
Pro Relief 
(Colgate 
Palmolive Pty Ltd, 
Sydney, Australia) 
Sodium 
Monofluorophosphate 
(1,450 ppm F) 
Calcium carbonate, Water, Sorbitol, 
Arginine 8%, Bicarbonate, Sodium 
lauryl sulphate, Flavour, Sodium 
silicate, Carmeliose sodium, Sodium 
bicarbonate, Titanium dioxide, 
Acesulfame potassium, Xanthan gum, 
Sucralose, Limonene 
Oral B Pro Health 
(Procter & 
Gamble, 
Cincinnati, USA) 
Stannous Fluoride 
(1,100ppm), Sodium 
fluoride (350 ppm) 
Hydrated silica, Sodium phosphate 
dodecahydrate, Glycerin, Propylene 
glycol 
 
Low dose fluoride 
dentifrice 
Colgate My First 
(Colgate 
Palmolive Pty Ltd, 
Sydney, Australia) 
Sodium 
Monofluorophosphate 
(500 ppm F) 
Water, Sorbitol, Hydrated silica, PEG-
12, Cellulose gum, Sodium lauryl 
sulphate, Flavour, Sodium saccharin, 
Tetrasodium pyrophosphate, FD&C 
blue no.1 
Oral B Stages 
(Procter & 
Gamble, 
Cincinnati, USA) 
Sodium fluoride 
(500 ppm F) 
Sorbitol, Aqua, Hydrated silica, 
Sodium lauryl sulphate, Cellulose 
gum, Aroma, Sodium saccharin, 
Carbomer, Limonene, Trisodium 
phosphate,Cl42090 
Macleans Milk 
Teeth 
(GlaxoSmithKline 
Pty Ltd, 
Melbourne, 
Australia) 
Sodium fluoride 
(500 ppm F) 
Water, Sorbitol, Hydrated silica, 
Glycerin, PEG-6, Sodium lauryl 
sulphate, Titanium dioxide, Xanthan 
gum, Genuvisco, Sodium saccharin, 
Flavour 
 
High Fluoride 
Specialty 
Toothpaste  
Colgate 
Neutrafluor 5000 
(Colgate 
Palmolive Pty Ltd, 
Sydney, Australia) 
Sodium fluoride 
(5,000 ppm F) 
Aqua, Silicon dioxide, Sorbitol, 
Macrogol 600, Carrageenan, Sodium 
lauryl sulphate, Flavour, Poloxamer, 
Cocamidopropyl, Betaine, Sodium 
saccharin, Mica, Sodium hydroxide, 
Titanium dioxide, Brilliant blue FCF, 
Quinoline Yellow 
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Table 2. Growth inhibitory effects of children's dentifrices with 500 ppm F 
  
Zone of inhibition 
Mean diameter (mm ± S.D.) 
 
 
P-Value 
Children’s 
Toothpaste 
Fluoride 
compound 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n
t
 SM v SS SM v LB 
Colgate My 
First 
NaMFP 
(500 ppm F) 
12.0 (±0.85) 12.1 (±1.15) 14.7 (±1.34) 12 N.S.* <0.001* 
Oral B 
Stages 
NaF 
(500 ppm F) 
11.7 (±0.69) 11.6  (±0.77) 14.1 (±0.76) 12 N.S.* <0.001* 
Macleans 
Milk Teeth 
NaF 
(500 ppm F) 
13.3 (±0.69) 13.0 (±0.54) 17.3 (±2.66) 12 N.S.* <0.001* 
Mean diameter (mm ± S.D.) 12.4 (±1.02) 12.3 (±1.03) 15.4 (±2.24) 
 
 
P value 
(Colgate My First v  
Oral B Stages) 
 
N.S.* N.S.^ N.S.^ 
P value 
(Colgate My First v 
Macleans Milk Teeth) 
<0.01* <0.05^ <0.01^ 
P value 
(Oral B Stages v  
Macleans Milk Teeth) 
<0.001* <0.001^ <0.001^ 
 
* Kruskal-Wallis test with Dunn post-tests  
^ One-way ANOVA with Bonferroni post-tests 
n
t
 = number of experiments 
N.S. = non-significant (>0.05) 
  
116 
 
Table 3. Growth inhibitory effects of adult strength dentifrices with 1450 ppm F  
 
 
Zone of inhibition 
Mean diameter (mm ± S.D.) 
 
 P-Value 
Toothpaste 
Fluoride 
compound 
(concentration) 
 
S. mutans 
(SM) 
 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n
t
 SM v SS SM v LB 
Colgate 
Total 
NaF 
(1,450 ppm F) 
44.6 (±2.33) 43.3 (±2.02) 16.8 (±1.80) 12 N.S.^ <0.001^ 
Oral B 
Tooth and 
Gum 
NaF 
(1,450 ppm F) 
33.5 (±2.07) 35.2 (±2.20) 15.8 (±0.96) 12 N.S.* <0.01* 
Macleans 
Extreme 
Clean 
NaF 
(1,450 ppm F) 
8.4 (±0.93) 8.0 (±1.32) 14.6 (±2.36) 12 N.S.* <0.001* 
Mean (Colgate, Oral B & 
Macleans 1,450 ppm NaF) 
28.8 (±15.45) 28.8 (±15.41) 15.7 (±1.98)  
Neutrafluor 
5000 
NaF 
(5,000 ppm F) 
9.8 (±0.50) 9.2 (±0.45) 13.0 (±1.31) 12 N.S.* <0.01* 
Colgate Pro 
Relief 
NaMFP  
(1,450 ppm F) 
13.8 (±1.12) 11.6 (±1.51) 17.9 (±0.54) 12 N.S.* <0.01* 
Oral B Pro 
Health 
SnF2  
(1,100 ppm F) 
NaF 
(3,50 ppm F) 
23.0 (±0.88) 19.3 (±1.48) 19.0 (±0.99) 12 <0.001* <0.001* 
 
* Kruskal-Wallis test with Dunn post-tests  
^ One-way ANOVA with Bonferroni post-tests 
n
t
 = number of experiments 
N.S. = non-significant (>0.05) 
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Table 4. Comparison of inhibitory effects of adult and child dentifrices  
 P-Value 
Comparison Groups S. mutans S. sanguinis L. acidophilus 
Colgate Total v Oral B 
Tooth and Gums 
<0.05* <0.05* N.S.* 
Colgate Total v Macleans 
Extreme Clean 
<0.001* <0.001* <0.05* 
Oral B Tooth and Gums v 
Macleans Extreme Clean 
<0.05* <0.05* N.S.* 
Colgate Pro Relief v 
Colgate Total 
<0.001* <0.001^ N.S.* 
Colgate Pro Relief v Oral B 
Pro Health 
<0.05* <0.001^ <0.01* 
Oral B Pro Health v 
Colgate Total 
<0.05* <0.001^ N.S.* 
Mean <500 ppm F v Mean 
1,450 ppm F 
0.014~ 0.014~ N.S.~ 
 
* Kruskal-Wallis test with Dunn post-tests  
^ One-way ANOVA with Bonferroni post-tests 
~ 
Mann-Whitney Test 
N.S. = non-significant (>0.05) 
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Table 5. Growth inhibitory effects of stannous fluoride 
 Zone of inhibition 
Mean diameter (mm ± S.D.) 
 
P-Value 
Concentratio
n of SnF2 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n
t 
SM v 
SS 
SM v 
LB 
5,000 ppm 0 0 0 12 - - 
10,000 ppm 9.4 (±0.51) 9.4 (±0.67) 8.7 (±0.49) 12 N.S.* <0.05* 
15,000 ppm 11.3 (±0.65) 11.3 (±0.62) 10.6 (±0.51) 12 N.S.* <0.05* 
20,000 ppm 12.6 (±0.51) 12.8 (±0.58) 13.1 (±0.69) 12 N.S.* N.S.* 
40,000 ppm 16.6 (±0.67) 16.8 (±0.58) 17.7 (±0.78) 12 N.S.* <0.01* 
80,000 ppm 21.3 (±0.65) 20.8 (±0.72) 21.1 (±0.90) 12 N.S.* N.S.* 
100,000 ppm 24.1 (±0.67) 23.4 (±1.00) 24.1 (±0.67) 12 N.S.* N.S* 
 
* Kruskal-Wallis test with Dunn post-tests 
n
t
 = number of experiments 
N.S. = non-significant (>0.05) 
  
119 
 
Table 6. Growth inhibitory effects of sodium lauryl sulphate  
 Zone of inhibition 
Mean diameter (mm ± S.D.) 
  
P-Value 
Concentratio
n of SLS 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n
t 
SM v 
SS 
SM v 
LB 
100 ppm 0 0 0 12 - - 
500 ppm 0 0 5.5  (±0.43) 12 N.S.* <0.001* 
1,000 ppm 0 0 7.5 (±0.99) 12 N.S.* <0.001* 
2,000 ppm 0 0 10.0 (±0.72) 12 N.S.* <0.001* 
2,500 ppm 7.0 (±0.85) 7.6 (±0.90) 10.5 (±0.67) 12 N.S.* <0.001* 
3,500 ppm 9.0 (±0.60) 9.7 (0.98) 11.7 (±0.49) 12 N.S.* <0.001* 
5,000 ppm 10.8 (±0.96) 10.1 (±0.76) 13.3 (±0.75) 12 N.S.* <0.001* 
8,000 ppm 12.8 (±0.72) 12.6 (±0.79) 14.7 (±0.75) 12 N.S.* <0.001* 
10,000 ppm 11.2 (±1.53) 12.3 (±0.78) 12.3 (±1.07) 12 N.S.* N.S.* 
 
* Kruskal-Wallis test with Dunn post-tests 
n
t
 = number of experiments 
N.S. = non-significant (>0.05) 
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Table 7. Growth inhibitory effects of triclosan 
 Zone of inhibition 
Mean diameter (mm ± S.D.) 
 
P-Value 
Concentratio
n of Triclosan 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n
t 
SM v 
SS 
SM v 
LB 
80 ppm 0 0 0 12 - - 
100 ppm 21.1 (±1.17) 21.4 (±1.56) 0 12 N.S.* <0.001* 
500 ppm 23.4 (±1.08) 24.6 (±1.78) 0 12 N.S.* <0.001* 
1,000 ppm 25.1 (±4.21) 27.3 (±2.49) 0 12 N.S.^ 
<0.001
^ 
2,000 ppm 25.6 (±1.68) 29.3 (±2.23) 0 12 <0.05* <0.01* 
5,000 ppm 18.3 (±4.21) 18.7 (±5.82) 0 12 N.S.* <0.001* 
8,000 ppm 21.0 (±3.45) 21.4 (±5.20) 0 12 N.S.^ 
<0.001
^ 
 
* Kruskal-Wallis test with Dunn post-tests 
^ One-way ANOVA with Bonferroni post-tests 
n
t
 = number of experiments 
N.S. = non-significant (>0.05) 
 
 
  
121 
 
 
 
 
 
Chapter 3:  
Inhibitory effects of antiseptic mouth rinses on 
Streptococcus mutans, Streptococcus sanguinis and 
Lactobacillus acidophilus 
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Abstract 
Objectives: Oral antiseptics are valuable in controlling oral infections caused by 
cariogenic bacteria.The aim of this study was to investigate the effects of mouth rinses 
and pure antiseptic compounds on Streptococcus mutans and non-mutans bacteria 
(Streptococcus sanguinis and Lactobacillus acidophilus).  
 
Methods: The agar diffusion assay was employed to determine bacterial growth 
inhibition. 
 
Results: Commercial mouth rinses containing chlorhexidine gluconate (0.2%), 
cetylpyridinium chloride (0.05%) and sodium fluoride (0.05%) produced statistically 
similar growth inhibition of S. mutans, S. sanguinis and L. acidophilus (with zones of 
inhibition ranging from 7.56 ± 0.52 mm to 7.39 ± 0.53 mm, 17.44 ± 0.94 mm to 18.31 ± 
0.62 mm and 8.61 ± 1.43 to 8.67 ± 1.43 mm respectively, p>0.05). The chlorhexidine 
mouth wash produced the greatest mean growth inhibition of S. sanguinis and S. mutans 
compared to all other mouth rinses tested (p<0.01). The minimum concentrations at 
which inhibition against S. mutans could be detected were chlorhexidine gluconate at 
0.005% (wt/vol), cetylpyridinium chloride 0.01% (wt/ vol), povidone iodine 10% (wt/ vol) 
and sodium hypochlorite 0.5% (vol/vol).  
 
Conclusions: Chlorhexidine (0.01%), cetylpyridinium chloride (0.01%) povidone iodine 
(10%) and sodium hypochlorite (0.5%) are effective at inhibiting the growth of S. mutans, 
S. sanguinis and L. acidophilus.  
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Introduction 
Caries in children is initiated by colonisation of the cariogenic bacteria, mutans 
streptococci, namely Streptococcus mutans and Streptococcus sobrinus.1, 2 Children who 
develop caries have high mutans streptococci counts and are colonised at younger ages 
compared to caries-free children.3 Lactobacillus is associated with caries progression due 
its aciduric and acidogenic properties.4 There is a great need to find preventive agents for 
caries which are safe and efficacious for children. Numerous antiseptic agents are 
potentially useful to reduce oral infection with cariogenic bacteria and control caries in 
children. Although mouth rinses may not be suitable for children younger than 6 years of 
age, antiseptic agents can be formulated as gels or added to toothpastes to augment the 
mechanical removal of bacteria from tooth brushing. 
 
Common antiseptics that are employed in oral hygiene products include chlorhexidine, 
povidone iodine, cetylpyridinium chloride, sodium hypochlorite and essential oils. 
Chlorhexidine is a potent, hydrophilic bisguanide antiseptic agent.5 It reduces plaque 
formation, and selectively inhibits the growth of Gram-positive cariogenic microorganisms 
including S. mutans and some species of Lactobacillus.5 It binds to negatively charged 
particles including bacterial cell walls, salivary pellicle and mucosa, giving it high 
substantivity.6 At low concentrations (<1%), chlorhexidine is bacteriostatic by interfering 
with cell wall transportation leading to leakage of intracellular components.7 At high 
concentrations (>1%), it is bactericidal by causing precipitation of the intracellular 
cytoplasm. It also impedes on the action of glycosyltransferase thus preventing adhesion 
of bacteria to the tooth surface.7 Numerous studies have shown chlorhexidine in both 
mouth rinse and toothpaste formulations can suppress mutans streptococci counts in 
children.6, 8  
 
Povidone iodine is an antiseptic with many uses in medicine and dentistry such as 
reducing bacterial contamination prior to, during and after dental surgery.9 The complex 
of iodine with polyvinyl pyrrolidone is used to minimise staining and irritation from the 
iodine as well as increase its water solubility for enhanced antibacterial actions.9 
Numerous studies have reported that povidone iodine reduces mutans streptococci 
counts in high caries risk children.10  
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Cetylpyridinium chloride is an antiseptic quaternary ammonium compound with a high 
affinity for Gram-positive bacteria such as mutans streptococci.11 As with chlorhexidine, 
cetylpyridinium chloride has a high binding affinity for negatively charged bacterial cell 
walls. It causes membrane disruption, leakage of cytoplasmic components and inhibition 
of metabolism and proliferation. In dental biofilms, it prevents cellular aggregation and 
thus plaque maturation.11, 12 Cetylpyridinium chloride has an inherently strong ability to 
adhere to oral surfaces, although it has limited substantivity.12  
 
Essential oils contained in mouth rinses such as Listerine® (Johnson & Johnson Pty Ltd, 
Melbourne Australia) can permeate through dental biofilms, disrupt bacterial cell walls, 
inhibit enzyme activity, and prevent bacterial aggregation and proliferation.13 A few 
studies have shown that essential oils mouth rinses significantly reduce plaque and total 
oral bacterial counts 14, 15 
 
Although the effects of common antiseptics used in oral hygiene products have been well 
investigated for their clinical effects on periodontal pathogens and S. mutans, relatively 
little is known about their effects on non-mutans streptococci and lactobacilli. Therefore, 
the aim of the present study was to compare the general effects of mouth rinses and pure 
antiseptic compounds on S. mutans and non-mutans bacteria, Streptococcus sanguinis 
and Lactobacillus acidophilus using  mono-bacterial cultures.  
 
Materials and methods 
Commercially available antiseptic mouth rinses were tested for growth inhibitory effects 
on S. mutans, S. sanguinis and L. acidophilus. Brands with alcohol-free formulations 
were selected for testing except for cetylpyridinium chloride mouth rinses as there were 
no alcohol-free formulations available commercially. The test mouth rinses include 
Colgate Savacol® (Colgate Palmolive Pty Ltd, Sydney, Australia), Colgate Neutrafluor® 
220 (Colgate Palmolive Pty Ltd), Betadine® (Sanofi-aventis, Virginia, Australia), 
Cepacol® (Bayer Healthcare, Sydney, Australia), Listerine® Zero (Johnson & Johnson 
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Pty Ltd, Melbourne Australia) and Milton® solution (Procter & Gamble, Cincinnati, USA). 
The details of the mouth rinses tested are shown in Table 1.  
 
Dose response testing was performed on pure active ingredients obtained from Sigma-
Aldrich (St Louis, MO, USA): chlorhexidine, povidone iodine, sodium hypochlorite, 
cetylpyridinium chloride and individual essential oils. Solutions of each agent were 
prepared at concentrations of 0.01%, 0.05%, 0.1%, 0.2%, 0.5% and 0.8% in 0.15M 
phosphate buffered saline, pH 7.2.  
 
Bacteria were obtained from the American Type Culture Collection (ATCC; Manassas, 
VA, USA). S. mutans ATCC 25175 and S. sanguinis ATCC 10556 were revived from 
freeze-dried vials. L. acidophilus was purchased in capsule form as L. acidophilus NCFM 
(Inner Health Plus, Northgate, Australia). The bacteria were cultured on tripticase soy 
agar (Becton Dickinson) supplemented with 5% defibrinated sheep blood (Equicell, 
Melbourne, Australia). The plates were incubated for 7 days at 37ºC. The bacterial 
colonies were subcultured in brain heart infusion broth (BHI; Becton Dickinson) and 
incubated for 2-3 days at 37 °C. Viability was checked by subculture, and the purity of the 
plate and broth cultures was monitored by Gram stain and colonial morphology. Bacterial 
identification was carried out using the API rapid ID 32 Strep and API 50 CHL 
identification kits (BioMerieux SA, Marcyl'Etoile, France). All strains were maintained in 
15% glycerol stocks at -80 °C.  
 
The inhibition of growth of S. mutans, S. sanguinis and L. acidophilus from each mouth 
rinse or pure compound was tested using the agar diffusion assay, an approach which 
has been validated in previous reports. 16-18 In this method, pre-prepared Mueller-Hilton 
agar petri dishes (MH agar, Thermo Fisher Scientific, Rockford, IL, USA) were employed 
for testing S. mutans and S. sanguinis. This protein-free agar is a standard bacterial 
medium for investigations of antimicrobial sensitivity testing19 for Streptococcal species. 
For testing of Lactobacilli species, Rogosa agar (MRS agar, Becton Dickinson, Franklin 
Lakes, NJ, USA) was used.20 In each agar plate, four wells of 5 mm in diameter were 
formed in the agar by removing plugs cut with a stainless steel borer.16 The wells were 
spaced approximately 30 mm apart and 20 mm from the outer edge. All procedures were 
performed under sterile conditions. Each well was loaded with a fine spiral of filter paper 
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weighing 0.03g. Sixty µL of mouth rinse or pure compound was pipetted into each well 
containing the filter paper. 
 
Five mL aliquots of a bacterial suspension (6x108 bacteria/mL) were added to five mL of 
melted Muller-Hinton agar at 45 °C, then mixed thoroughly and poured evenly over the 
surface of each agar plate containing wells loaded with test medicaments.16 The culture 
plates were inverted and incubated at 37 °C for 72 hrs. At the end of incubation time, 
bacterial growth was confluent on the agar surface except at areas of growth inhibition 
where there was a clear zone surrounding the test well (Figure 1).17, 18  The areas of 
growth inhibition were viewed by inverting the agar plate, and were measured directly 
using a micrometer gauge. All experiments and measurements were performed in 
triplicate, and the mean and standard deviations obtained. Phosphate buffered saline 
(PBS) was used as a negative control.  
Statistical analysis 
One-way ANOVA with Bonferroni post-tests (for parametric data) and the Kruskal-Wallis 
test with Dunn post-tests (for non-parametric data) were used to test for differences in 
zone of inhibition among the mouth rinses, individual compounds and bacteria. Statistical 
analysis was performed using GraphPad (GraphPad Software Inc., California, USA), and 
the alpha value was set at 0.05. 
 
Results 
Results from screening various commercial brands of antiseptic mouth rinses are shown 
in Table 2. Neutrafluor 220, Savacol and Cepacol were the only products to produce 
growth inhibitory effects against S. mutans and S. sanguinis. These mouth rinses 
produced similar growth inhibition of S. mutans and S. sanguinis (p>0.05). Savacol 
produced the greatest mean growth inhibition on S. sanguinis and S. mutans (18.2 ± 0.78 
mm and 17.2 ± 0.96 mm respectively) by comparison to Neutrafluor 220 (7.5 ± 0.67 mm 
and 7.5 ± 0.69 mm respectively) and Cepacol (8.7 ±1.42 mm and 8.6 ± 1.33 mm 
respectively, all p<0.01).  
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L. acidophilus was inhibited by all mouth rinses tested. The greatest zones of inhibition 
were achieved by Listerine (15.3 ± 1.70 mm) and Savacol (14.4 ± 0.95 mm, p>0.01). The 
smallest zones of inhibition were produced by Betadine (7.4 ± 0.77 mm), and Milton (7.5 
± 0.69 mm, p>0.01). Neutrafluor 220 and Cepacol showed statistically greater growth 
inhibition on L. acidophilus than S. mutans (12.0 ± 0.69 mm v 7.5 ± 0.69 mm, 11.1 ± 0.51 
mm v 8.6 ± 1.33 mm respectively, p<0.01). Savacol produced significantly less growth 
inhibition on L. acidophilus than on S. mutans (14.4 ± 0.95 mm v 17.2 ± 0.96 mm, 
p<0.01). 
 
Results from the chlorhexidine dose response experiments are shown in Table 3. 
chlorhexidine in solution at all concentrations from 0.01% to 0.8% inhibited growth of S. 
mutans, S. sanguinis and L. acidophilus, with increasing zones of inhibition observed with 
increasing concentrations of chlorhexidine. S. sanguinis underwent the greatest growth 
inhibition from 11.2 ± 0.86 mm at 0.01% to 21.8 ± 0.75 mm at 0.8%. L. acidophilus 
showed the least growth inhibition from 7.5 ± 0.50 mm at 0.01% to 16.3 ± 0.45 mm at 
0.8%. There was a statistically significant difference in growth inhibition of S. mutans and 
L. acidophilus for all concentrations (p<0.05). 
 
Table 4 shows the results of the dose response experiments using sodium hypochlorite. 
The minimum inhibitory concentration of sodium hypochlorite on S. mutans, S. sanguinis 
and L. acidophilus was 0.5% which produced a mean inhibition diameter of 5.5 ± 0.52 
mm, 5.7 ± 0.78 mm and 10.8 ± 1.11 mm respectively. The greatest growth inhibitory 
effect of sodium hypochlorite was on L. acidophilus (10.8 ± 1.12 mm at a concentration of 
0.5% to 20.8 ± 0.72 mm at a concentration of 4%). There was no difference in growth 
inhibition between S. mutans and S. sanguinis except at a concentration of 5% where 
there was significantly greater inhibition of S. mutans (18.2 ± 0.72 mm v 14.3 ± 0.78 mm, 
p<0.01). 
 
Table 5 shows the results of the dose response experiments using povidone iodine. The 
minimum inhibitory concentration for povidone iodine on S. mutans, S. sanguinis and L. 
acidophilus was 10%, which produced inhibition of 8.1 ± 1.17 mm, 8.1 ± 0.67 mm and 
12.1 ± 2.15 mm respectively. Growth inhibition continued to increase with increasing 
concentration of povidone iodine for all bacteria. There were no statistically significant 
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differences in growth inhibition on S. mutans and S. sanguinis at concentrations of 10%, 
20% and 40% (p>0.05). At the high concentration of 80%, there was greater inhibition on 
S. mutans compared to S. sanguinis or L. acidophilus (20.4 ± 1.68 mm for S. mutans, 
18.7 ± 1.07 mm for S. sanguinis, 17.4 ± 1.83 mm for L. acidophilus, p<0.05).  
 
The results of the dose response experiments using cetylpyridinium chloride are shown 
in Table 6. The minimum inhibitory concentration for cetylpyridinium chloride on S. 
mutans, S. sanguinis and L. acidophilus was 0.01%, which gave inhibition zones of 6.0 ± 
0.00 mm, 5.9 ± 0.23 mm and 7.9 ± 1.00 mm respectively. Growth inhibition increased 
with higher concentrations of cetylpyridinium chloride for all three bacteria. As shown in 
Table 6, the growth inhibitory effect on L. acidophilus appeared to plateau from a 
concentration of 0.8% to 1.6% (13.9 ± 0.71 mm to 14.3 ±1.44 mm). There was a 
statistically significant difference in growth inhibition between S. mutans and S. sanguinis 
only at the concentration of 1.6% (16.1 ± 0.90 mm, 13.4 ± 1.44 mm respectively, 
p<0.001). There was a statistically significant difference between S. mutans and L. 
acidophilus at all concentrations except for 1.2% (p>0.05, Table 6). 
 
The four key active ingredients from essential oils rinses investigated were menthol, 
thymol, methyl salicylate and eucalyptol. These were tested at a concentration in buffer 
of 0.1%, as their concentrations were all below 0.1% in Listerine Zero mouth rinse. None 
of the individual essential oils inhibited the growth of S. mutans, S. sanguinis or L. 
acidophilus (Results not shown). 
 
Discussion 
As indicated in recent reviews 21-23 and an authoritative textbook on oral microbiology,24 
the antimicrobial effects of oral antiseptics have been well investigated with respect to the 
periodontal effects in adult populations.  By contrast, there is comparatively little 
information on the use of antiseptics for caries prevention. As S. mutans is an important 
cariogenic bacteria and reducing its counts is associated with a decrease in caries risk,1, 6 
it is worthwhile examining the comparative effects of commercial antiseptics on S. 
mutans and non-mutans bacteria to determine their potential as anti-caries agents.  
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Of the antiseptics tested in the present study, chlorhexidine showed the greatest activity 
against both S. mutans and S. sanguinis. In the experiments using pure chlorhexidine, 
the extremely low concentration of 0.005% gave approximately the same amount of 
inhibition as 20% povidone iodine, 0.8% cetylpyridinium chloride and 2.0% sodium 
hypochlorite. There were no effects on L. acidophilus at this low concentration of 
chlorhexidine, although inhibitory effects were observed at doses of 0.01% and higher. In 
contrast, the other antiseptics tested produced greater inhibitory effects on L. acidophilus 
compared to that observed with S. mutans. The present results are thus supported by our 
previous clinical studies which reported that the percentage of 3-4 year-old children who 
eliminated mutans streptococci from their mouths increased from 28% after three months 
to 48% after six months and over 70% after 12 months of 0.2% chlorhexidine gel use.6 
They also substantiate the results of Emilson and co-workers25 which showed that after 
14 days of applying a 1% chlorhexidine gel, all  participants in the study eliminated S. 
mutans from their mouths. 
 
The inclusion of S. sanguinis and L. acidophilus as test organisms in this study helps to 
demonstrate the comparative effectiveness of the antiseptics on other oral bacteria 
besides S. mutans. The results showed that at all concentrations, S. sanguinis was as 
susceptible as S. mutans to the inhibitory effects of chlorhexidine, and that L. acidophilus 
was also inhibited, although to a lesser extent compared to S. mutans. These 
observations thus suggest that there is a potential for the relative proportions of plaque to 
change after treatment with chlorhexidine. Our findings regarding S. sanguinis are 
different to those reported in early clinical studies, where S. sanguinis increased in 
proportion in plaque after treatment with chlorhexidine, whilst Lactobacillus levels were 
not affected.25, 26 These differences found between various experimental methods are 
most likely explained by the fact that the inhibitory effects on planktonic cells of S. 
sanguinis and Lactobacilli used in the present method are negated in the environment of 
the biofilm mass whereas those of S. mutans are not. 
 
By comparison, there is minimal evidence for the use of cetylpyridinium chloride in 
children as an anti-caries agent, although studies have demonstrated that pre-surgical 
0.05% cetylpyridinium chloride mouth rinses by children aged 10-15 years are efficacious 
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at reducing both aerobic and anaerobic microorganisms.27 In the present study, the 
bacterial growth inhibition shown by 0.05% pure cetylpyridinium chloride solution was 
slightly less than that produced by the commercial product Cepacol containing 0.05% 
cetylpyridinium chloride, suggesting that the commercial product has additional inhibitory 
actions over the pure compound, possibly related to the ethanol content, or other 
components such as surfactants. Our results also demonstrated that pure solutions of 
cetylpyridinium chloride are effective at concentrations as low as 0.01% suggesting that 
cetylpyridinium chloride has potential for use in children, although its effects on S. 
mutans are comparatively less than those of chlorhexidine. 
 
Our results are thus supported by clinical studies which showed that a fluoride mouth 
rinse (Neutrafluor 220) has growth inhibiting effects against S. mutans, S. sanguinis and 
L. acidophilus.28-30 In the present study, it is most likely that other antibacterial 
compounds in the mouth rinse formulation enhanced the action of sodium fluoride.  As 
Neutrafluor 220 contains sodium benzoate, a common food preservative with known 
bacteriostatic properties,31 it is highly likely that it contributes to the antibacterial effects 
observed in this study. These effects will be investigated in follow-up studies where other 
components of the antiseptics will be evaluated. 
 
Povidone iodine is available in a mouth rinse formulation and as a topical chair-side 
treatment for prevention of caries. Our present results are supported by clinical studies 
which show that povidone iodine at concentrations of 10% can inhibit the growth of S. 
mutans. These studies demonstrated that topical applications of 10% povidone iodine is 
effective at preventing white spot lesions in toddlers when applied every 2 months, even 
if the child is bottle feeding on cariogenic substrates at naptime.32, 33 Similarly, a once-
only topical application of 10% povidone iodine followed by acidulated phosphate fluoride 
in children can result in a decrease in mutans streptococci and lactobacilli levels over 3 
months, and a 3-monthly topical application of 10% povidone iodine following dental 
restorative treatment can reduce S. mutans levels and prevent further occurrence of 
caries. 10, 34 
 
Tanzer et al., achieved bactericidal effects on S. mutans using inorganic iodine at 
concentrations as low as 0.04% and showed the selective suppression of S. mutans over 
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S. sanguinis at these concentrations.35 In the present study, the compound povidone 
iodine (iodine with polyvinyl pyrrolidone) was applied in a form that is commonly used in 
medicine and dentistry. This formulation has fewer of the problematic side effects 
compared to pure iodine (staining and mucosal irritation), while still being effective at 
altering biofilm formation.9 Using this form of povidone iodine, our results show 
comparable inhibition of S. mutans and S. sanguinis, and thus contrast with the report of 
Tanzer et al., who used an inorganic iodine preparation.35  
 
Mouth rinses containing essential oils are available commercially, and one of the leading 
brands is Listerine (Johnson and Johnson, Melbourne, Australia). This commercial 
product was tested and produced the greatest inhibition on L. acidophilus of all mouth 
rinses tested. However, the principal active agents (menthol, thymol, methyl salicylate 
and eucalyptol) in pure forms and at higher concentrations compared to those found in 
Listerine, did not show inhibition of the growth of S. mutans, S. sanguinis or L. 
acidophilus. There was no surfactant used when preparing these individual agents in the 
present experiments, so the bioavailability of these agents may have been limited. We 
did not use a surfactant to dissolve the active agents as it would have itself exerted 
antibacterial effects.36  
 
The bactericidal properties of essential oils have been attributed to their ability to 
effectively permeate through established plaque leading to inhibition of enzymes.13 
Several studies have shown beneficial effects of essential oils mouth rinses such as 
significantly reducing total plaque bacterial counts,14 reducing mutans streptococci levels 
in teenagers,37 and improving plaque and bleeding scores in orthodontic patients38 In our 
assays, Listerine Zero (no ethanol) mouth rinse was ineffective at inhibiting bacterial 
growth. However, we did not test the ability of the rinse or its components to permeate 
plaque, which is a key bactericidal property of essential oils. Our present results suggest 
that essential oils do not have a dominant role for preventing caries in high risk children. 
 
Sodium hypochlorite was included in the present study as it is commonly used as a 
disinfectant for baby bottles and pacifiers and may have potential as a disinfectant to 
prevent the colonisation of cariogenic bacteria in children.39  Although it has poor 
palatability as a mouth rinse, its use for treating adult periodontal disease is currently 
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being reviewed as studies have demonstrated an improvement of plaque and bleeding 
scores at concentrations as low as 0.05%.40, 41 The present results showed that 2% 
sodium hypochlorite in the form of commercial Milton’s solution was less effective against 
S. mutans, S. sanguinis and L. acidophilus compared to the pure sodium hypochlorite at 
the same concentration. These findings could be due to antagonistic effects of other 
agents that are present within the commercial formulation such as the metal salts which 
were not investigated in this study. 
 
Although this study is limited by the testing of planktonic cells rather than a biofilm, the 
results are valuable for providing an understanding of the basic mode of action of these 
various products on single bacterial cultures. The agar diffusion method employed in this 
report measures only growth inhibition of the bacteria, and does not indicate 
bacteriostatic or bactericidal activity. It is also possible that the test compounds could 
possess other mechanisms of antibacterial activity such as interference with adherence 
to the tooth surface or suppression of other bacteria which are not evaluated in the 
present study. To determine changes in the biofilm after extended use of chlorhexidine 
and other preventive compounds in children, we are conducting longitudinal clinical and 
microbiological studies. From the clinical oral microbiological samples obtained in these 
studies, it may be possible to evaluate the effects of the antiseptics on the biofilms in 
children and determine the persistent microbial populations that are resistant to the 
effects of the antiseptics.    
 
In conclusion, the present study shows that common antiseptics at low concentrations 
have the potential to inhibit the growth of cariogenic bacteria. Of the agents tested, 
chlorhexidine produced the greatest growth inhibition against S. mutans, S. sanguinis 
and L. acidophilus at the lowest concentration. Further testing of these compounds at low 
concentrations in gel or paste formulations is required, both in vitro and in clinical 
settings, to find antibacterial agents suitable for use in children younger than 6 years of 
age who are unable to use a mouth rinse. 
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Tables and Figures 
 
 
Figure 1. Photograph of a microbial culture plate with wells containing sodium 
hypochlorite at various concentrations. Well No. 1 contained a pure solution of 1% 
sodium hypochlorite, Well No. 2 a pure solution of 4% sodium hypochlorite, Well No. 3 a 
pure solution of 2% sodium hypochlorite, and Well No. 4 contained a pure solution of 
0.5% sodium hypochlorite. Clear zones of growth inhibition were observed in all wells. 
The test bacteria used on this plate was L. acidophilus. 
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Table 1. Active ingredients found in antiseptic mouth rinses commercially available 
in Australia 
Mouth rinse 
Brand name 
Manufacturer 
(Town, 
Country) 
Active Ingredients Concentration 
Colgate 
Savacol 
Colgate 
Palmolive Pty 
Ltd (Sydney, 
Australia) 
Chlorhexidine 2 mg/ml (0.2%) 
Colgate 
Neutrafluor 220 
Alcohol Free 
Colgate 
Palmolive Pty 
Ltd (Sydney, 
Australia) 
Sodium fluoride 0.5 mg/ml (0.05%) 
Betadine 
Sanofi-Aventis 
(Virginia, 
Australia) 
Povidone iodine 10 mg/ml (0.1%) 
Cepacol 
Bayer 
Healthcare 
(Sydney, 
Australia) 
Cetylpyridinium 
chloride 
0.5 mg/ml (0.05%) 
Listerine Zero 
Johnson & 
Johnson Pacific 
Pty Ltd 
(Melbourne, 
Australia) 
Essential oils - menthol 
(0.042%), thymol 
(0.064%), methyl 
salicylate (0.06%), 
eucalyptol (0.092%) 
2.5 mg/ml (0.25%) 
Milton 
Procter & 
Gamble 
(Cincinnati, 
Ohio, USA) 
Sodium hypochlorite 
 
20 mg/ml (2%) 
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Table 2. Comparison of the growth inhibition by commercial brands of antiseptic 
mouth rinses on Streptococcus mutans, Streptococcus sanguinis and 
Lactobacillus acidophilus 
 
* Kruskal-Wallis test with Dunn post-tests 
N.S. = non-significant (>0.05) 
 
 
 
  
  
Zone of inhibition 
Mean diameter (mm ± S.D.) 
 p-value 
Mouth 
rinse 
Active 
compound 
(concentration %) 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. 
acidophilus 
(LB) 
n SM v SS SM v LB 
Colgate 
Neutrafluor 
220 
Sodium Fluoride 
(0.05%) 
7.5 (±0.69) 7.5 (±0.67) 12.0 (±0.69) 12 N.S.* <0.001* 
Colgate 
Savacol 
Chlorhexidine 
(0.2%) 
17.2 (±0.96) 18.2 (±0.78) 14.4 (±0.95) 12 N.S.* <0.01* 
Betadine 
Povidone Iodine 
(1%) 
0 0 7.4 (±0.77) 12 N.S.* <0.001* 
Cepacol 
Cetylpyridinium 
Chloride (0.05%) 
8.6 (±1.33) 8.7 (±1.42) 11.1 (±0.51) 12 N.S.* <0.001* 
Listerine 
Zero 
Essential Oils 
(0.25%) 
0 0 15.3 (±1.70) 12 N.S.* <0.001* 
Milton 
Sodium 
Hypochlorite (2%) 
0 0 7.5 (±0.69) 12 N.S.* <0.001* 
 Distilled Water 0 0 0 12 - - 
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Table 3. Growth inhibition by chlorhexidine on Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus acidophilus 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
 p-value 
Chlorhexidine 
(%wt/vol) 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n SM v SS SM v LB 
0.005% 10.7 (1.15) 9.8 (0.94) 0 12 N.S.* - 
0.01% 10.0 (±0.95) 11.2 (±0.86) 7.5 (±0.50) 12 N.S.* <0.001* 
0.05% 13.3 (±1.27) 16.1 (±0.51) 9.6 (±0.64) 12 <0.05* <0.05* 
0.1% 15.8(±0.62) 17.2 (±0.45) 11.9 (±0.56) 12 <0.05* <0.05* 
0.2% 19.3 (±0.69) 19.5 (±0.45) 13.5 (±0.50) 12 N.S.* <0.001* 
0.5% 19.9 (±0.57) 19.9 (±0.76) 14.5 (±0.72) 12 N.S.* <0.001* 
0.8% 21.1 (±0.64) 21.8 (±0.75) 16.3 (±0.45) 12 N.S.* <0.001* 
 
* Kruskal-Wallis test with Dunn post-tests 
N.S. = non-significant (>0.05) 
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Table 4. Growth inhibition by sodium hypochlorite on Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus acidophilus 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
 p-value 
Sodium 
Hypochlorite 
(%vol/vol) 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n SM v SS SM v LB 
0.5% 5.5 (±0.52) 5.7 (±0.78) 10.8 (±1.12) 12 N.S.* <0.001* 
1% 7.3 (±1.42) 7.8 (±1.22) 14.8 (±0.62) 12 N.S.* <0.001* 
2% 10.8 (±0.72) 10.7 (±0.49) 18.2 (±1.19) 12 N.S.* <0.001* 
4% 13.2 (±0.72) 13.5 (±1.51) 20.8 (±0.72) 12 N.S.* <0.001* 
5% 18.2 (±0.72) 14.3 (±0.78) 19.7 (±1.61) 12 <0.01* N.S.* 
 
* Kruskal-Wallis test with Dunn post-tests 
N.S. = non-significant (>0.05) 
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Table 5. Growth inhibition by povidone iodine on Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus acidophilus 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
 p-value 
Povidone Iodine 
(%wt/vol) 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
n 
SM v 
SS 
SM v 
LB 
<1% 0 0 0 12 - - 
5% 0 0 0 12 - - 
10% 8.1 (±1.17) 8.1 (±0.67) 12.1 (±2.15) 12 N.S.* <0.001* 
20% 9.3 (±0.65) 7.7 (±1.88) 9.6 (±1.00) 12 N.S.* N.S.* 
40% 15.5 (±1.24) 13.9 (±1.31) 12.7 (±1.07) 12 N.S.* <0.001* 
60% 18.7 (±1.61) 15.8 (±0.87) 14.7 (±2.31) 12 <0.01* <0.001* 
80% 20.4 (±1.68) 18.7 (±1.07) 17.4 (±1.83) 12 <0.05^ <0.001^ 
 
* Kruskal-Wallis test with Dunn post-tests 
^ One-way ANOVA with Bonferroni post-tests 
N.S. = non-significant (>0.05) 
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Table 6. Growth inhibition by cetyl pyridinium chloride on Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus acidophilus 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
 p-value 
Cetylpyridinium 
chloride  
(%wt/vol) 
S. mutans 
(SM) 
S. sanguinis 
(SS) 
L. acidophilus 
(LB) 
N SM v SS SM v LB 
0.005% 0 0 0 12 NA NA 
0.01% 6.0 (±0.00) 5.9 (±0.23) 7.9 (±1.00) 12 N.S.* <0.001* 
0.05% 7.1 (±0.74) 7.9 (±0.98) 10.9(±0.97) 12 N.S.* <0.001* 
0.1% 7.7 (0.69) 8.4 (±0.53) 11.8 (±1.05) 12 N.S.* <0.001* 
0.2% 8.5 (±0.72) 9.4 (±0.48) 12.5 (±0.69) 12 N.S.* <0.001* 
0.5% 9.6 (±0.73) 9.4 (±0.90) 13.1 (±0.77) 12 N.S.^ <0.001^ 
0.8% 10.7 (±1.47) 9.8 (±0.69) 13.9 (±0.71) 12 N.S.^ <0.001^ 
1.2% 12.7 (±0.78) 12.3 (±0.45) 12.6 (±0.51) 12 N.S.* N.S.* 
1.6% 16.1 (±0.90) 13.4 (±1.44) 14.3 (±1.44) 12 <0.001* <0.05* 
 
*Kruskal-Wallis test with Dunn post-tests 
^ One-way ANOVA with Bonferroni post-tests 
N.S. = non-significant (>0.05) 
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Chapter Four: 
Interference of antimicrobial activity in combinations of 
oral antiseptics against Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus 
acidophilus 
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Abstract 
Objectives: The aims of this study were to compare the effects of combinations of 
sodium fluoride and antiseptic compounds on the growth of Streptococcus mutans, 
Streptococcus sanguinis and Lactobacillus acidophilus.  
 
Methods: The agar diffusion assay was used to determine bacterial growth inhibition.  
 
Results: Of the combinations tested, 0.1% sodium fluoride with 5% povidone iodine 
produced synergistic anti-bacterial effects against S. mutans and S. sanguinis. The 
combination of 10% povidone iodine with 0.5% sodium hypochlorite produced additive 
anti-bacterial effects against L. acidophilus. Interference was seen in some combinations 
such as chlorhexidine with sodium lauryl sulphate, most likely through anion-cation 
reactions. However, 0.1% sodium fluoride when combined with 0.01% chlorhexidine did 
not interfere with the anti-bacterial effects of chlorhexidine alone against S. mutans or S. 
sanguinis, but it reduced the anti-bacterial effects of cetyl pyridinium chloride alone 
against these bacteria.  
 
Conclusions: Combinations of common antiseptics and fluoride compounds can 
produce interference, synergistic or additive effects. Of the combinations tested, 0.1% 
sodium fluoride with 5% povidone iodine has the greatest potential for suppression of S. 
mutans. 
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Introduction 
As Streptococcus mutans is one of the key bacterial species implicated in the initiation of 
early childhood caries, suppressing the levels of this bacterium in children's mouths using 
antiseptic agents is a possible method of caries control.1 Although both chlorhexidine 
(CHX)2, 3 and povidone iodine (PI)4-6 have shown potential for reducing early childhood 
caries, there is a paucity of information on the efficacy of other agents and combinations 
of various compounds. 2-4 The range of potential agents currently found in mouthwashes 
and dentifrices includes cetyl pyridinium chloride (CPC),7-9 sodium lauryl sulphate (SLS)10 
and fluoride compounds, e.g. sodium fluoride (NaF).11, 12 In addition, sodium hypochlorite 
(NaOCl) mouth rinses at low concentrations of 0.05% to 0.25% that are harmless to soft 
tissues, are effective in disrupting dental plaques.13, 14 Although many of these 
compounds would be unsuitable for use at high concentrations in mouthwash 
formulations for children younger than 6 years old, they could be employed in other 
delivery systems including gels and varnishes, which offer better dosage control. 
 
As low concentrations of active agents improve the safety and reduce the likelihood of 
adverse effects in children, it is important to utilize where possible combinations of 
individual compounds at low concentrations that have synergistic or additive anti-
bacterial effects. As synergistic agents produce a combined effect greater than the sum 
of their separate effects, efficacy can be achieved using low concentrations of individual 
compounds, and thus enhance safety for products intended to be used in children. 15 
Combinations which give additive effects are also beneficial. 6 
 
Relatively few combinations of anti-bacterial compounds have been tested for their 
inhibitory effects on the growth of S. mutans. CPC is not used in combination with CHX, 
even though they are both cationic antiseptics with similar modes of action and side 
effects. 16 The combination of CHX and NaF in both dentifrices and mouth rinses has 
attracted much interest, despite the challenges faced by ionic interactions between them. 
17, 18 The interactions of sodium monofluorophosphate (MFP) with CHX appear to be 
rather different than those of NaF. MFP may show effects on the growth of S. mutans 
comparable to those of CHX.19 
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Although the combined use of NaF and CPC has not yet been evaluated in clinical trials, 
this combination is likely to be problematic given inactivation of CPC by NaF similar to the 
pattern seen with CHX when combined with NaF.9, 19 Likewise, although applications of 
separate fluoride or iodine containing varnishes may give additive effects on reducing 
new carious lesions, 5, 6 little is known regarding the use of NaF and PI combined 
together into a single product.   
 
Sodium hypochlorite (NaOCl) as Milton's solution (one percent NaOCl) is a common 
disinfectant with broad spectrum anti-bacterial activity, and has been recommended for 
sterilising baby bottles, baby comforters and toothbrushes.20, 21 It is also commonly used 
in endodontics to irrigate root canals. 22 More recently, mouth rinses containing low 
concentrations of 0.05% to 0.25% NaOCl have been reported to be effective in disrupting 
dental plaques and preventing gingivitis, with minimal adverse effects on the mucosa.13, 
14 The use of separate applications of NaOCl and CHX in endodontics is well known 23, 
but this combination has not yet been examined in terms of effects on the growth of S. 
mutans. Likewise, although the synergistic effects of separate applications of PI and CHX 
have been used in medicine for surgical site antisepsis,24 how this combination affects 
the growth of S. mutans has not yet been investigated. 
 
The aims of this study, therefore, were to investigate the effects of various combinations 
of antiseptics and NaF on the growth of S. mutans and non-mutans bacteria 
(Streptococcus sanguinis and Lactobacillus acidophilus) to determine if the effects of 
individual antiseptics or combinations are specific to S. mutans or extend to non-mutans 
bacteria. S. sanguinis was selected as it is thought to compete with S. mutans in the 
biofilm.25, 26 We aimed to identify those antiseptics or combinations that have only anti-S. 
mutans activity, as these would reduce numbers of S. mutans without affecting the 
general microbial composition. In addition, we also aimed to identify combinations of 
compounds that show synergistic or additive effects at relatively low concentrations, as 
these would be particularly suitable for use in young children. 
 
Methods 
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Bacterial stocks were obtained from the American Type Culture Collection (ATCC; 
Manassas, VA, USA). S. mutans ATCC 25175 and S. sanguinis ATCC 10556 were 
revived from freeze-dried vials. L. acidophilus was purchased in capsule form as L. 
acidophilus NCFM (Inner Health Plus, Northgate, Australia). The bacteria were cultured 
on Trypticase soy agar supplemented with 5% defibrinated sheep blood (Equicell, 
Melbourne, VIC, Australia). The plates were incubated aerobically for 7 days at 37ºC. 
The bacterial colonies were then subcultured in brain heart infusion broth (BHI; Becton 
Dickinson, Franklin Lakes, NJ, USA) and incubated for 2-3 days at 37ºC. Viability was 
checked by subculture, and the purity of the plate and broth cultures was monitored by 
Gram stain and colonial morphology. Bacterial identification was carried out using the 
API rapid ID 32 Strep and API 50 CHL identification kits (BioMerieux SA, Marcy l'Etoile, 
France). All strains were maintained in 15% glycerol stocks at -80ºC.  
 
The compounds tested for inhibition of bacterial growth included NaF, CHX diacetate, PI, 
CPC and NaOCl (all from Sigma-Aldrich, St Louis, USA), and SLS (Amresco Inc, Ohio, 
USA). Various combinations of these pure compounds were combined at their known 
minimum inhibitory concentrations (MIC) in this assay system, using the MIC values 
established in a pilot study.27 The extent of inhibition of growth of S. mutans, S. sanguinis 
and L. acidophilus by each agent in solution was tested using the agar diffusion assay, 28, 
29 with 150 mmol/L phosphate buffered saline pH 7.2 (PBS) as the diluent. In this method, 
pre-prepared Mueller-Hilton agar petri dishes (MH agar, Thermo Fisher Scientific, 
Rockford, IL, USA) were employed for testing S. mutans and S. sanguinis. This protein-
free agar is a standard bacterial medium used for sensitivity testing, and it supports the 
growth of many bacterial species, including streptococci.30 For Lactobacillus species, 
Rogosa agar was used (MRS agar, Becton Dickinson).31 In each agar plate, four wells of 
5 mm diameter were formed in the agar by removing plugs cut with a stainless steel 
punch.28 The wells were spaced approximately 30 mm apart and 20 mm from the outer 
edge. All procedures were performed under sterile conditions. Each well was loaded with 
a fine spiral of filter paper weighing 0.03g, and 60 µl of solution was pipetted into each 
well. To inoculate the plates, 5 mL aliquots of bacterial suspensions (6 x 108 bacteria/ mL) 
were added to 5 mL volumes of melted Mueller-Hinton agar at 45 °C, and the resulting 
mixture mixed thoroughly and poured evenly over the surface of each agar plate 
containing the wells loaded with the test medicaments.28 The culture plates were inverted 
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and incubated aerobically at 37°C for 72 hrs. At the end of the incubation period, 
bacterial growth was confluent on the agar surface except at areas of growth inhibition, 
where clear areas around the test wells could be seen clearly.29 The areas of growth 
inhibition were viewed by inverting the agar plate, and the diameters of the zones of 
inhibition measured directly using a micrometer gauge, with measurements being taken 
three times. Every experiment contained a positive control (CHX), a negative control 
(normal saline), the single pure compounds and the combinations. These were placed on 
the same agar dishes. All experiments were performed in triplicate, and means and 
standard deviations obtained.  
 
In a previous paper, we tested a range of concentrations of the compounds used in the 
present experiments to determine the concentrations that will produce measureable 
responses in the agar diffusion system.32 In the experiments designed to test synergism 
in combinations of compounds, concentrations at or below the minimum inhibitory levels 
of the individual compounds were used. The minimum inhibitory concentrations are 
approximately 0.01% for CPC, 10% for PI, 0.25% for SLS, <0.01% for CHX and <0.5% 
for NaOCl. 32 In the experiments designed to test additive or interference effects, 
concentrations that produced measurable effects were selected. 
Statistical Analysis 
The Kruskal-Wallis test with Dunn post-tests (for non-parametric data) was used to test 
for differences in the zones of inhibition among preparations and between bacteria. 
Statistical analysis was performed using GraphPad (GraphPad Software Inc., California, 
USA) and the alpha value was set at 0.05. 
 
Results 
Almost all combinations of the antiseptic compounds and NaF showed similar anti-
bacterial effects on S. mutans and S. sanguinis (Table 1). The only exception to this 
pattern was the combination of CHX with CPC, which produced greater anti-bacterial 
effects on S. sanguinis than on S. mutans (10.2 ± 0.94 mm and 8.9 ± 1.08 mm 
respectively, p<0.001). However, comparing results for S. mutans and L. acidophilus 
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revealed statistically significant differences in growth inhibitory zones for all combinations 
of antiseptic compounds, except for CHX + CPC, CHX + NaOCl, and CHX + PI. Zones of 
inhibition were greater for L. acidophilus than for S. mutans for all combinations except 
NaF with CHX.  
 
The addition of CPC to CHX (Table 2a) did not interfere with the anti-bacterial activity of 
the CHX against S. mutans or S. sanguinis but produced a greater anti-bacterial effect 
against L. acidophilus than that found for CHX alone (p<0.001). Compared to CPC alone, 
CHX + CPC produced greater anti-bacterial effects against S. mutans (p<0.01) and S. 
sanguinis (p<0.001), but not L. acidophilus.  
 
The combination of CHX + NaOCl (Table 2b) did not show evidence of interference when 
used against S. mutans or S. sanguinis as the zones of inhibition were not significantly 
different for the pure compounds alone versus the combination. However, CHX + NaOCl 
produced anti-bacterial effects against L. acidophilus that were similar to 0.01% CHX on 
its own, but less than 0.5% NaOCl, indicating interference (p<0.001).  
 
The addition of PI to CHX (Table 2c) did not interfere with the anti-bacterial activity of the 
CHX against S. mutans or S. sanguinis but enhanced the anti-bacterial effect against L. 
acidophilus (p<0.05) over that of CHX alone. Zones of inhibition for S. mutans and S. 
sanguinis were greater than for PI alone (p<0.01 and p<0.001 respectively) but for L. 
acidophilus less than for PI alone (p<0.05).  
 
The combination of CHX + SLS (Table 2d) produced anti-bacterial effects against S. 
mutans and S. sanguinis that were less than CHX alone (p<0.001) but comparable to 
SLS alone, indicating interference. No such interference was seen for L. acidophilus, for 
which CHX + SLS was comparable to SLS alone but better than CHX alone (p<0.001).  
 
CPC + NaOCl (Table 3a) produced zones of inhibition against S. mutans that were 
similar to either CPC or NaOCl used alone. The anti-bacterial effects of this combination 
against S. sanguinis were greater than CPC on its own (p<0.001) but similar to NaOCl 
used alone, indicating no interference. This same combination, however, produced anti-
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bacterial effects against L. acidophilus that were comparable to CPC used alone, but less 
than seen for NaOCl on its own (p<0.01), indicating interference.  
 
The combination of CPC + PI (Table 3b) for S. mutans was comparable to either CPC or 
PI alone. For S. sanguinis and L. acidophilus, the effects were comparable to CPC alone, 
but less than for PI alone (p<0.01), indicating interference. 
 
The anti-bacterial effects of the combination of CPC + SLS (Table 3c) against all three 
bacteria were greater than for CPC alone but comparable to the effects of SLS alone, 
indicating no interference. 
 
The combination of NaOCl + PI (Table 4a) did not inhibit the growth of either S. mutans 
or S. sanguinis; however, when used alone each individual compound gave inhibition, 
indicating interference. On the other hand, for L. acidophilus the combination of NaOCl + 
PI produced an enhanced (additive) anti-bacterial effect which was greater than either of 
the effects produced by individual components., compared to NaOCl (p<0.01) or PI 
(p<0.001) used alone.  
 
The anti-bacterial effects of NaOCl + SLS (Table 4b) on the growth of S. sanguinis were 
comparable to NaOCl and SLS used alone. This combination produced zones of 
inhibition against S. mutans that were comparable to NaOCl alone, but additive to those 
seen with SLS (p<0.05). Addition of SLS interfered with the anti-bacterial effects of 
NaOCl against L. acidophilus (p<0.01).  
 
The combination of PI + SLS (Table 5) on S. mutans and L. acidophilus was comparable 
to either PI or SLS used alone. The anti-bacterial effects against S. sanguinis were 
comparable to 10% PI used alone, but less than SLS used alone (p<0.01), indicating 
interference. 
 
Solutions of NaF did not inhibit the growth of S. mutans, S. sanguinis or L. acidophilus in 
this assay system at the concentration used (0.1%). Neither was there any additional 
effect for L. acidophilus of NaF added to CHX, CPC, or PI (Table 6). Adding NaF to CHX 
did not interfere with the anti-bacterial effects of CHX against S. mutans or S. sanguinis, 
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but caused interference for CPC. PI at 5% and NaF at 0.1% have no measurable effects 
when used individually on S. mutans and S. sanguinis, but in combination there was 
inhibition, suggesting the presence of synergism of NaF with PI. 
 
Overall, synergistic anti-bacterial effects were observed only for NaF + PI against S. 
mutans and S. sanguinis. There were additive effects of NaOCl + PI against L. 
acidophilus, and NaF + PI against S. mutans and S. sanguinis. There were several 
combinations for which interference was noted (Table 7). The compound most likely to be 
affected was NaOCl, especially when used against L. acidophilus. 
 
Discussion 
Oral antiseptics have attracted interest as potential anti-caries agents due to the 
recognition that S. mutans is an important cariogenic bacteria in caries initiation and that 
achieving a reduction in its levels is likely to lead to a lower caries risk.1 Clinical studies 
have provided evidence that children who develop caries are colonized by S. mutans at 
younger ages and have higher S. mutans counts compared to caries-free children. 33 
Furthermore, timely suppression of S. mutans in the mouths of young children can 
reduce caries risk, as demonstrated in studies using chlorhexidine varnish, 2 
chlorhexidine gel, 3 and povidone iodine solutions.4 
 
Topical fluoride exposure from fluoride dentifrices is well accepted as one of the 
mainstays of caries prevention for all patients, while in-office applications of fluoride 
containing varnishes are recommended for high risk children. 11, 12 In addition to topical 
fluorides, high risk children are likely to benefit from the additional use of anti-bacterial 
compounds to suppress the growth of cariogenic bacteria. 34 For reasons of safety, the 
lowest effective concentrations of agents that can be combined with fluoride compounds 
should be considered for pediatric use. The advantages of combinations with synergistic 
or additive effects are greater anti-caries and/or anti-plaque effects compared to the 
individual compounds, whilst reducing dose and therefore enhancing safety. Such 
strategies for boosting the efficacy and safety of medications are used commonly in 
medicine and dentistry. For example, the staining and mucosal irritation of pure iodine is 
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reduced by combining iodine with polyvinyl pyrrolidone. 35 However, in contrast to 
synergistic and additive effects which are usually beneficial, some combinations of 
antiseptics can result in interference and reduced efficacy .36 The results of the present 
study show that a range of interference issues can occur (Table 7). 
 
The results of the present study provide additional support to the notion that PI can form 
part of a caries preventive program. To date, PI has been used in children for 
professional topical applications for control of early childhood caries. The combined use 
of topical polyvinyl-pyrrolidone-iodine and fluoride varnish can result in more caries-free 
first permanent molars in children aged 5 to 7 years compared to fluoride varnish alone.6 
Another study by the same research group concluded that a combination of 10% PI and 
5% NaF in a varnish reduced the rate of new carious lesions by 31% over a fluoride 
varnish alone in children aged 1 to 3 years.5 Initially in this study, 10% PI was combined 
with 0.1% NaF which produced comparable results to PI alone for all three bacteria. PI 
and NaF were then combined at concentrations well below those at which the individual 
compounds are normally used. This produced additive anti-bacterial effects against S. 
mutans and S. sanguinis, in agreement with previous studies. Such low dose 
combinations could have promise for safe use in small children and infants.  
 
Also of interest, NaOCl in combination with PI produced additive anti-bacterial effects 
against L. acidophilus. This combination has not been tested previously as these agents 
are not commonly used together and NaOCl is only in the early stages of testing for anti-
plaque effects.13, 14 Despite this additive effect against L. acidophilus, caution must be 
used as there was interference between these agents when tested against S. mutans. 
 
Overall, of the numerous combinations tested, few produced useful additive anti-bacterial 
effects over and above those seen from the individual compounds. In most cases, growth 
inhibition was comparable to the more effective individual compound within the pair used. 
For example, NaF and CHX produced anti-S. mutans effects that were comparable to 
pure CHX, but greater than that found for NaF alone. These results agree with previous 
data where varnish and gel formulations showed a useful reduction of S. mutans levels 
and increased enamel mineral density.17, 18, 37  
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 In fact, many combinations tested showed interference and reduced efficacy. The results 
of the present study show that if chlorhexidine (0.01%) is combined with sodium lauryl 
sulfate (0.25%) or sodium hypochlorite (0.5%) with povidone iodine (10%), or cetyl 
pyridinium chloride (0.01%) with sodium fluoride (0.1%), the inhibitory activities against S. 
mutans and S. sanguinis of the primary compounds will be reduced. These agents are, 
therefore, not ideal for use in a single anti-bacterial product. 
CPC combined with NaF is one such combination that showed interference against both 
S. mutans and S. sanguinis. This is in agreement with the known interactions of this 
molecule with several studies showing antagonism between fluoride toothpaste and CPC 
mouth rinse use.8, 16 
Similarly, it is well known that toothpastes containing SLS can impair the antimicrobial 
effects and substantivity of CHX due to formation of an insoluble salt following the 
reaction between CHX (a cation) and SLS (an anion).19 One clinical investigation has 
showed that rinsing with a 1.5% SLS slurry prior to using a 0.2% CHX rinse reduced the 
anti-plaque efficacy of the CHX. 38 The results of the present study are in agreement with 
these findings as SLS interfered with the anti-bacterial properties of CHX against both S. 
mutans and S. sanguinis . 
 
The current results also show differences in the responses of individual bacterial species. 
L. acidophilus was inhibited by all the combinations tested, whereas S. mutans and S. 
sanguinis were inhibited by most but not all combinations. The comparable effects 
observed with S. mutans and S. sanguinis likely reflect the fact that the two Streptococcal 
species have general similar cell wall structural properties.39 On the other hand, the 
combinations of CPC + PI and PI +SLS elicited interference on S. sanguinis but not on S. 
mutans, suggesting that some differences exist between these bacteria that can lead to 
different responses with different combinations of antiseptics.40, 41 Similarly, cell wall and 
metabolic differences between the streptococci and lactobacilli can cause differences in 
responses of the bacteria.42, 43 Although the exact roles of these bacteria in the caries 
process are not clear, it is generally thought that S. mutans is actively involved in the 
caries process while lactobacilli are likely to be secondary invaders.44, 45 S. sanguinis, on 
the other hand is thought to exist in competition with S. mutans in the dental biofilm, and 
children with caries have less S. sanguinis and more S. mutans while the reverse is true 
for children without caries.25, 26  
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Based on these concepts, the combinations of antiseptics that selectively inhibit S. 
mutans, but not S. sanguinis nor lactobacilli would be desirable for removal of S. mutans 
without affecting other plaque bacteria. The combination CPC+ PI meets this criteria as it 
interfered with the inhibition of S. sanguinis and L. acidophilus without affecting the 
inhibitory effects on S. mutans of the individual compounds. In contrast, the combination 
of PI + SLS, while it interferes with inhibition of S. sanguinis, does not alter the inhibition 
of L. acidophilus by the individual compounds.  
 
Although the present study is limited by the testing of single bacterial cultures under 
neutral pH conditions rather than in complex biofilms under varying pH conditions, the 
results add to the understanding of the antimicrobial effects of the test compounds 
individually and in combinations.36 The present results do not, however, indicate the 
clinical effectiveness of the agents.36 This is due to the nature of the plaque biofilm and 
the protection provided by the extracellular matrix which elevates the minimum inhibitory 
concentrations required for testing biofilms versus planktonic cells.36 Furthermore, saliva 
plays an important role in the dilution and clearance of compounds from the oral cavity, 
and it may interact with antiseptic agents.36 Hence, clinical trials are necessary to 
elucidate further the interactions between the antiseptic compounds, saliva and the 
bacterial biofilm. A further and final point is that the agar diffusion method employed in 
this study measured only the growth inhibition of the bacteria under neutral pH 
conditions. It is possible that the individual compounds and combinations tested could 
possess other mechanisms of anti-bacterial activity at neutral or at other pH values such 
as interference with adherence to the tooth surface or to other bacteria which could not 
be investigated in the present assay system. 
 
In conclusion, the present study shows that: 
 Combinations of certain common antiseptics and sodium fluoride solutions at low 
concentrations have the potential to reduce growth of S. mutans. 
 If chlorhexidine (0.01%) is combined with sodium lauryl sulfate (0.25%) or sodium 
hypochlorite (0.5%) with povidone iodine (10%), or cetyl pyridinium chloride (0.01%) 
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with sodium fluoride (0.1%), the inhibitory activities against S. mutans and S. 
sanguinis of the primary compounds will be reduced  
 Sodium fluoride (0.1%) combined with povidone iodine (5%) show synergistic 
inhibitory effects against S. mutans and S. sanguinis. The combination of povidone 
iodine (10%) and sodium hypochlorite (0.5%) produces additive effects against L. 
acidophilus.  
 Further testing is required to determine if these combinations are suitable for use in 
young children, and whether they are efficacious in preventing early childhood caries.  
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Tables and Figures 
 Table 1. Growth inhibitory effects of combinations of antiseptic compounds and 
sodium fluoride (NaF) 
 
 
  
Compound 
(Wt/Vol) 
Added 
compound 
(Wt/Vol) 
Zone of inhibition 
Mean diameter (mm ± S.D.) 
p-values 
S. mutans 
(SM) 
S. 
sanguinis 
(SS) 
L. acidophilus 
(LB) 
SM v SS 
SM v 
LB 
CHX 
(0.01%) 
CPC 
(0.01%) 
8.9 (±1.08) 
10.2 
(±0.94) 
9.4 (±1.08) <0.05 N.S. 
 
NaOCl 
(0.5%) 
9.8 (±0.62) 9.5 (±1.38) 8.6 (±2.31) N.S. N.S. 
 PI (10%) 9.4 (±1.24) 9.9 (±0.67) 9.6 (±0.90) N.S. N.S. 
 
SLS 
(0.25%) 
7.3 (±1.06) 8.3 (±1.22) 14.3 (±1.54) N.S. <0.001 
CPC 
(0.01%) 
NaOCl 
(0.5%) 
7.2 (±1.11) 8.8 (±1.06) 11.1 (±1.98) N.S. <0.001 
 PI (10%) 6.5 (±0.67) 6.2 (±0.39) 10.1 (±1.08) N.S. <0.001 
 
SLS 
(0.25%) 
7.6 (±0.67) 7.5 (±0.67) 14.3 (±1.07) N.S. <0.001 
NaOCl 
(0.5%) 
PI (10%) 0 0 22.8 (±1.90) N.S. <0.001 
 
SLS 
(0.25%) 
8.5 (±1.17) 8.5 (±1.00) 13.6 (±0.90) N.S. <0.001 
PI (10%) 
SLS 
(0.25%) 
6.7 (±0.65) 7.1 (±0.79) 12.7 (±1.56) N.S. <0.001 
NaF 
(0.1%) 
CHX 
(0.01%) 
8.8 (±0.83) 9.3 (±0.89) 5.7 (±0.65) N.S. <0.001 
 
CPC 
(0.01%) 
0 0 6.8 (±0.72) N.S. <0.001 
 PI (5%) 5.2 (±0.39) 5.3 (±0.45) 7.1 (±0.68) N.S. <0.001 
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Table 2. Growth inhibitory effects of chlorhexidine (CHX) with cetyl pyridinium 
chloride (CPC), sodium hypochlorite (NaOCl), povidone iodine (PI) and sodium 
lauryl sulphate (SLS) 
(a) Growth inhibitory effects of CHX with CPC 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CHX 
(0.01% 
Wt/Vol) 
CPC 
(0.01% 
Wt/Vol) 
Combination 
CHX + CPC 
CHX v 
Combination 
CPC v 
Combination 
S. mutans 10.1 (±1.38) 6.3 (±0.45) 8.9 (±1.08) N.S. <0.01 
S. sanguinis 10.4 (±0.51) 5.9 (±0.29) 10.2 (±0.94) N.S. <0.001 
L. 
acidophilus 
7.3 (±0.75) 9.5 (±1.68) 9.4 (±1.08) <0.001 N.S. 
 
(b) Growth inhibitory effects of CHX with NaOCl 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CHX 
(0.01% 
Wt/Vol) 
NaOCl 
(0.5% 
Wt/Vol) 
Combination 
CHX + 
NaOCl 
CHX v 
Combination 
NaOCl v 
Combination 
S. mutans 10.1 (±1.38) 9.0 (±2.26) 9.8 (±0.62) N.S. N.S. 
S. sanguinis 10.4 (±0.51) 8.9 (±1.00) 9.5 (±1.38) N.S. N.S. 
L. 
acidophilus 
7.3 (±0.75) 15.4 (±1.08) 8.6 (±2.31) N.S. <0.001 
 
(c) Growth inhibitory effects of CHX with PI 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CHX 
(0.01% 
Wt/Vol) 
PI (10% 
Wt/Vol) 
Combination 
CHX + PI 
CHX v 
Combination 
PI v 
Combination 
S. mutans 10.1 (±1.38) 7.2 (±1.34) 9.4 (±1.24) N.S. <0.01 
S. sanguinis 10.4 (±0.51) 6.9 (±0.67) 9.9 (±0.67) N.S. <0.001 
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L. 
acidophilus 
7.3 (±0.75) 12.6 (±1.38) 9.6 (±0.90) <0.05 <0.05 
 
(d) Growth inhibitory effects of CHX with SLS 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CHX 
(0.01% 
Wt/Vol) 
SLS (0.25% 
Wt/Vol) 
Combination 
CHX + SLS 
CHX v 
Combination 
SLS v 
Combination 
S. mutans 10.1 (±1.38) 7.0 (±0.74) 7.3 (±1.06) <0.001 N.S. 
S. sanguinis 10.4 (±0.51) 8.4 (±0.67) 8.3 (±1.22) <0.001 N.S. 
L. 
acidophilus 
7.3 (±0.75) 13.3 (±1.07) 14.3 (±1.54) <0.001 N.S. 
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Table 3. Growth inhibitory effects of cetyl pyridinium chloride (CPC) with sodium 
hypochlorite (NaOCl), povidone iodine (PI) and sodium lauryl sulphate (SLS) 
(a) Growth inhibitory effects of CPC with NaOCl 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CPC 
(0.01% 
Wt/Vol) 
NaOCl 
(0.5% 
Wt/Vol) 
Combination 
CPC + 
NaOCl 
CPC v 
Combination 
NaOCl v 
Combination 
S. mutans 6.3 (±0.45) 9.0 (±2.26) 7.2 (±1.11) N.S. N.S. 
S. sanguinis 5.9 (±0.29) 8.9 (±1.00) 8.8 (±1.06) <0.001 N.S. 
L. 
acidophilus 
9.5 (±1.68) 15.4 (±1.08) 11.1 (±1.98) N.S. <0.01 
 
(b) Growth inhibitory effects of CPC with PI 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CPC 
(0.01% 
Wt/Vol) 
PI (10% 
Wt/Vol) 
Combination 
CPC + PI 
CPC v 
Combination 
PI v 
Combination 
S. mutans 6.3 (±0.45) 7.2 (±1.34) 6.5 (±0.67) N.S. N.S. 
S. sanguinis 5.9 (±0.29) 6.9 (±0.67) 6.2 (±0.39) N.S. <0.01 
L. 
acidophilus 
9.5 (±1.68) 12.6 (±1.38) 10.1 (±1.08) N.S. <0.01 
 
(c) Growth inhibitory effects of CPC with SLS 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
CPC 
(0.01% 
Wt/Vol) 
SLS (0.25% 
Wt/Vol) 
Combination 
CPC + SLS 
CPC v 
Combination 
SLS v 
Combination 
S. mutans 6.3 (±0.45) 7.0 (±0.74) 7.6 (±0.67) <0.001 N.S. 
S. sanguinis 5.9 (±0.29) 8.4 (±0.67) 7.5 (±0.67) <0.01 N.S. 
L. 
acidophilus 
9.5 (±1.68) 13.3 (±1.07) 14.3 (±1.07) <0.001 N.S. 
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Table 4. Growth inhibitory effects of sodium hypochlorite (NaOCl) with povidone 
iodine (PI) and sodium lauryl sulphate (SLS) 
(a) Growth inhibitory effects of NaOCl with PI 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
NaOCl 
(0.5% 
Wt/Vol) 
PI (10% 
Wt/Vol) 
Combination 
NaOCl + PI 
NaOCl v 
Combination 
PI v 
Combination 
S. mutans 9.0 (±2.26) 7.2 (±1.34) 0 <0.001 <0.001 
S. sanguinis 8.9 (±1.00) 6.9 (±0.67) 0 <0.001 <0.001 
L. 
acidophilus 
15.4 (±1.08) 12.6 (±1.38) 22.8 (±1.90) <0.01 <0.001 
 
(b) Growth inhibitory effects of NaOCl with SLS 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
NaOCl 
(0.5% 
Wt/Vol) 
SLS (0.25% 
Wt/Vol) 
Combination 
NaOCl + 
SLS 
NaOCl v 
Combination 
SLS v 
Combination 
S. mutans 9.0 (±2.26) 7.0 (±0.74) 8.5 (±1.17) N.S. <0.05 
S. sanguinis 8.9 (±1.00) 8.4 (±0.67) 8.5 (±1.00) N.S. N.S. 
L. 
acidophilus 
15.4 (±1.08) 13.3 (±1.07) 13.6 (±0.90) <0.01 N.S. 
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Table 5. Growth inhibitory effects of povidone iodine (PI) with sodium lauryl 
sulphate (SLS) 
 
Zone of inhibition 
Mean diameter (mm ± S.D.)   
p-values 
PI (10% 
Wt/Vol) 
SLS (0.25% 
Wt/Vol) 
Combination 
PI + SLS 
PI v 
Combination 
SLS v 
Combination 
S. mutans 7.2 (±1.34) 7.0 (±0.74) 6.7 (±0.65) N.S. N.S. 
S. sanguinis 6.9 (±0.67) 8.4 (±0.67) 7.1 (±0.79) N.S. <0.01 
L. 
acidophilus 
12.6 (±1.38) 13.3 (±1.07) 12.7 (±1.56) N.S. N.S. 
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Table 6. Growth inhibitory effects of sodium fluoride (NaF) with chlorhexidine 
(CHX), cetyl pyridinium chloride (CPC) and povidone iodine (PI) 
 
Compound 
(Wt/Vol) 
Zone of inhibition 
Mean diameter (mm ± S.D.) 
p-values 
(Compound v 
Combination) Compound  
Compound + 
NaF (0.1%) 
S. mutans 
CHX (0.01%) 9.3 (±1.06) 8.8 (±0.83) N.S. 
CPC (0.01%) 5.8 (±0.58) 0 <0.001 
PI (5%) 0 5.2 (±0.39) <0.001 
S. sanguinis 
CHX (0.01%) 9.7 (±0.65) 9.3 (±0.89) N.S. 
CPC (0.01%) 5.7 (±0.49) 0 <0.001 
PI (5%) 0 5.3 (±0.45) <0.001 
L. acidophilus 
CHX (0.01%) 5.3 (±0.45) 5.7 (±0.65) N.S. 
CPC (0.01%) 6.2 (±1.34) 6.8 (±0.72) N.S. 
PI (5%) 7.5 (±0.80) 7.1 (±0.68) N.S. 
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Table 7. Compounds whose inhibitory effects against certain bacteria were 
reduced if combined with another compound 
Compound (Wt/Vol) Added compound (Wt/Vol) 
Bacteria that had 
interference effects by the 
combination 
CHX (0.01%) SLS (0.25%) 
S. mutans 
S. sanguinis 
NaOCl (0.5%) 
CHX (0.01%) L. acidophilus 
CPC (0.01%) L. acidophilus 
PI (10%) 
S. mutans 
S. sanguinis 
SLS (0.25%) L. acidophilus 
PI (10%) CPC (0.01%) 
S. sanguinis  
L. acidophilus 
SLS (0.25%) PI (10%) S. sanguinis 
NaF (0.1%) CPC (0.01%) 
S. mutans 
S. sanguinis 
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Chapter Five: 
Discussion and Conclusions 
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As caries is increasing in prevalence and severity among children, there is great need to 
find effective preventive agents for children. There is increasing recognition that  S. 
mutans is one of the most important cariogenic bacteria and of the concept that its 
reduction is likely to lead to a decrease in caries risk.1 It has been shown that children 
who develop caries are colonised by S. mutans at younger ages and have higher counts 
compared to caries-free children.2 Timely removal of S. mutans from the mouths of young 
children using good oral hygiene and plaque control can reduce the risk for early 
childhood caries by preventing their colonisation in the mouth.3, 4 
 
Tooth brushing has long been accepted as a mechanism to maintain acceptable oral 
health and is recommended to all children and adults alike in many countries, including 
Australia.5 Since the understanding that caries is associated with increased bacterial 
levels, toothpaste is also used for enhanced anti-bacterial action. A recent study by 
Pukallus and coworkers6 has shown that brushing alone can reduce the risk of caries. 
This is likely due to the physical disturbance of plaque which relies on good motor control 
of the tooth brush to engage all areas of plaque accumulation. Children are still 
developing motor skills so it is recommended that children have their teeth cleaned by a 
parent until their manual dexterity is improved, around 10 years of age. This requires 
good compliance by child and parent alike. Close monitoring and direct tooth brushing by 
the parent depends on the parent making time for oral hygiene over their other parental 
tasks and employment. It also depends on the child’s cooperation with the parent at the 
time of tooth brushing. Additionally, compliance depends on the taste of the product and 
ease of application. Children’s toothpastes are designed with a sweet taste and minimal 
foaming effect to address this concern. As compliance is often difficult, the use of a 
dentifrice containing antiseptic or remineralising agents is recommended for added 
benefit over brushing alone.  
 
Dentifrices are able to produce anti-bacterial effects throughout the oral cavity due to the 
foaming action of the dentifrice and don’t rely solely on the physical disturbance of the 
plaque. This is especially important in high caries risk children, whether due to poor diet, 
poor oral hygiene or developmental anomalies. Tooth brushing is taught from a young 
age so this is considered an easy and well-accepted method of fluoride application. In 
high caries risk children, tooth brushing alone may indeed reduce plaque and bacterial 
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levels, but not to a level low enough to prevent caries development, hence the necessity 
for an anti-caries agent such as fluoride. 
 
Another parameter to account for when prescribing a caries preventive agent is the 
physical limitations of the child. Children have a lower body mass and reduced 
awareness and control over their use of such chemicals. These factors result in greater 
side effects such as toxicity most commonly due to ingestion. In dentistry, the risk of 
fluorosis is of concern. Children with a high fluoride intake are at risk of fluorosis which 
can present as faint white lines or mottling in its milder form to brown staining or pitting 
with breakdown of the enamel in its more severe form.7 The benefits and risks must be 
carefully examined on a case to case basis as some high caries risk children gain great 
health benefits from the use of a topical fluoride agent of higher fluoride concentration. 
Furthermore, children must be closely supervised when using a high fluoride 
concentration product such as mouth rinse or toothpaste to reduce the chances of 
ingestion. This is especially pertinent when prescribing mouth rinses to small children. 
Mouth rinses have increased risk of ingestion as children are unaware of the adverse 
side effects from ingestion and are not adept at spitting out a liquid. One suggestion is 
that children learn the art of rinsing and spitting out with a safe liquid such as water or 
milk, prior to the use of a mouth rinse. Varnishes also offer additional caries preventive 
effects. Similar to tooth brushing, child compliance is of the utmost importance to allow 
application of the varnish, whether at home or in the dental chair. The decision to use a 
particular product should be made on a case by case basis weighing up the risks and 
benefits for that child. 
 
Fluoridated toothpaste is the gold standard in caries prevention with in-office varnishes 
and mouth rinses used for high risk patients.8 Fluoride has been shown to have greater 
anti-bacterial action with higher concentration so it can be recommended that children 
use small quantities of high fluoride concentration toothpaste.9, 10 In Australia, however, 
low dose fluoride toothpastes are commercially available as this lowers the risk of 
fluorosis in children. Although the primary mechanism of caries reduction by fluoride is 
remineralisation of early lesions and prevention of demineralisation, it is also often 
thought that caries reduction may additionally result from the anti-bacterial activity of 
fluoride.11 It is thus interesting to note from the results of the present study that NaF and 
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NaMFP in concentrations up to over nearly 10 times that found in toothpastes did not 
inhibit the growth of S. mutans, S. sanguinis or L. acidophilus.  
 
Clinically, the bioavailability of fluoride is of great importance.12 Bioavailability depends on 
the mode of application, the solubility of the fluoride compound and the adhesion of 
fluoride to the tooth surface. Sodium fluoride is highly soluble, so the fluoride ion is able 
to react with minerals readily to form calcium fluoride at the tooth's surface or fluorapatite 
within the enamel, and hence produce an enhanced anti-caries effect. Below the critical 
pH of 5.5, hydroxyapatite usually undergoes demineralisation. However, in the presence 
of fluoride, there is enhanced remineralisation through the formation of fluorapatite and a 
raised critical pH for demineralisation.13 Also at low pH and short exposure times, calcium 
fluoride compounds form on the tooth's surface which act as a fluoride reservoir and 
prevents demineralisation.13 This clearly explains fluorides increased interactions in lower 
pH environments. This intricate interaction between pH and fluoride may explain the 
findings in this study as it is in these low pH environments that fluoride is most able to 
bind to tooth surfaces or bacterial cells.14 For example, an in vitro study has shown that 
lower concentrations of fluoride (100 ppm versus 300 ppm) result in spontaneous 
precipitation of calcium fluoride at lower pH (pH 5.0 versus pH 7.2).15 This is further 
corroborated by Rolla who showed fluoride release from calcium fluoride to be pH 
dependent, with greater fluoride release at low pH, when it is most needed.16 Koch and 
coworkers compared the cariostatic effect of toothpaste with different fluoride 
concentrations and pH. 17 They observed that a toothpaste with 250 ppm F as NaF at pH 
5.5 reduced caries development to the same extent as a neutral 1000 ppm NaF. 
Similarly, Arnold and coworkers showed a dentifrice of amine fluoride at pH 4.5 to be 
more effective at remineralising enamel than a dentifrice of amine fluoride at pH 6.9.18 
This supports the hypothesis that fluoride is more active in low pH environments.  
 
It has also been shown that S. mutans is more sensitive to fluoride in low pH 
environments and that fluoride-resistant strains of S. mutans are less able to maintain 
acid production in the presence of fluoride.19, 20 For example, the glycolysis of a fluoride-
resistant mutant of S. salivarius was not affected by fluoride at pH 7.0, but was inhibited 
at pH 5.8.21 This is due to fluoride being able to bind specific enzymes and proteins to 
inhibit their actions to a greater extent in acidic environments.22 Furthermore, practically 
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all the free fluoride ions exist as HF.14 Due to the weak acid nature of HF, in acidic 
environments fluoride is able to cross the bacterial cell membrane and dissociate in the 
cytoplasm. F- acts as a metabolic inhibitor while H+ acidifies the cytoplasm, leading to 
cell death.22, 23 Interestingly, this predicts that if an organism does not lower the 
extracellular pH, then fluoride inhibition of glucose fermentation might not occur. These 
data support the conclusion that fluoride is able to better inhibit glycolysis under 
cariogenic conditions, ie in acidic environments.  
 
In this study, the agar diffusion assay was used with Meuller-Hinton agar as the medium 
for growth of S. mutans. Meuller-Hinton agar has a neutral pH of 7.2-7.4.24 At this pH, 
fluoride is less active, and less able to interfere with acid production and growth and 
proliferation of these bacteria. This may explain why NaF was ineffective at inhibiting the 
growth of S. mutans in this assay. It could, therefore, be reasonably expected that 
greater growth inhibition of S. mutans by NaF would occur in an acidic environment.  
 
By comparison, SnF2, found in several adult toothpaste formulations, did inhibit the 
growth of these bacteria, as expected.25, 26 This may be attributed to the tin ion. A study 
by Ferretti and coworkers showed SnF2 to be more bacteriostatic and bactericidal than 
NaF with a lower minimum inhibitory concentration and a reduced amount of soluble 
glucans and hence reduced bacterial binding to enamel.27 There was also a high level  of 
tin uptake by S. mutans treated with SnF2 suggesting increased inhibitory properties of 
the compound. This is further corroborated by Attramadal and Svatun who showed SnF2 
to have a strong anti-bacterial effect against S. mutans in mouth rinse and dentifrice 
formulations with up to 25% of the tin ion remaining in saliva for up to 4 hours post 
rinsing.28 Tinanoff and Camosci explored the effects of SnF2 on S. mutans using electron 
microscopy. They found an increase in tin on the bacterial cell walls as well as 
intracellularly.29 The tin on the cell walls was assumed to interrupt bacterial attachment to 
other bacteria and to tooth structure. Metal ions such as tin can affect growth, 
morphology and biochemical activity of microbes through the blocking of functional sites, 
inactivation of enzymes and disruption of cellular membrane integrity.30 Tin specifically, is 
known to be germicidal due to its ability to precipitate protein.30 It has been suggested 
that tin reduces DNA production by interfering with glycolytic enzymes, hence reducing 
cell viability.31  Intracellular tin is also metabolically disruptive so can alter cell 
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morphology leading to unbalanced growth.29 This is evident by the greater growth 
inhibition of S. mutans produced by SnF2 than NaF. However, these two agents have 
been shown to have comparable effects on acid production,31, 32 a property not tested in 
this study. 
 
In contrast to fluoride, the compound in toothpaste that was shown to have considerable 
anti-bacterial activity is the detergent/surfactant, SLS. In previous studies, SLS has been 
shown to reduce lactate production and extracellular polysaccharide formation by S. 
mutans.33 SLS also interferes with the adsorption of proteins to enamel, thus affecting the 
formation of the salivary pellicle.34 In the present study, SLS produced growth inhibition 
against all three bacteria tested. There was a minimum inhibitory concentration of 2500 
ppm against S. mutans and S. sanguinis and 500 ppm against L. acidophilus. Our results 
are thus in agreement with previous data which suggest that SLS can inhibit the growth 
of S. mutans, previously suggested to be closely related to the inhibition of enzymic 
activities of glucosyltransferases which are involved in glucan synthesis and caries 
initiation.35  
 
Law and Seow3 reported that a significant number of children infected with S. mutans did 
not show the presence of S. mutans after the commencement of tooth brushing with 
children’s toothpaste. Further extending these findings are the results of Plonka and 
coworkers2 which demonstrated that there were fewer mutans streptococci positive 
children in the group who had their teeth brushed twice daily with children’s toothpaste 
compared to the group who had less frequent tooth brushing. These findings are the end 
result of a complex interaction between the anti-mutans activity of SLS, the enhanced 
action of fluoride in a potentially low pH intraoral environment and the physical 
disturbance of plaque by tooth brushing. 
 
Another compound found in toothpaste that was tested in this study was triclosan. This 
biocide is known to exert broad-spectrum anti-bacterial activity against both Gram 
negative and Gram positive bacteria including S. mutans.36 Its main mode of action 
involves disruption of bacterial cytoplasmic membranes and blockade of fatty acid 
biosynthesis.37 It is most effective on plaque-free surfaces, which suggests that  it  
interferes with bacterial adhesion and growth.36 In the present study, triclosan showed a 
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minimum inhibitory concentration of 100 ppm on S. mutans and S. sanguinis, although it 
did not inhibit the growth of L. acidophilus at concentrations less than 8,000 ppm. Due to 
its poor water solubility and low retention in the oral cavity,38 triclosan is combined with a 
copolymer of polyvinylmethylether/ maleic acid (PVM/MA) for enhanced substantivity and 
efficacy in toothpastes.37, 39 In this study, the toothpastes containing triclosan (Colgate 
Total and Oral B Tooth and Gums) produced statistically greater growth inhibition on all 
three bacteria compared to the pure triclosan solutions tested, which is likely due to the 
presence of SLS. Furthermore, these two toothpastes produced the greatest growth 
inhibition against S. mutans and S. sanguinis compared to the other pastes. The 
inhibition was more pronounced in the two Streptococcal species compared to L. 
acidophilus, suggesting triclosan may have enhanced selective activity against 
Streptococcal bacteria. The present findings are substantiated by two review articles 
which report clinically significant improvements in plaque control and gingivitis following 
use of a triclosan-containing dentifrice.37, 39 
 
In the case of toothpastes containing triclosan and SLS, the growth of S. mutans and S. 
sanguinis were inhibited, probably due to the fact that both Streptococcal species have 
similar structural properties.40, 41 While most studies have reported that a reduced caries 
risk is associated with regular tooth brushing, whether this is due more to reduced 
numbers of cariogenic bacteria, disruption of biofilm, or remineralisation from fluoride is 
unclear. Furthermore, long-term effects such as changes in the relative proportions of 
microorganisms in the microbial biofilm, resulting from dentifrices, have not been well 
investigated.  
 
In this study, other compounds found in toothpastes were also assessed for possible 
inhibitory properties. These included xylitol and sorbitol, which are added to improve the 
taste of the pastes, polyethylene glycol, which is added as a humectant and sodium 
pyrophosphate which is added as an anti-tartar agent. The results did not show growth 
inhibition from xylitol and sorbitol with S. mutans, S. sanguinis and L. acidophilus, 
probably due to the fact that xylitol and sorbitol are metabolised minimally by these 
bacteria.42, 43  
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Although sodium pyrophosphate is added to toothpaste as a tartar control agent, some 
authors have proposed that sodium pyrophosphate can reduce bacterial adhesion to 
tooth surfaces resulting from the blocking of active protein sites on apatite crystals.44 The 
results from this study, however, suggest there is no direct growth inhibition of S. mutans, 
S. sanguinis and L. acidophilus from sodium pyrophosphate.  Similarly, there was no 
growth inhibition noted with polyethylene glycol (PEG), the humectant used in toothpaste. 
Although PEG has been shown to reduce bacterial adhesion to enamel surfaces through 
a high binding affinity for hydroxyapatite crystals,45, 46 interference with bacterial growth is 
not a known property of PEG.  
 
More recently, the use of oral antiseptics has been re-focussed as a strategy for caries 
prevention in young children. Recent systematic reviews have reported on the 
effectiveness of CHX,47  CPC 48 and EO 49 for reducing plaque and gingivitis in adult 
populations. In paediatrics, as in adult dentistry, oral antiseptics are applied mainly to 
reduce infections before and after oral surgical procedures as well as after oral trauma. In 
addition, oral antiseptics are used to reduce gingivitis and oral infections in high risk 
children such as those who are immunocompromised. 
 
Thus far, it is more common to prescribe children at high caries risk two separate 
products, such as a separate fluoride toothpaste and mouth rinse or additional in-office 
topical application of another agent such as chlorhexidine. This enables control of the 
concentration and quantity of product applied. Much data supports the use of a fluoride 
dentifrice and separate CHX or CPC mouth rinse.50-52  
 
Of the antiseptics tested in the present study, CHX showed the greatest activity against 
S. mutans and S. sanguinis. In the experiments using the pure compounds, at an 
extremely low concentration of 0.005%, CHX gave approximately the same amount of 
inhibition as 20% PI, 0.8% CPC and 2.0% NaOCl. There were no effects on L. 
acidophilus at this low concentration of CHX, although inhibitory effects were observed at 
doses of 0.01% and higher. In contrast, the other antiseptics tested produced greater 
inhibitory effects on L. acidophilus compared to that observed with S. mutans. The 
present results thus extend our teams previous clinical studies which reported that the 
percentage of 3-4 year-old children who eliminated MS from their mouths increased from 
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28% after three months to 48% after six months and over 70% after 12 months of a 0.2% 
CHX gel use.53 They also substantiate the results of Emilson and co-workers54 which 
showed that after 14 days of applying a 1% CHX gel, all 5 participants in the study 
eliminated S. mutans from their mouths. 
 
The inclusion of S. sanguinis and L. acidophilus in this study helps to demonstrate the 
comparative effectiveness of the antiseptics on other oral bacteria besides S. mutans. 
The results showed that at all concentrations, S. sanguinis was as susceptible as S. 
mutans to the inhibitory effects of CHX, and that L. acidophilus was also inhibited, 
although to a lesser extent compared to S. mutans. These observations thus suggest that 
there is a potential for the relative proportions of plaque to change after treatment with 
CHX. These findings regarding S. sanguinis are thus different to those reported in early 
clinical studies where S. sanguinis increased in proportion in plaque after treatment with 
CHX, whilst Lactobacillus levels were not affected.50, 54 These differences are most likely 
explained by the fact that the inhibitory effects on planktonic cells of S. sanguinis and 
Lactobacilli used in the present method are negated in the environment of the biofilm 
mass whereas those of S. mutans are not. 
 
For use in paediatric dentistry, CHX has been shown to be highly effective in reducing 
early childhood caries when applied in the form of a high concentration (40%) varnish 
delivered 6 monthly by professionals.55 On the other hand the present study showed that 
a concentration as low as 0.01% gave clear evidence of bacterial inhibition, suggesting 
that very low levels applied frequently (e.g. daily) may be equally effective. However, 
clinical trials conducted by our team showed that daily application of 0.12% CHX gel did 
not result in lower caries rates compared to controls, probably due to poor compliance of 
gel use associated with the unacceptable taste of the gel for young children.56 
 
By comparison, there is minimal evidence for the use of CPC in children as an anti-caries 
agent. Work by Pawha and coworkers57 demonstrated the clinical effectiveness of a 
commercially available 0.07% CPC mouth rinse at reducing the plaque index and 
bleeding scores in children and young adults (10-25 years old) undergoing fixed 
orthodontic appliance treatment. Further, use of a pre-surgical 0.05% CPC mouth rinse 
by children aged 10-15 years has shown efficacy at reducing both aerobic and anaerobic 
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microorganisms.58 Our results are in agreement with these data in that a 0.05% CPC-
containing mouth rinse (Cepacol) was effective in inhibiting growth of S. mutans, S. 
sanguinis and L. acidophilus.  
 
The bacterial growth inhibition shown by 0.05% pure CPC solution was slightly lower 
than that by the commercial product Cepacol containing 0.05% CPC, suggesting that the 
commercial product has additional inhibitory action, possibly related to the ethanol 
content or another component such as the surfactant. A study by Sreenivasan and 
coworkers59 has shown CPC-containing mouth rinses with alcohol to have a reduced 
minimal inhibitory concentration when inhibiting the growth of  S. mutans and Gram 
negative periodontal microorganisms compared to a CPC-containing mouth rinse without 
alcohol. Hence our results using a commercial CPC preparation containing alcohol 
provides an unfair comparison with the other non-alcohol containing antiseptic mouth 
rinses. Our results also revealed pure solutions of CPC to be effective at concentrations 
as low as 0.01%, suggesting that frequent application of CPC at low concentrations has 
potential for use in children. The use of CPC in gel or varnish form has thus far only been 
studied by combining CPC with zinc gluconate in a gel60, 61 or with acrylic resin in a 
varnish62 producing anti-calculus and anti-bacterial effects. Our finding that CPC is less 
effective than CHX at inhibiting bacterial growth, agrees with work by Nelson-Filho and 
coworkers63, which showed that a 0.05% CPC mouth rinse is effective at disinfecting 
toothbrushes used by preschool-aged children at day-care, although not to the extent of 
CHX.  
 
The NaF mouth rinse (Colgate Neutrafluor 220) was also found to be effective at 
inhibiting the growth of S. mutans, S. sanguinis and L. acidophilus. It contains NaF at a 
concentration of 0.05%, which has both strong remineralisation and bactericidal effects.11 
According to a Cochrane review, use of a fluoride mouth rinse as an adjunct to regular 
twice daily use of fluoride toothpaste has long been recommended to children of high 
caries rate with fluoride mouth rinses showing a clear reduction of caries in terms of 
decayed, missing and filled tooth surfaces.64 Fluoride containing mouth rinses in children 
can also reduce MS levels,65 but they are not recommended for children under 6 years of 
age due to the risk of fluoride toxicity from acute and chronic fluoride ingestion.8 Our 
results are in agreement with previous studies showing that a fluoride mouth rinse 
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(Neutrafluor 220) has growth inhibitory effects against S. mutans, S. sanguinis and L. 
acidophilus.  
 
As explained above, pure NaF solutions up to a concentration of 100,000 ppm were 
ineffective at inhibiting growth of S. mutans, S. sanguinis and L. acidophilus. Hence, in 
the present study, it is most likely that other compounds in the mouth rinse formulation 
enhanced the action of NaF or had anti-bacterial effects in their own right. For example, 
Neutrafluor 220 contains sodium benzoate, a common food preservative with known 
bacteriostatic properties.66, 67 Benzoate reduces biofilm thickness and bacterial vitality, 
though not to the extent of CHX. 66 However, benzoate has not been tested on oral 
bacteria, and was not tested as part of this study. 
 
PI is available in a mouth rinse formulation and as a topical chair-side treatment for 
children and adults. Tanzer et al68 (1977) achieved bactericidal effects on S. mutans 
using inorganic iodine at concentrations as low as 0.04% and showed the selective 
suppression of S. mutans versus S. sanguinis at these concentrations. In the present 
study, the compound PI (iodine with polyvinyl pyrrolidone) was used as it is commonly 
found as an antiseptic in medicine and dentistry. It has fewer of the problematic side 
effects compared to pure iodine (staining and mucosal irritation), while still being effective 
at altering biofilm formation.69 Our results show comparable inhibition of S. mutans and 
S. sanguinis, and thus do not agree with those reported by Tanzer and coworkers.68  
 
Previous studies have shown that in-chair topical application of 10% PI is effective at 
preventing white spot lesions in toddlers when applied every 2 months, even if the child is 
bottle feeding on cariogenic substrates at naptime.70, 71 Similarly, a once-only topical 
application of 10% PI followed by acidulated phosphate fluoride in children produced a 
prolonged decrease in MS and Lactobacillus levels over 3 months.72, 73 This approach did 
not, however, prevent new carious lesions from developing over the subsequent year 
post application, probably due to persistent cariogenic dietary factors and poor oral 
hygiene.72, 73 Research by Simratvir and coworkers74 showed that a 3-monthly topical 
application of 10% PI following dental restorative treatment can reduce S. mutans levels 
and prevent further occurrence of caries. Our present results are in agreement with the 
above studies showing PI at concentrations of 10% and higher can inhibit the growth of 
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S. mutans, S. sanguinis and L. acidophilus. Our results also extend previous studies by 
showing that a mouth rinse containing 0.1% PI (Betadine) is ineffective at inhibiting the 
growth of S. mutans and S. sanguinis.  
 
Mouth rinses containing EO are found in the market and one of the leading brands is 
Listerine. This commercial product was tested and produced the greatest inhibition on L. 
acidophilus of all mouth rinses tested. On testing the four principal active agents in pure 
form dissolved in buffer, none of the four agents (menthol, thymol, methyl salicylate and 
eucalyptol) was effective at inhibiting the growth of S. mutans, S. sanguinis and L. 
acidophilus. The test concentration of 0.1% was a higher concentration than that found in 
Listerine, however, there was no surfactant used in the present study, so the bio-
availability of these agents would be limited. We avoided the use of a surfactant to 
dissolve the active agents as the surfactant would have itself exerted anti-bacterial 
effects. The bactericidal properties of EO have been attributed to their ability to effectively 
permeate through established plaque leading to inhibition of enzymes.75 Moreover, the 
combination of the actives is thought to be synergistic, and this was not tested in the 
present study. However, conflicting data exists in respect to Listerine's anti-plaque 
efficacy. Several studies have shown beneficial effects of EO mouth rinses such as 
significantly reducing total plaque bacterial counts,76, 77 reducing MS levels in 
teenagers,78 and improving plaque and bleeding scores in orthodontic patients79, 80 while 
another study has shown negligible anti-bacterial effects.81 In the assay system used, the 
zero ethanol Listerine Zero mouth rinse was ineffective at inhibiting bacterial growth. 
However, we did not test the ability of the rinse or its components to permeate plaque, a 
key bactericidal property of EO. Our present results suggest that EO do not figure 
dominantly for prevention of caries in high risk children. 
 
NaOCl is commonly used as a disinfectant for cleaning baby products such as bottles 
and pacifiers. Disinfecting objects shared between mother and child, such as bottles, 
cutlery and toothbrushes, with a strong disinfectant is a possible mechanism for reducing 
the vertical transmission of oral cariogenic bacteria from mother to child. NaOCl has also 
been suggested as a disinfectant for toothbrushes with promising results for MS 
reduction.82, 83 NaOCl is not commonly used as a mouth rinse due to its poor palatability; 
however, recent studies are reviewing its use for treating adult periodontal disease as 
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evidence shows it can improve plaque and bleeding scores at concentrations as low as 
0.05%.84, 85  
 
Our present results disagree with previous results as we found that pure NaOCl at 
concentrations below 2% gave no bacterial inhibition. In the present study, 2% NaOCl in 
the form of commercial Milton’s solution was ineffective against S. mutans and S. 
sanguinis; however pure NaOCl at 2% concentration produced growth inhibition of both 
S. mutans and S. sanguinis. Similarly, Milton produced less growth inhibition against L. 
acidophilus compared to a pure 2% NaOCl solution. These results suggest that Milton 
rinse is less effective compared to pure NaOCl at inhibiting bacterial growth. This could 
be due to antagonistic effects with other agents within the formulation which were not 
investigated in this study or the solution reaching its expiry date, and thus having a 
diminished anti-bacterial activity. 
 
In high caries risk children, another alternative to a high fluoride product is using 
combinations of agents that are low in individual concentrations, ideally with synergistic 
anti-bacterial effects. For reasons of safety, the lowest effective concentrations of agents 
that can be combined with fluoride compounds should be considered for pediatric use. 
The advantages of combinations with synergistic or additive effects are greater anti-
caries and/or anti-plaque effects compared to the individual compounds, whilst reducing 
dose and therefore enhancing safety. Such strategies for boosting the efficacy and safety 
of medications are used commonly in medicine and dentistry. For example, the staining 
and mucosal irritation of pure iodine is reduced by combining iodine with polyvinyl 
pyrrolidone. 69 However, in contrast to synergistic and additive effects which are usually 
beneficial, some combinations of antiseptics can result in interference and reduced 
efficacy .86 The results of the present study show that a range of interference issues can 
occur (Table 7). Minimal evidence exists for combinations of antiseptics such as CPC, PI, 
CHX or NaOCl so these compounds were tested in all combinations, including with NaF. 
As a detergent commonly found in fluoride dentifrices, SLS was also included as it has 
already been shown to have growth inhibitory effects. 
 
The results of the present study provide additional support to the notion that PI can form 
part of a caries preventive program. To date, PI has been used in children for 
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professional topical applications for control of early childhood caries. The combined use 
of topical polyvinyl-pyrrolidone-iodine and fluoride varnish can result in more caries-free 
first permanent molars in children aged 5 to 7 years compared to fluoride varnish alone.87 
Another study by the same research group concluded that a combination of 10% PI and 
5% NaF in a varnish reduced the rate of new carious lesions by 31% over a fluoride 
varnish alone in children aged 1 to 3 years.88 Initially in this study, 10% PI was combined 
with 0.1% NaF which produced comparable results to PI alone for all three bacteria. PI 
and NaF were then combined at concentrations well below those at which the individual 
compounds are normally used. This produced additive anti-bacterial effects against S. 
mutans and S. sanguinis, in agreement with previous studies. Such low dose 
combinations could have promise for safe use in small children and infants.  
 
Also of interest, NaOCl in combination with PI produced additive anti-bacterial effects 
against L. acidophilus. This combination has not been tested previously as these agents 
are not commonly used together and NaOCl is only in the early stages of testing for anti-
plaque effects.84, 85 Despite this additive effect against L. acidophilus, caution must be 
used as there was interference between these agents when tested against S. mutans. 
 
Overall, of the numerous combinations tested, few produced useful additive anti-bacterial 
effects over and above those seen from the individual compounds. In most cases, growth 
inhibition was comparable to the more effective individual compound within the pair used. 
For example, NaF and CHX produced anti-S. mutans effects that were comparable to 
pure CHX, but greater than that found for NaF alone. These results agree with previous 
data where varnish and gel formulations showed a useful reduction of S. mutans levels 
and increased enamel mineral density.89-91  
 
 In fact, many combinations tested showed interference and reduced efficacy. The results 
of the present study show that if chlorhexidine (0.01%) is combined with sodium lauryl 
sulfate (0.25%) or sodium hypochlorite (0.5%) with povidone iodine (10%), or cetyl 
pyridinium chloride (0.01%) with sodium fluoride (0.1%), the inhibitory activities against S. 
mutans and S. sanguinis of the primary compounds will be reduced. These agents are, 
therefore, not ideal for use in a single anti-bacterial product. 
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CPC combined with NaF is one such combination that showed interference against both 
S. mutans and S. sanguinis. This is in agreement with the known interactions of this 
molecule with several studies showing antagonism between fluoride toothpaste and CPC 
mouth rinse use.92, 93 
 
Similarly, it is well known that toothpastes containing SLS can impair the antimicrobial 
effects and substantivity of CHX due to formation of an insoluble salt following the 
reaction between CHX (a cation) and SLS (an anion).94 One clinical investigation has 
showed that rinsing with a 1.5% SLS slurry prior to using a 0.2% CHX rinse reduced the 
anti-plaque efficacy of the CHX. 95 The results of the present study are in agreement with 
these findings as SLS interfered with the anti-bacterial properties of CHX against both S. 
mutans and S. sanguinis . 
 
The current results also show differences in the responses of individual bacterial species. 
L. acidophilus was inhibited by all the combinations tested, whereas S. mutans and S. 
sanguinis were inhibited by most but not all combinations. The comparable effects 
observed with S. mutans and S. sanguinis likely reflect the fact that the two Streptococcal 
species have general similar cell wall structural properties.41 On the other hand, the 
combinations of CPC + PI and PI +SLS elicited interference on S. sanguinis but not on S. 
mutans, suggesting that some differences exist between these bacteria that can lead to 
different responses with different combinations of antiseptics.96, 97 Similarly, cell wall and 
metabolic differences between the streptococci and lactobacilli can cause differences in 
responses of the bacteria.98, 99 Although the exact roles of these bacteria in the caries 
process are not clear, it is generally thought that S. mutans is actively involved in the 
caries process while lactobacilli are likely to be secondary invaders.100, 101 S. sanguinis, 
on the other hand is thought to exist in competition with S. mutans in the dental biofilm, 
and children with caries have less S. sanguinis and more S. mutans while the reverse is 
true for children without caries.102, 103  
 
Based on these concepts, the combinations of antiseptics that selectively inhibit S. 
mutans, but not S. sanguinis nor lactobacilli would be desirable for removal of S. mutans 
without affecting other plaque bacteria. The combination CPC+ PI meets this criteria as it 
interfered with the inhibition of S. sanguinis and L. acidophilus without affecting the 
184 
 
inhibitory effects on S. mutans of the individual compounds. In contrast, the combination 
of PI + SLS, while it interferes with inhibition of S. sanguinis, does not alter the inhibition 
of L. acidophilus by the individual compounds.  
 
Although this study is limited by the testing of single bacterial cultures under neutral pH 
conditions rather than in complex biofilms under varying pH conditions, the results add to 
the understanding of the antimicrobial effects of the test compounds individually and in 
combinations.86 The present results do not, however, indicate the clinical effectiveness of 
the agents.86 This is due to the nature of the plaque biofilm and the protection provided 
by the extracellular matrix which elevates the minimum inhibitory concentrations required 
for testing biofilms versus planktonic cells.86 Furthermore, saliva plays an important role 
in the dilution and clearance of compounds from the oral cavity, and it may interact with 
antiseptic agents.86 Saliva also affects the diffusivity of the agents, reducing the 
concentration of agents and hence their inhibitory effects. In the agar diffusion system, 
the dentifrices likely reacted differently to the individual compounds in solution due to 
their differences in ability to diffuse across the agar system. Once again, this is not a 
good representation of the intraoral interactions of these compounds. Hence, clinical 
trials are necessary to elucidate further the interactions between the antiseptic 
compounds, saliva and the bacterial biofilm.  
 
A further and final point is that the agar diffusion method employed in this study 
measured only the growth inhibition of the bacteria under neutral pH conditions. It is 
possible that the individual compounds and combinations tested could possess other 
mechanisms of anti-bacterial activity at neutral or at other pH values such as interference 
with adherence to the tooth surface or to other bacteria which could not be investigated in 
the present assay system. For example, fluoride reduces caries largely through 
remineralisation mechanisms rather than anti-bacterial activity. The ability for fluoride to 
promote remineralisation may in fact be more important for disease control than its anti-
bacterial effects. As such, these results should be analysed cautiously, taking into 
account this study's limitations. On the other hand, inhibiting the growth of S. mutans in 
young children during the early stages of colonisation may prevent its long term 
establishment in the oral cavity. To this end, tooth brushing with paste containing 
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compounds with anti-S. mutans activity can contribute to the prevention of early 
childhood caries.  
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Recommendations for future research 
This research has isolated several compounds and combinations of compounds that 
have growth inhibitory effects against both mutans and non-mutans bacteria. The pure 
agents chlorhexidine, triclosan and sodium lauryl sulphate, are already available on the 
market in toothpaste and mouth rinse formulations. However, this research has shown 
that lower concentrations of these compounds can have significant bacterial growth 
inhibitory effects. As such, further research should be undertaken to find a formulation 
with low concentration of active ingredients with maximal inhibitory effect.  
Also of note, the agents tested have other modes of action besides the ability to 
inhibit bacterial growth. For example, chlorhexidine at high concentrations is bactericidal 
causing direct cellular effects through precipitation of intracellular cytoplasm and 
impeding the action of glucosyltransferase thus preventing adhesion of bacteria to the 
tooth’s surface. Further testing of these other modes of action should be undertaken to 
determine the minimum concentration required to create such effects. The formulation of 
a product suitable for children requires the balancing of a low concentration active agent 
while maximising the anti-bacterial effects.  
The combinations found to have additive growth inhibitory effects were povidone 
iodine with sodium fluoride and cetyl pyridinium chloride with sodium lauryl sulphate. 
Initial in vitro testing of experimental products containing povidone iodine with sodium 
fluoride has been undertaken but further testing in other formulations is required. In vitro 
studies of products containing both cetyl pyridinium chloride and sodium lauryl sulphate 
in a single agent has not been undertaken and requires further research. It must also be 
determined that the active ingredients are compatible with the abrasive system or 
surfactant in the paste or rinse formulation. 
Following the in vitro testing of these agents and combinations of compounds, clinical 
trials are required to determine the effect of these agents on a variable plaque mass, 
comparing the effects on salivary versus plaque bacteria and taking into account patient 
compliance. These agents show great promise for use by children due to their growth 
inhibitory effects at low concentrations. With further research, a new low concentration 
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formulation may be produced which is suitable for the prevention of early childhood 
caries.  
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Conclusions 
In conclusion, this research showed that children's toothpaste can inhibit the growth of 
both mutans and non-mutans bacteria, although the inhibition is comparatively lower 
compared to standard toothpastes containing 1450 ppm F. Pure sodium fluoride and 
sodium monofluorophosphate did not produce growth inhibitory effects against S. 
mutans, S. sanguinis or L. acidophilus. Further testing of compounds within the 
toothpaste formulations revealed sodium lauryl sulphate and triclosan at concentrations 
found in toothpastes inhibited bacterial growth. Other common components of 
toothpaste, such as polyethylene glycol and pyrophosphate at concentrations as high as 
8000 ppm, did not show bacterial growth inhibitory effects.  
Common antiseptics at low concentrations have potential to inhibit the growth of 
cariogenic bacteria. Of the agents tested, chlorhexidine produced the greatest growth 
inhibition against S. mutans, S. sanguinis and L. acidophilus at the lowest concentration.  
Various combinations of antiseptics and sodium fluoride solutions at low 
concentrations have potential to decrease numbers of cariogenic bacteria and may be 
suitable as an adjunct agent for reducing risk for early childhood caries. Of the agents 
tested, povidone iodine with sodium hypochlorite produces additive growth inhibition 
against L. acidophilus while povidone iodine with sodium fluoride produced synergistic 
growth inhibition against S. mutans and S. sanguinis.  
These compounds isolated as having growth inhibitory effects against mutans 
bacteria may be suitable for use by children, especially those at high risk for early 
childhood caries. Further testing of these compounds at low concentrations in vitro and in 
clinical settings is necessary to determine if combinations of these agents may be 
suitable for use in children.  
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